Independent reporting on medical research: what the evidence actually shows.https://thefirstcohort.com/https://thefirstcohort.com/articles/2026-10-17-the-pac-man-enzyme-that-eats-bioplastic-also-breaks-down-penicillinhttps://thefirstcohort.com/articles/2026-10-17-the-pac-man-enzyme-that-eats-bioplastic-also-breaks-down-penicillinKonstanz researchers pulled an enzyme from forest soil that digests an experimental bioplastic and also cuts open penicillin. The press release says every bioplastic completely degraded. The paper's carbon numbers and the intact buried films say otherwise, and nobody put the gene in a living bacteriSat, 17 Oct 2026 00:00:00 GMTinfectious-diseaseenvironmental-healthinfectious-diseaseantibiotic-resistancepreclinicalSarah Okonkwohttps://thefirstcohort.com/articles/2026-10-17-novartis-halted-eight-autoimmune-car-t-trials-after-three-deaths-then-called-thehttps://thefirstcohort.com/articles/2026-10-17-novartis-halted-eight-autoimmune-car-t-trials-after-three-deaths-then-called-theThree people in Novartis's rap-cel trials died after a runaway inflammatory syndrome, and Bristol Myers froze enrollment in its rival product. Faster manufacturing is the leading suspect, and no public report yet says how many patients got the drug.Sat, 17 Oct 2026 00:00:00 GMTautoimmune-inflammationautoimmuneimmunotherapydrug-safetyclinical-trialsSarah Okonkwohttps://thefirstcohort.com/articles/2026-10-17-merck-and-moderna-say-their-melanoma-vaccine-worked-but-two-months-on-the-publichttps://thefirstcohort.com/articles/2026-10-17-merck-and-moderna-say-their-melanoma-vaccine-worked-but-two-months-on-the-publicMerck and Moderna have announced only that their phase 3 met its endpoints. The smaller trial behind the excitement missed the conventional two-sided significance bar, and one bank has modeled a price as high as $475,000 per patient.Sat, 17 Oct 2026 00:00:00 GMTcancercancermrnadrug-pricingclinical-trialsMarcus Chenhttps://thefirstcohort.com/articles/2026-10-17-men-who-iced-after-lifting-gained-a-third-of-the-thigh-muscle-their-peers-didhttps://thefirstcohort.com/articles/2026-10-17-men-who-iced-after-lifting-gained-a-third-of-the-thigh-muscle-their-peers-didTwelve weeks of cold water after leg day left men with 103 grams of new quadriceps muscle against 309 for those who cycled, and most of the recovery aisle is sold on soreness, not gains.Sat, 17 Oct 2026 00:00:00 GMTnutrition-foodexercisesupplementsinflammationconflict-of-interestSarah Okonkwohttps://thefirstcohort.com/articles/2026-10-17-after-30-hours-awake-a-20-minute-bike-ride-saved-about-as-much-memory-as-a-90-mihttps://thefirstcohort.com/articles/2026-10-17-after-30-hours-awake-a-20-minute-bike-ride-saved-about-as-much-memory-as-a-90-miSleepless volunteers who cycled for 20 minutes recognized nearly as many photos three days later as those given a 90-minute nap, even though the ride left their fatigue markers right where they were.Sat, 17 Oct 2026 00:00:00 GMTbrain-agingexercisecognitionneurosciencesleepMarcus Chenhttps://thefirstcohort.com/articles/2026-10-16-your-country-s-estimated-heat-death-toll-depends-on-which-heat-metric-the-modelehttps://thefirstcohort.com/articles/2026-10-16-your-country-s-estimated-heat-death-toll-depends-on-which-heat-metric-the-modeleJapan recorded 1,522 heatstroke deaths in 2020. One model called that unusually high; a better-fitting one put it inside the expected range. Europe's estimated heat tolls bend to the same kind of choice.Fri, 16 Oct 2026 00:00:00 GMTinvestigationsenvironmental-healthpublic-healthagingresearch-integritySarah Okonkwohttps://thefirstcohort.com/articles/2026-10-16-under-propofol-the-hippocampus-still-sorts-nouns-from-verbs-and-leans-toward-thehttps://thefirstcohort.com/articles/2026-10-16-under-propofol-the-hippocampus-still-sorts-nouns-from-verbs-and-leans-toward-theRecordings from 651 neurons in seven anesthetized patients show the hippocampus learning tones and tracking word meaning, and a German trial suggests that what reaches those ears can change how much opioid a patient needs afterward.Fri, 16 Oct 2026 00:00:00 GMTbrain-agingneurosciencecognitionanesthesiaSarah Okonkwohttps://thefirstcohort.com/articles/2026-10-16-kennedy-s-peptide-plan-reaches-the-white-house-and-wall-street-is-already-countihttps://thefirstcohort.com/articles/2026-10-16-kennedy-s-peptide-plan-reaches-the-white-house-and-wall-street-is-already-countiPeptides already sell on a Queens bodega shelf, so moving them into licensed pharmacies is progress. Whether it protects anyone depends on one missing rule: test each lot and report every injury.Fri, 16 Oct 2026 00:00:00 GMTdrugs-fdafdadrug-safetyconflict-of-interestregulationMarcus Chenhttps://thefirstcohort.com/articles/2026-10-16-gensight-s-blindness-gene-therapy-reached-the-nejm-on-the-same-day-it-reported-0https://thefirstcohort.com/articles/2026-10-16-gensight-s-blindness-gene-therapy-reached-the-nejm-on-the-same-day-it-reported-0Seven of ten patients blinded by retinitis pigmentosa sensed more light through special goggles after one gene injection, in an uncontrolled trial whose sponsor held €0.7 million on September 30 and warned it may not survive the year.Fri, 16 Oct 2026 00:00:00 GMTdrugs-fdagene-therapyclinical-trialsrare-diseasepharmaLena Marshallhttps://thefirstcohort.com/articles/2026-10-16-eating-after-dinner-tracked-with-more-fatty-liver-and-cirrhosis-in-nearly-200-00https://thefirstcohort.com/articles/2026-10-16-eating-after-dinner-tracked-with-more-fatty-liver-and-cirrhosis-in-nearly-200-00Across nearly 200,000 nurses and health professionals, eating after dinner or bedtime tracked with 20 to 30 percent more fatty liver disease and cirrhosis. Nobody can patent a closed kitchen.Fri, 16 Oct 2026 00:00:00 GMTmetabolic-weightmetabolic-healthnutritionmetabolismSarah Okonkwohttps://thefirstcohort.com/articles/2026-10-15-when-the-shocks-stopped-people-with-insomnia-got-more-aroused-not-lesshttps://thefirstcohort.com/articles/2026-10-15-when-the-shocks-stopped-people-with-insomnia-got-more-aroused-not-lessIn a third analysis of the same Boston volunteers, people with insomnia grew more aroused once the shocks stopped. The signal showed up only after engineers modeled the slow background sweat, and the next-day test missed significance.Thu, 15 Oct 2026 00:00:00 GMTbrain-agingmental-healthneurosciencemedical-researchsleepMarcus Chenhttps://thefirstcohort.com/articles/2026-10-15-novo-nordisk-paid-to-count-the-inflamed-heart-failure-patients-its-antibody-is-chttps://thefirstcohort.com/articles/2026-10-15-novo-nordisk-paid-to-count-the-inflamed-heart-failure-patients-its-antibody-is-cThree big studies putting heart failure inflammation anywhere from 38% to more than half were funded by Novo Nordisk, whose IL-6 antibody missed its first outcomes trial in July. Their predictor tables point at fat, smoking and kidneys.Thu, 15 Oct 2026 00:00:00 GMTautoimmune-inflammationinflammationcardiovascularconflict-of-interestpharmaSarah Okonkwohttps://thefirstcohort.com/articles/2026-10-15-knee-pain-fell-from-7-to-3-after-this-artery-procedure-but-it-keeps-struggling-thttps://thefirstcohort.com/articles/2026-10-15-knee-pain-fell-from-7-to-3-after-this-artery-procedure-but-it-keeps-struggling-tBerlin doctors plugged inflamed knee vessels with gelatin beads built to dissolve within hours, and median pain fell from 7 to 3 over a year. Nobody got a sham, and the Rotterdam trial that used one calls the effect mainly placebo.Thu, 15 Oct 2026 00:00:00 GMTautoimmune-inflammationosteoarthritismedical-devicesinflammationclinical-trialsSarah Okonkwohttps://thefirstcohort.com/articles/2026-10-15-in-lab-tests-the-alzheimer-s-fragment-labeled-non-amyloidogenic-builds-amyloid-fhttps://thefirstcohort.com/articles/2026-10-15-in-lab-tests-the-alzheimer-s-fragment-labeled-non-amyloidogenic-builds-amyloid-fFor decades the alpha pathway was billed as the safe way to cut the Alzheimer's precursor protein. Its leftover fragment, p3, builds fibrils in less than half the time amyloid beta needs in lab tests, forms ring-shaped pores, and turns up in plaques where a common antibody stain can't tell the two aThu, 15 Oct 2026 00:00:00 GMTbrain-agingalzheimersneurodegenerationpreclinicaldrug-developmentSarah Okonkwohttps://thefirstcohort.com/articles/2026-10-15-fda-s-anktiva-approval-for-papillary-only-bladder-cancer-cites-no-papillary-onlyhttps://thefirstcohort.com/articles/2026-10-15-fda-s-anktiva-approval-for-papillary-only-bladder-cancer-cites-no-papillary-onlySeventeen months after refusing even to review ImmunityBio's application, the FDA expanded Anktiva's label by extrapolating from carcinoma in situ, and its announcement never mentioned the 80 papillary-only patients the company had actually studied.Thu, 15 Oct 2026 00:00:00 GMTdrugs-fdafdacancerimmunotherapyregulationLena Marshallhttps://thefirstcohort.com/articles/2026-10-14-same-calories-on-paper-116-fewer-absorbed-what-your-gut-microbes-do-with-a-wholehttps://thefirstcohort.com/articles/2026-10-14-same-calories-on-paper-116-fewer-absorbed-what-your-gut-microbes-do-with-a-wholeOn calorie-matched menus, 17 adults absorbed about 116 fewer calories a day eating whole foods than eating processed ones, with no measurable rise in hunger, and the century-old Atwater arithmetic undercounted the processed plate.Wed, 14 Oct 2026 00:00:00 GMTnutrition-foodgut-microbiomenutritionmetabolismobesitySarah Okonkwohttps://thefirstcohort.com/articles/2026-10-14-physics-of-fluids-sent-a-postdoc-s-name-to-the-authors-whose-algebra-he-flaggedhttps://thefirstcohort.com/articles/2026-10-14-physics-of-fluids-sent-a-postdoc-s-name-to-the-authors-whose-algebra-he-flaggedAIP Publishing tells its editors to protect the anonymity of anyone raising a concern. Physics of Fluids sent a postdoc's name, institution and rank to the authors he challenged, and 8 referees later found nothing to defend in their paper.Wed, 14 Oct 2026 00:00:00 GMTinvestigationsresearch-integrityaccountabilityresearch-retractionspublic-trustMira Petrovhttps://thefirstcohort.com/articles/2026-10-14-feeling-fine-in-pregnancy-was-no-shield-against-dirty-air-s-link-to-postpartum-dhttps://thefirstcohort.com/articles/2026-10-14-feeling-fine-in-pregnancy-was-no-shield-against-dirty-air-s-link-to-postpartum-dAmong 475 Mexico City mothers, each 5 microgram per cubic meter rise in fine-particle pollution during pregnancy tracked with 2.67 times the risk of depression symptoms that first appeared after birth. The link was stronger in women who reported little stress.Wed, 14 Oct 2026 00:00:00 GMTbrain-agingair-pollutionmental-healthpregnancywomens-healthSarah Okonkwohttps://thefirstcohort.com/articles/2026-10-14-cancer-wasting-was-hiding-in-two-million-routine-weigh-inshttps://thefirstcohort.com/articles/2026-10-14-cancer-wasting-was-hiding-in-two-million-routine-weigh-insAt Memorial Sloan Kettering, 48.8% of 59,493 tumor-sequenced cancer patients had at least one cachectic weight-loss episode over about five years. No drug is approved for it, and a French hospital coded it in under 1% of its cancer patients.Wed, 14 Oct 2026 00:00:00 GMTcancercancernutritiondrug-developmentgeneticsLena Marshallhttps://thefirstcohort.com/articles/2026-10-14-a-week-of-immunology-a-shared-hotel-and-a-transformative-claim-with-no-alumni-cohttps://thefirstcohort.com/articles/2026-10-14-a-week-of-immunology-a-shared-hotel-and-a-transformative-claim-with-no-alumni-coNine IUIS educators call their one-week immunology courses in low- and middle-income countries transformative. Their 2022 guidelines say the committee's budget partly funds 3 courses a year, and the program's 2019 self-assessment measured enjoyment and quiz scores, not careers.Wed, 14 Oct 2026 00:00:00 GMTinfectious-diseaseimmunologyinfectious-diseasepublic-healthSarah Okonkwohttps://thefirstcohort.com/articles/2026-10-14-a-heart-failure-implant-won-by-40-points-on-a-questionnaire-filled-out-by-patienhttps://thefirstcohort.com/articles/2026-10-14-a-heart-failure-implant-won-by-40-points-on-a-questionnaire-filled-out-by-patienPatients given Berlin Heals' microcurrent implant reported quality-of-life gains eight times the control arm's in an open-label trial. The blood marker and exercise test that could have backed them up showed no significant difference, and the company paid for the study.Wed, 14 Oct 2026 00:00:00 GMTdrugs-fdamedical-devicescardiovascularclinical-trialsconflict-of-interestLena Marshallhttps://thefirstcohort.com/articles/2026-10-13-the-self-destruct-fat-shot-billed-as-obesity-medicine-faces-its-pivotal-trial-behttps://thefirstcohort.com/articles/2026-10-13-the-self-destruct-fat-shot-billed-as-obesity-medicine-faces-its-pivotal-trial-beCaliway's CBL-514 shrank belly fat in small trials and drew obesity headlines at EASD, but its phase 3 caps enrollment below a BMI of 30 and grades flatter stomachs, not weight.Tue, 13 Oct 2026 00:00:00 GMTmetabolic-weightobesityglp-1drug-developmentclinical-trialsSarah Okonkwohttps://thefirstcohort.com/articles/2026-10-13-in-cancer-alley-the-most-polluted-air-came-with-more-than-four-times-the-odds-ofhttps://thefirstcohort.com/articles/2026-10-13-in-cancer-alley-the-most-polluted-air-came-with-more-than-four-times-the-odds-ofAmong Louisiana mothers without private insurance, the heaviest modeled industrial air toxics tracked with 4.29 times the odds of a baby born with a heart defect. The scientist who led the work says Tulane gagged her pollution research.Tue, 13 Oct 2026 00:00:00 GMTinvestigationsenvironmental-healthair-pollutionpregnancycardiovascularSarah Okonkwohttps://thefirstcohort.com/articles/2026-10-13-in-a-toronto-husky-study-owners-moved-first-more-than-twice-as-often-as-their-dohttps://thefirstcohort.com/articles/2026-10-13-in-a-toronto-husky-study-owners-moved-first-more-than-twice-as-often-as-their-doEarlier sensor studies had the dog moving and the owner following. Among 22 synchronized Toronto owner-dog pairs, the human led in 10 and the dog in 4, and bedsharing showed no significant link to owners' measured sleep.Tue, 13 Oct 2026 00:00:00 GMTbrain-agingsleepmedical-researchpublic-healthMarcus Chenhttps://thefirstcohort.com/articles/2026-10-13-forget-you-ate-lunch-and-you-ll-eat-another-one-your-memory-center-helps-run-youhttps://thefirstcohort.com/articles/2026-10-13-forget-you-ate-lunch-and-you-ll-eat-another-one-your-memory-center-helps-run-youTwo amnesic patients ate a second full lunch minutes after the first. Rats with silenced meal-memory neurons came back to eat sooner. In healthy young adults, one week of waffles and fast food dulled both word recall and the normal drop in food craving after a full breakfast.Tue, 13 Oct 2026 00:00:00 GMTnutrition-foodneurosciencenutritioncognitiongut-microbiomeSarah Okonkwohttps://thefirstcohort.com/articles/2026-10-13-d-serine-helped-old-mice-in-the-maze-and-did-nothing-for-their-skin-or-boneshttps://thefirstcohort.com/articles/2026-10-13-d-serine-helped-old-mice-in-the-maze-and-did-nothing-for-their-skin-or-bonesRestoring the protein menin in one patch of hypothalamus gave 20-month-old mice thicker skin, more bone and better learning. D-serine, the amino acid now in the headline, improved only the learning, and the one trial in healthy older adults that both news stories cite gave each person a single doseTue, 13 Oct 2026 00:00:00 GMTbrain-agingbrain-agingsupplementspreclinicalcognitive-declineSarah Okonkwohttps://thefirstcohort.com/articles/2026-10-12-the-heartmate-3-won-its-market-on-a-low-stroke-count-the-neurologic-events-it-lehttps://thefirstcohort.com/articles/2026-10-12-the-heartmate-3-won-its-market-on-a-low-stroke-count-the-neurologic-events-it-leEight percent of HeartMate 3 patients have a stroke. Another 8 percent have a seizure, a transient ischemic attack, or a brain bleed its headline safety score never tallied, and two-year survival in those patients runs as low as 45 percent.Mon, 12 Oct 2026 00:00:00 GMTinvestigationsmedical-devicesheart-failurestrokepatient-safetySarah Okonkwohttps://thefirstcohort.com/articles/2026-10-12-the-gut-lining-was-supposed-to-be-plumbing-a-500-000-cell-atlas-caught-it-fightihttps://thefirstcohort.com/articles/2026-10-12-the-gut-lining-was-supposed-to-be-plumbing-a-500-000-cell-atlas-caught-it-fightiSix microbes, six different reprogrammings of the intestinal lining, including a cell state that appears only during one bacterial infection and concentrates inside the lesions that bug builds.Mon, 12 Oct 2026 00:00:00 GMTinfectious-diseasemicrobiomegut-healthimmunologyinfectious-diseaseSarah Okonkwohttps://thefirstcohort.com/articles/2026-10-12-the-eye-s-hidden-cleanup-system-has-so-far-been-mapped-only-in-micehttps://thefirstcohort.com/articles/2026-10-12-the-eye-s-hidden-cleanup-system-has-so-far-been-mapped-only-in-miceToronto and UBC researchers traced a tracer from the back of a mouse eye to the neck in 20 minutes. The coverage aimed it at glaucoma patients. Nobody has looked for the pathway in a human eye yet, and a space agency helped pay for the work.Mon, 12 Oct 2026 00:00:00 GMTbrain-agingglaucomamacular-degenerationvisionanimal-studyLena Marshallhttps://thefirstcohort.com/articles/2026-10-12-terence-tao-fears-a-cancer-cure-nobody-can-explain-the-fda-clears-cancer-drugs-thttps://thefirstcohort.com/articles/2026-10-12-terence-tao-fears-a-cancer-cure-nobody-can-explain-the-fda-clears-cancer-drugs-tTerence Tao says he would want a human expert to understand an AI cancer cure before taking it. The oncologist Vinay Prasad says that misses how medicine already works, and the receipts show the cancer drugs worth fearing are the legible ones approved on a shrinking tumor that never proved they helpMon, 12 Oct 2026 00:00:00 GMTdrugs-fdafdacancerclinical-trialsdrug-approvalsLena Marshallhttps://thefirstcohort.com/articles/2026-10-12-sugar-on-the-hospital-tray-tracked-with-deeper-antibiotic-damage-to-the-guthttps://thefirstcohort.com/articles/2026-10-12-sugar-on-the-hospital-tray-tracked-with-deeper-antibiotic-damage-to-the-gutAmong 173 transplant patients on antibiotics, each extra 100 grams of sugar went with 24 percent lower gut diversity, and the nutrition shakes hospitals often recommend appeared to do the most harm.Mon, 12 Oct 2026 00:00:00 GMTnutrition-foodmicrobiomeantibioticsnutritiongut-healthLena Marshallhttps://thefirstcohort.com/articles/2026-10-12-keto-raised-tumor-counts-in-one-stretch-of-mouse-gut-and-cut-them-in-the-next-whhttps://thefirstcohort.com/articles/2026-10-12-keto-raised-tumor-counts-in-one-stretch-of-mouse-gut-and-cut-them-in-the-next-whIn cancer-prone mice, a ketogenic diet meant more small-intestine tumors and fewer colon tumors, and the ketones long credited for keto's anticancer promise turned out to be bystanders.Mon, 12 Oct 2026 00:00:00 GMTnutrition-foodketogenic-dietcancermetabolismnutritionSarah Okonkwohttps://thefirstcohort.com/articles/2026-10-12-in-pfizer-s-pivotal-trial-a-volunteer-s-pericarditis-became-a-suspected-covid-cahttps://thefirstcohort.com/articles/2026-10-12-in-pfizer-s-pivotal-trial-a-volunteer-s-pericarditis-became-a-suspected-covid-caThe only Argentine site in Pfizer's pivotal trial was run by the same doctor who authored the results, and when a 35-year-old developed pericarditis after his second dose, the records moved the episode off the vaccine's ledger.Mon, 12 Oct 2026 00:00:00 GMTinvestigationspfizercovid-19clinical-trialsvaccine-safetyMarcus Chenhttps://thefirstcohort.com/articles/2026-10-12-gaming-a-cancer-trial-is-cheap-and-easy-says-a-former-top-fda-officialhttps://thefirstcohort.com/articles/2026-10-12-gaming-a-cancer-trial-is-cheap-and-easy-says-a-former-top-fda-officialVinay Prasad says nobody needs AI to fake a phase 3 cancer win, and a Mayo Clinic audit found 16 of 96 FDA cancer approvals rested on control arms its authors judged suboptimal.Mon, 12 Oct 2026 00:00:00 GMTdrugs-fdaclinical-trialsfdacancerdrug-approvalsLena Marshallhttps://thefirstcohort.com/articles/2026-10-12-forty-five-years-after-acyclovir-the-fda-s-herpes-headline-is-a-warning-letter-thttps://thefirstcohort.com/articles/2026-10-12-forty-five-years-after-acyclovir-the-fda-s-herpes-headline-is-a-warning-letter-tSome 520 million people carry the virus behind most genital herpes, and no drug clears it. The FDA's October move was a warning letter over herpes ointments and washes sold on Amazon.Mon, 12 Oct 2026 00:00:00 GMTinfectious-diseaseherpesfdapublic-healthstiMarcus Chenhttps://thefirstcohort.com/articles/2026-10-12-a-siberian-plague-lab-lost-a-scientist-and-moscow-is-asking-for-the-trust-it-burhttps://thefirstcohort.com/articles/2026-10-12-a-siberian-plague-lab-lost-a-scientist-and-moscow-is-asking-for-the-trust-it-burDaria Shipilova, 28, studied plague in Irkutsk until a severe pneumonia killed her, and about 200 people were quarantined. The biology says stay calm. The history says make Moscow show its work.Mon, 12 Oct 2026 00:00:00 GMTinfectious-diseaseinfectious-diseasepublic-healthbiosafetyoutbreak-responseMarcus Chenhttps://thefirstcohort.com/articles/2026-10-12-a-few-degrees-of-foot-angle-beat-a-convincing-fake-for-arthritic-kneeshttps://thefirstcohort.com/articles/2026-10-12-a-few-degrees-of-foot-angle-beat-a-convincing-fake-for-arthritic-kneesPersonalized foot-angle retraining cut knee arthritis pain 1.2 points more than a sham program over a year, and an MRI marker of cartilage health held up better. Taxpayers paid for it, and there is nothing to refill.Mon, 12 Oct 2026 00:00:00 GMTautoimmune-inflammationosteoarthritischronic-paingait-retrainingwellnessSarah Okonkwohttps://thefirstcohort.com/articles/2026-10-11-the-fda-s-former-biologics-chief-says-public-health-can-t-see-the-next-disasterhttps://thefirstcohort.com/articles/2026-10-11-the-fda-s-former-biologics-chief-says-public-health-can-t-see-the-next-disasterVinay Prasad ran the FDA's biologics center until this spring. His warning: the apparatus chases lettuce recalls and measles while a blood test for dozens of cancers heads toward Medicare with its central question unanswered.Sun, 11 Oct 2026 00:00:00 GMTdrugs-fdafdadrug-safetycancer-screeningpublic-healthMarcus Chenhttps://thefirstcohort.com/articles/2026-10-11-the-80-5-percent-headline-and-the-three-confirmed-responses-behind-ithttps://thefirstcohort.com/articles/2026-10-11-the-80-5-percent-headline-and-the-three-confirmed-responses-behind-itVividion led its colorectal announcement with an 80.5 percent disease-control rate. In that same group, three tumors shrank enough to count as a response.Sun, 11 Oct 2026 00:00:00 GMTcancercancerclinical-trialscolorectal-cancerpharmaLena Marshallhttps://thefirstcohort.com/articles/2026-10-01-the-mandatory-drug-pricing-rule-nearly-every-major-drugmaker-was-allowed-to-skiphttps://thefirstcohort.com/articles/2026-10-01-the-mandatory-drug-pricing-rule-nearly-every-major-drugmaker-was-allowed-to-skipMedicare's actuaries scored the final rule at $440 million in savings. The proposal they started with was worth $12 billion.Thu, 01 Oct 2026 00:00:00 GMTinvestigationsdrug-pricingmedicarepharmaregulatory-captureLena Marshallhttps://thefirstcohort.com/articles/2026-10-01-the-fda-is-recruiting-new-advisers-without-publishing-the-rule-for-who-s-too-conhttps://thefirstcohort.com/articles/2026-10-01-the-fda-is-recruiting-new-advisers-without-publishing-the-rule-for-who-s-too-conActing commissioner Kyle Diamantas is inviting scientists and 'consumer voices' onto the FDA's advisory panels. The agency has never published how it decides which of them carries a disqualifying conflict, thirteen years after Congress ordered it to.Thu, 01 Oct 2026 00:00:00 GMTinvestigationsfdaadvisory-committeesconflict-of-interestregulatory-captureLena Marshallhttps://thefirstcohort.com/articles/2026-10-01-mulberry-blunts-your-blood-sugar-by-handing-the-carbs-to-your-gut-bacteriahttps://thefirstcohort.com/articles/2026-10-01-mulberry-blunts-your-blood-sugar-by-handing-the-carbs-to-your-gut-bacteriaMulberry's post-meal glucose effect has been tested in people across 12 trials. The gut-microbiome makeover sold on the strength of it still exists only in mice and petri dishes.Thu, 01 Oct 2026 00:00:00 GMTmetabolic-weightgut-microbiomemetabolic-healthblood-sugarsupplementsSarah Okonkwohttps://thefirstcohort.com/articles/2026-10-01-a-protein-that-should-surge-before-birth-went-flat-in-pregnancies-later-linked-thttps://thefirstcohort.com/articles/2026-10-01-a-protein-that-should-surge-before-birth-went-flat-in-pregnancies-later-linked-tEach standard-deviation drop in third-trimester placental growth factor came with 2.6 times the odds of a later ADHD diagnosis, and the signal held even after researchers accounted for preeclampsia, growth restriction, and early preterm birth.Thu, 01 Oct 2026 00:00:00 GMTbrain-agingadhdpregnancyneurodevelopmentplacentaSarah Okonkwohttps://thefirstcohort.com/articles/2026-10-01-a-creatine-industry-advisor-ran-the-study-behind-the-skip-the-gym-headlineshttps://thefirstcohort.com/articles/2026-10-01-a-creatine-industry-advisor-ran-the-study-behind-the-skip-the-gym-headlinesA new trial says creatine builds lean mass without exercise, and his own society's journal published it. The measurement it leaned on is the one creatine is known to inflate with water.Thu, 01 Oct 2026 00:00:00 GMTmetabolic-weightcreatinesupplementsmetabolic-healthlongevitySarah Okonkwohttps://thefirstcohort.com/articles/2026-09-30-the-maha-summit-charged-corporations-up-to-300-000-for-a-seat-beside-the-officiahttps://thefirstcohort.com/articles/2026-09-30-the-maha-summit-charged-corporations-up-to-300-000-for-a-seat-beside-the-officiaUnitedHealth got a panel. Grail, whose cancer test sat before the FDA, helped foot the bill. The regenerative ranchers and pesticide experts were nowhere on the program.Wed, 30 Sep 2026 00:00:00 GMTinvestigationsmaharegulatory-captureconflict-of-interestpublic-healthMarcus Chenhttps://thefirstcohort.com/articles/2026-09-30-for-five-years-this-nurse-led-florida-clinic-was-a-federal-look-alike-now-it-s-whttps://thefirstcohort.com/articles/2026-09-30-for-five-years-this-nurse-led-florida-clinic-was-a-federal-look-alike-now-it-s-wA West Palm Beach clinic run by nursing faculty, nurse practitioners, and their students spent five years as a federal 'look-alike.' Funded status adds a $650,000 grant, federal malpractice cover, and loan backing on top of the deep 340B drug discounts and sliding-scale mandate it already ran on.Wed, 30 Sep 2026 00:00:00 GMTinvestigationscommunity-healthprimary-care340bchronic-diseaseSarah Okonkwohttps://thefirstcohort.com/articles/2026-09-30-five-coffee-companies-paid-for-the-study-behind-the-coffee-fixes-your-gut-and-brhttps://thefirstcohort.com/articles/2026-09-30-five-coffee-companies-paid-for-the-study-behind-the-coffee-fixes-your-gut-and-brThe headlines credit your morning cup with less stress, sharper memory, and a healthier gut. The study behind them was paid for by ISIC, the trade body funded by five coffee companies including illycaffè, Lavazza, and Tchibo.Wed, 30 Sep 2026 00:00:00 GMTnutrition-foodcoffeegut-microbiomegut-brain-axisindustry-fundingSarah Okonkwohttps://thefirstcohort.com/articles/2026-09-30-federal-agents-seized-counterfeit-ozempic-and-warned-the-public-prosecutors-sayhttps://thefirstcohort.com/articles/2026-09-30-federal-agents-seized-counterfeit-ozempic-and-warned-the-public-prosecutors-sayThe counterfeits came from China with fake needles and packaging and sold to distributors at a discount. The indictment says the alleged scheme kept running for months after the FDA had already seized counterfeit Ozempic and warned the country.Wed, 30 Sep 2026 00:00:00 GMTdrugs-fdaglp-1ozempiccounterfeit-drugsfdaSarah Okonkwohttps://thefirstcohort.com/articles/2026-09-30-a-lupus-drug-failed-its-trial-its-patients-got-better-anywayhttps://thefirstcohort.com/articles/2026-09-30-a-lupus-drug-failed-its-trial-its-patients-got-better-anywayEnpatoran missed its primary endpoint in 354 lupus patients. But disease activity dropped, the interferon signature fell, and the rashes cleared. The trial's model was built to catch a climbing dose-response, and the drug's effect had plateaued.Wed, 30 Sep 2026 00:00:00 GMTautoimmune-inflammationlupusautoimmuneclinical-trialsinterferonSarah Okonkwohttps://thefirstcohort.com/articles/2026-09-29-two-labs-on-two-continents-watched-a-pomegranate-compound-relax-stiff-mouse-hearhttps://thefirstcohort.com/articles/2026-09-29-two-labs-on-two-continents-watched-a-pomegranate-compound-relax-stiff-mouse-hearHeart failure with preserved ejection fraction has few disease-modifying options. A gut metabolite from pomegranates and walnuts, already sold as a supplement, improved measures of heart function up to 80 percent in mice.Tue, 29 Sep 2026 00:00:00 GMTnutrition-foodheart-failuresupplementsmitochondriagut-microbiomeSarah Okonkwohttps://thefirstcohort.com/articles/2026-09-29-the-inherited-lung-cancer-gene-that-rode-out-of-appalachia-on-a-wagon-roadhttps://thefirstcohort.com/articles/2026-09-29-the-inherited-lung-cancer-gene-that-rode-out-of-appalachia-on-a-wagon-roadCarriers were about 25 times as likely to develop lung cancer as everyone else, more than 60 times if they never smoked. The variant came over with British and Irish settlers, concentrated in Southern Appalachia after a founder event two centuries ago, and surfaced in a consumer spit-kit database, nTue, 29 Sep 2026 00:00:00 GMTcancerlung-cancergeneticscancer-screeninghereditary-cancerLena Marshallhttps://thefirstcohort.com/articles/2026-09-29-pesticides-outlawed-in-the-1970s-are-still-in-women-s-blood-and-they-track-withhttps://thefirstcohort.com/articles/2026-09-29-pesticides-outlawed-in-the-1970s-are-still-in-women-s-blood-and-they-track-withFrench scientists screened 45 banned or barely-regulated chemicals in 468 women's blood. Two pesticides cancelled decades ago still tracked with elevated inflammation, and the PFAS quietly pushed an immune signal down.Tue, 29 Sep 2026 00:00:00 GMTautoimmune-inflammationpfasenvironmental-healthinflammationwomens-healthSarah Okonkwohttps://thefirstcohort.com/articles/2026-09-29-one-hormone-starves-the-brain-and-floods-the-heart-the-fda-s-first-mct8-drug-trehttps://thefirstcohort.com/articles/2026-09-29-one-hormone-starves-the-brain-and-floods-the-heart-the-fda-s-first-mct8-drug-treEmcitate is being called the first treatment for MCT8 deficiency, but its FDA label covers the racing heart and the wasting body, not the brain disability that defines the disease.Tue, 29 Sep 2026 00:00:00 GMTdrugs-fdafda-approvalrare-diseasethyroidmetabolicSarah Okonkwohttps://thefirstcohort.com/articles/2026-09-29-a-scientist-chased-one-missing-blood-marker-for-twenty-years-the-answer-was-a-tihttps://thefirstcohort.com/articles/2026-09-29-a-scientist-chased-one-missing-blood-marker-for-twenty-years-the-answer-was-a-tiMore than 99.9 percent of people carry a blood marker called AnWj. For most of the few who don't, the absence is acquired, a sign of an underlying blood disorder or cancer rather than something they were born with.Tue, 29 Sep 2026 00:00:00 GMTcancercell-biologygeneticsblood-transfusionrare-diseaseSarah Okonkwohttps://thefirstcohort.com/articles/2026-09-28-the-fraud-hunter-says-she-can-no-longer-tell-fake-science-from-realhttps://thefirstcohort.com/articles/2026-09-28-the-fraud-hunter-says-she-can-no-longer-tell-fake-science-from-realJournals retracted more than 10,000 papers in a single year. In one test, 2 of 3 biomedical experts could not tell AI-fabricated images from real ones, and Elisabeth Bik, the field's most relentless fraud hunter, says peer review is not prepared.Mon, 28 Sep 2026 00:00:00 GMTinvestigationsresearch-integrityartificial-intelligencepeer-reviewscientific-fraudLena Marshallhttps://thefirstcohort.com/articles/2026-09-28-the-fda-will-now-accept-real-world-evidence-for-devices-without-the-patient-recohttps://thefirstcohort.com/articles/2026-09-28-the-fda-will-now-accept-real-world-evidence-for-devices-without-the-patient-recoThe curation that turns raw medical charts into "regulatory-grade" evidence happens inside private vendors like Roche-owned Flatiron Health. The public record does not show who, if anyone, independently audits it.Mon, 28 Sep 2026 00:00:00 GMTinvestigationsfdareal-world-evidenceregulatory-capturedata-integrityMira Petrovhttps://thefirstcohort.com/articles/2026-09-28-mounjaro-turned-on-calorie-burning-fat-in-mice-that-ate-exactly-the-same-amounthttps://thefirstcohort.com/articles/2026-09-28-mounjaro-turned-on-calorie-burning-fat-in-mice-that-ate-exactly-the-same-amountTirzepatide mice ate the same calories as the controls and still burned more, by firing up brown fat. Adults carry only a few grams of it, and it shrinks in exactly the people taking the drug.Mon, 28 Sep 2026 00:00:00 GMTmetabolic-weightglp-1tirzepatideobesitybrown-fatSarah Okonkwohttps://thefirstcohort.com/articles/2026-09-28-kangaroo-care-was-built-for-babies-fighting-to-survive-a-trial-now-asks-what-ithttps://thefirstcohort.com/articles/2026-09-28-kangaroo-care-was-built-for-babies-fighting-to-survive-a-trial-now-asks-what-itSkin-to-skin contact cut deaths among low-birth-weight newborns by a quarter. A 516-baby trial in Uttar Pradesh is now testing whether eight hours a day helps healthy, full-term infants too, and whether medicine has been underselling it.Mon, 28 Sep 2026 00:00:00 GMTmetabolic-weightkangaroo-carebreastfeedingneonatal-healthmaternal-healthSarah Okonkwohttps://thefirstcohort.com/articles/2026-09-28-alzheimer-s-drugmakers-bet-on-raising-this-brain-sugar-glucosamine-may-be-overfehttps://thefirstcohort.com/articles/2026-09-28-alzheimer-s-drugmakers-bet-on-raising-this-brain-sugar-glucosamine-may-be-overfeIn UF Health records, people with mild cognitive impairment who took the joint supplement were 25 percent more likely to slip into dementia. Glucosamine feeds the same brain chemistry a failed Alzheimer's drug was built to raise.Mon, 28 Sep 2026 00:00:00 GMTbrain-agingsupplementsalzheimersdementiametabolismSarah Okonkwohttps://thefirstcohort.com/articles/2026-09-28-a-memphis-team-linked-tap-water-fluoride-to-kids-testosterone-sodium-and-uric-achttps://thefirstcohort.com/articles/2026-09-28-a-memphis-team-linked-tap-water-fluoride-to-kids-testosterone-sodium-and-uric-acIn 4,470 American children, each unit of predicted plasma fluoride from tap water tracked with a testosterone geometric mean ratio of 0.49, plus higher serum sodium and uric acid. The authors declared no external funding.Mon, 28 Sep 2026 00:00:00 GMTinvestigationsfluorideenvironmental-healthendocrine-disruptionchildrens-healthSarah Okonkwohttps://thefirstcohort.com/articles/2026-09-27-the-cell-long-dismissed-as-brain-glue-is-presenting-your-nerves-to-the-immune-syhttps://thefirstcohort.com/articles/2026-09-27-the-cell-long-dismissed-as-brain-glue-is-presenting-your-nerves-to-the-immune-syFor a century, astrocytes were dismissed as the brain's passive scaffolding. Now researchers have caught them inside multiple sclerosis lesions dressed as immune cells, arming the very T cells that attack the brain.Sun, 27 Sep 2026 00:00:00 GMTautoimmune-inflammationneuroinflammationautoimmunemultiple-sclerosisastrocytesSarah Okonkwohttps://thefirstcohort.com/articles/2026-09-27-kennedy-s-ultra-processed-food-rule-leaves-open-the-loophole-he-promised-to-closhttps://thefirstcohort.com/articles/2026-09-27-kennedy-s-ultra-processed-food-rule-leaves-open-the-loophole-he-promised-to-closIn February he vowed to act on the petition that demanded real safety review of food additives. In August his FDA proposed a rule that still lets companies certify their own chemicals as safe, and sell them before anyone at the agency looks.Sun, 27 Sep 2026 00:00:00 GMTinvestigationsultra-processed-foodrfk-jrfdafood-additivesLena Marshallhttps://thefirstcohort.com/articles/2026-09-27-britain-is-building-a-national-genetic-screening-service-on-scores-that-miss-ninhttps://thefirstcohort.com/articles/2026-09-27-britain-is-building-a-national-genetic-screening-service-on-scores-that-miss-ninIn 2019 the same company's test convinced a health secretary he might die of prostate cancer. He was near average. Now its scores are heading into a biobank of five million Britons and the NHS's new prevention service.Sun, 27 Sep 2026 00:00:00 GMTinvestigationsgenomicspolygenic-scoresnhsscreeningLena Marshallhttps://thefirstcohort.com/articles/2026-09-27-blood-pours-into-the-mouse-cortex-seconds-before-rem-then-the-neurons-run-low-onhttps://thefirstcohort.com/articles/2026-09-27-blood-pours-into-the-mouse-cortex-seconds-before-rem-then-the-neurons-run-low-onAbout 50 seconds before REM sleep starts, blood volume surges across a sleeping mouse's cortex. Then the neurons' usable energy drops sharply anyway, and no one can yet say what they are burning it on.Sun, 27 Sep 2026 00:00:00 GMTbrain-agingsleepneurosciencebrain-metabolismdreamsSarah Okonkwohttps://thefirstcohort.com/articles/2026-09-27-a-34-year-mammography-advocate-co-wrote-the-study-that-shrinks-screening-s-biggehttps://thefirstcohort.com/articles/2026-09-27-a-34-year-mammography-advocate-co-wrote-the-study-that-shrinks-screening-s-biggeOverdiagnosis, the risk that screening treats cancers that never would have killed you, was pegged as high as 50 percent. A reinterpretation of eight old trials now puts it under 5, with an author who has promoted screening for 34 years.Sun, 27 Sep 2026 00:00:00 GMTcancerbreast-cancercancer-screeningoverdiagnosisconflict-of-interestLena Marshallhttps://thefirstcohort.com/articles/2026-09-26-the-fibroid-procedure-that-spares-the-uterus-its-best-head-to-head-evidence-washttps://thefirstcohort.com/articles/2026-09-26-the-fibroid-procedure-that-spares-the-uterus-its-best-head-to-head-evidence-wasRadiofrequency ablation matched myomectomy on two-year symptom relief in a randomized trial. The device maker paid for that trial, and the durability question it cannot answer is the one that matters most.Sat, 26 Sep 2026 00:00:00 GMTinvestigationsuterine-fibroidsradiofrequency-ablationmyomectomyindustry-fundingwomens-healthMarcus Chenhttps://thefirstcohort.com/articles/2026-09-26-the-company-behind-the-crispr-leukemia-breakthrough-shut-itself-down-a-year-befohttps://thefirstcohort.com/articles/2026-09-26-the-company-behind-the-crispr-leukemia-breakthrough-shut-itself-down-a-year-befoThirty patients with aggressive blood cancers got a CRISPR-edited transplant that worked as designed. Vor Biopharma, the company that built it, had already laid off 95 percent of its staff and left the program behind.Sat, 26 Sep 2026 00:00:00 GMTcancercrisprleukemiacell-therapyvor-biopharmagemtuzumabbiotechLena Marshallhttps://thefirstcohort.com/articles/2026-09-26-argenx-s-own-scientists-found-antibody-levels-alone-don-t-explain-who-its-225-00https://thefirstcohort.com/articles/2026-09-26-argenx-s-own-scientists-found-antibody-levels-alone-don-t-explain-who-its-225-00Six of the paper's authors work for argenx and hold its stock. Their data on 50 patients shows efgartigimod's benefit tracked more closely with how thoroughly it disarmed the rogue antibodies than with how many it stripped away.Sat, 26 Sep 2026 00:00:00 GMTautoimmune-inflammationmyasthenia-gravisautoimmuneefgartigimodpharmacomplementSarah Okonkwohttps://thefirstcohort.com/articles/2026-09-26-a-warehouse-stored-infant-formula-among-26-rodents-after-32-inspections-no-one-whttps://thefirstcohort.com/articles/2026-09-26-a-warehouse-stored-infant-formula-among-26-rodents-after-32-inspections-no-one-wThe FDA found infant formula stored among 26 rodents at a Minneapolis warehouse the state had inspected 26 times since 2013. The remedy was a cleanup order and no charges, the same month the Justice Department let Abbott pay nearly $385 million and close its own formula criminal case with no one chaSat, 26 Sep 2026 00:00:00 GMTinvestigationsfdafood-safetyinfant-formulaaccountabilityconsent-decreeLena Marshallhttps://thefirstcohort.com/articles/2026-09-26-87-trials-found-the-whole-grain-sweet-spot-sixteen-markers-nudged-healthier-nonehttps://thefirstcohort.com/articles/2026-09-26-87-trials-found-the-whole-grain-sweet-spot-sixteen-markers-nudged-healthier-noneSixty to a hundred grams of whole grain a day nudged weight, cholesterol, blood pressure and inflammation the right way across 87 randomized trials. The median trial ran eight weeks, every effect was tiny, and not one counted an actual heart attack.Sat, 26 Sep 2026 00:00:00 GMTnutrition-foodwhole grainsheart healthnutritioncholesterolinflammationmetabolicSarah Okonkwohttps://thefirstcohort.com/articles/2026-09-25-trump-s-fda-nominee-backed-cutting-the-vaccine-schedule-then-hid-behind-safe-andhttps://thefirstcohort.com/articles/2026-09-25-trump-s-fda-nominee-backed-cutting-the-vaccine-schedule-then-hid-behind-safe-andHeidi Overton stood beside Trump as he cut the childhood vaccine schedule from 18 diseases to 11. At her confirmation hearing she spent two hours calling every FDA-approved vaccine 'safe and effective' and refused to defend the reform she coordinated.Fri, 25 Sep 2026 00:00:00 GMTdrugs-fdafdavaccineschildhood-vaccinesrfk-jrregulatory-captureSarah Okonkwohttps://thefirstcohort.com/articles/2026-09-25-the-fda-s-new-fast-lane-for-experimental-drugs-is-run-by-a-lawyer-who-defended-thttps://thefirstcohort.com/articles/2026-09-25-the-fda-s-new-fast-lane-for-experimental-drugs-is-run-by-a-lawyer-who-defended-tOperation TrialBlazer lets drug sponsors feed their first-in-human safety data to the FDA in pieces, on a rolling clock, to shave months off the wait. The review it speeds is the one that decides whether an untested drug can go into a person at all.Fri, 25 Sep 2026 00:00:00 GMTdrugs-fdafdaclinical-trialsdrug-developmentregulatory-captureoperation-trialblazerLena Marshallhttps://thefirstcohort.com/articles/2026-09-25-one-in-six-kids-on-weight-loss-drugs-was-diagnosed-with-a-nutrient-deficiency-anhttps://thefirstcohort.com/articles/2026-09-25-one-in-six-kids-on-weight-loss-drugs-was-diagnosed-with-a-nutrient-deficiency-anThe alarm about kids going short on vitamin D on Ozempic-style drugs came from a study funded by Abbott, which sells the very nutrition drinks marketed to fill those gaps.Fri, 25 Sep 2026 00:00:00 GMTmetabolic-weightglp-1childhood obesitynutritionconflicts of interestvitamin dpediatricsSarah Okonkwohttps://thefirstcohort.com/articles/2026-09-25-i-track-my-rem-sleep-every-night-this-study-made-me-stop-trusting-the-numberhttps://thefirstcohort.com/articles/2026-09-25-i-track-my-rem-sleep-every-night-this-study-made-me-stop-trusting-the-numberThe viral headline says more REM sleep guards you against 83 diseases. But a brain sliding toward Parkinson's shreds REM years before diagnosis, and the study's own two-year exclusion test quietly agrees.Fri, 25 Sep 2026 00:00:00 GMTbrain-agingsleeprem-sleepneurodegenerationparkinsonsdementiauk-biobankSarah Okonkwohttps://thefirstcohort.com/articles/2026-09-25-forever-chemicals-pregnancy-and-the-vitamin-that-might-decide-who-gets-hurthttps://thefirstcohort.com/articles/2026-09-25-forever-chemicals-pregnancy-and-the-vitamin-that-might-decide-who-gets-hurtEarly-pregnancy PFAS tracked with gestational diabetes in a 420-woman China cohort, but almost entirely in mothers already low on vitamin D. A 5,229-pregnancy US analysis found no added risk at all. The gap between them may come down to one cheap blood test.Fri, 25 Sep 2026 00:00:00 GMTmetabolic-weightpfasgestational-diabetesvitamin-dpregnancyendocrine-disruptorsmetabolicSarah Okonkwohttps://thefirstcohort.com/articles/2026-09-24-the-fda-warned-a-generation-off-hormones-a-danish-registry-puts-the-clot-risk-inhttps://thefirstcohort.com/articles/2026-09-24-the-fda-warned-a-generation-off-hormones-a-danish-registry-puts-the-clot-risk-inOral hormone therapy was tied to more clots, and to strokes and heart attacks at higher doses taken longer. The patches and gels carried no general increase. The warning that scared a generation of women off never drew the line.Thu, 24 Sep 2026 00:00:00 GMTdrugs-fdamenopausehormone-therapyfdaestrogenwomens-healthLena Marshallhttps://thefirstcohort.com/articles/2026-09-24-the-compound-that-outsmarts-cancer-s-defenses-eight-cell-lines-a-few-mice-and-ahttps://thefirstcohort.com/articles/2026-09-24-the-compound-that-outsmarts-cancer-s-defenses-eight-cell-lines-a-few-mice-and-aBaylor researchers say CS18 dismantles the survival switch tumors use to resist treatment. It works in eight cell lines and a handful of mice, and its inventors just incorporated a company around it.Thu, 24 Sep 2026 00:00:00 GMTcancercancerdrug-resistancepreclinicaloncologyconflict-of-interestLena Marshallhttps://thefirstcohort.com/articles/2026-09-24-no-fda-approved-drug-stops-preterm-labor-a-vanderbilt-screen-of-all-1-191-approvhttps://thefirstcohort.com/articles/2026-09-24-no-fda-approved-drug-stops-preterm-labor-a-vanderbilt-screen-of-all-1-191-approvEvery drug used to halt preterm contractions is borrowed off-label; the FDA has never approved one for the job. A Vanderbilt team screened all 1,191 approved drugs and landed on an asthma steroid.Thu, 24 Sep 2026 00:00:00 GMTdrugs-fdapreterm-laborfdadrug-repurposingtocolyticsciclesonideLena Marshallhttps://thefirstcohort.com/articles/2026-09-24-months-after-the-fda-recalled-these-frozen-clams-no-one-can-say-which-ecuadorianhttps://thefirstcohort.com/articles/2026-09-24-months-after-the-fda-recalled-these-frozen-clams-no-one-can-say-which-ecuadorianThirty-seven people across four states, thirty of them hospitalized, all linked to La Serranita black-shell clams imported frozen from Ecuador. The source waters are still under investigation.Thu, 24 Sep 2026 00:00:00 GMTinfectious-diseasehepatitis-afoodborne-illnessfood-safetyshellfishimportsMarcus Chenhttps://thefirstcohort.com/articles/2026-09-24-caffeine-can-flatten-your-deep-sleep-while-you-sleep-right-through-the-nighthttps://thefirstcohort.com/articles/2026-09-24-caffeine-can-flatten-your-deep-sleep-while-you-sleep-right-through-the-nightOn caffeine, the slow brain waves that make sleep restorative can thin out even when you fall asleep fast and wake up sure you rested.Thu, 24 Sep 2026 00:00:00 GMTnutrition-foodcaffeinesleepdeep-sleepadenosinewellnessSarah Okonkwohttps://thefirstcohort.com/articles/2026-09-23-the-who-halted-a-global-drug-trial-on-data-a-tiny-company-would-not-let-auditorshttps://thefirstcohort.com/articles/2026-09-23-the-who-halted-a-global-drug-trial-on-data-a-tiny-company-would-not-let-auditorsNinety-six thousand patients across six continents, supplied by a Chicago firm that would not open its database to independent auditors, and the WHO changed course in days.Wed, 23 Sep 2026 00:00:00 GMTinvestigationssurgispherereal-world-datahydroxychloroquinewholancetresearch-integrityMira Petrovhttps://thefirstcohort.com/articles/2026-09-23-the-study-being-used-to-close-the-vaccine-death-question-can-t-rule-out-zero-exchttps://thefirstcohort.com/articles/2026-09-23-the-study-being-used-to-close-the-vaccine-death-question-can-t-rule-out-zero-excNew Zealand's headline pandemic death study was co-authored by one of the country's most visible COVID modellers, and its four-year estimate runs from 1,134 fewer deaths than expected to 2,927 more. The modellers are calling it settled.Wed, 23 Sep 2026 00:00:00 GMTinvestigationsexcess-mortalitycovid-vaccinesnew-zealandpublic-health-modelingregulatory-captureMarcus Chenhttps://thefirstcohort.com/articles/2026-09-23-the-older-adults-whose-biological-age-dropped-ate-more-carbs-and-kept-the-meathttps://thefirstcohort.com/articles/2026-09-23-the-older-adults-whose-biological-age-dropped-ate-more-carbs-and-kept-the-meatThe omnivorous, low-fat, high-carbohydrate group showed the strongest drop. The keto-style omnivore group was the only one of four that didn't budge at all.Wed, 23 Sep 2026 00:00:00 GMTnutrition-foodnutritionlongevitymetabolic-healthagingdietSarah Okonkwohttps://thefirstcohort.com/articles/2026-09-23-the-headlines-blamed-stress-the-data-blamed-belly-fat-cigarettes-and-povertyhttps://thefirstcohort.com/articles/2026-09-23-the-headlines-blamed-stress-the-data-blamed-belly-fat-cigarettes-and-povertyIn 488,079 UK adults, chronic inflammation tracked with a heart quietly remodeling into a smaller, stiffer pump. The loudest drivers were belly fat, cigarettes, and poverty. The paper points at a druggable inflammation pathway; its senior author discloses fees and grants from Bayer and Google's CaliWed, 23 Sep 2026 00:00:00 GMTmetabolic-weightinflammationheart-diseasemetabolic-healthcardiovascular-riskuk-biobankSarah Okonkwohttps://thefirstcohort.com/articles/2026-09-23-the-air-never-arrives-one-pollutant-at-a-time-but-the-rules-pretend-it-doeshttps://thefirstcohort.com/articles/2026-09-23-the-air-never-arrives-one-pollutant-at-a-time-but-the-rules-pretend-it-doesIn a big European analysis, almost every pollutant tested on its own came back borderline. Measure the whole mixture the way it actually reaches the lung, and the adult-asthma signal shows up.Wed, 23 Sep 2026 00:00:00 GMTautoimmune-inflammationair pollutionasthmapm2.5ozoneinflammationenvironmental healthSarah Okonkwohttps://thefirstcohort.com/articles/2026-09-23-calcium-and-vitamin-d-cut-hip-fractures-16-percent-the-authors-called-that-littlhttps://thefirstcohort.com/articles/2026-09-23-calcium-and-vitamin-d-cut-hip-fractures-16-percent-the-authors-called-that-littlThe combined calcium and vitamin D arm cut hip fractures with a confidence interval that cleared significance. Then a bar the researchers set for themselves, one that would take more than halving hip fractures to meet, turned the result into a headline telling people to stop.Wed, 23 Sep 2026 00:00:00 GMTnutrition-foodcalciumvitamin-dsupplementsbone-healthhip-fracturesuspstfLena Marshallhttps://thefirstcohort.com/articles/2026-09-22-where-taiwan-s-air-got-dirtier-early-kidney-disease-turned-severe-2-25-times-ashttps://thefirstcohort.com/articles/2026-09-22-where-taiwan-s-air-got-dirtier-early-kidney-disease-turned-severe-2-25-times-asTaiwan tracked 424,000 people with early kidney disease and the air they breathed. Where PM2.5 climbed, more of them slid toward dialysis and death. Where it fell, fewer did.Tue, 22 Sep 2026 00:00:00 GMTmetabolic-weightkidney diseaseair pollutionpm2.5ckdenvironmental healthSarah Okonkwohttps://thefirstcohort.com/articles/2026-09-22-four-years-after-congress-dropped-the-animal-testing-requirement-for-new-drugs-thttps://thefirstcohort.com/articles/2026-09-22-four-years-after-congress-dropped-the-animal-testing-requirement-for-new-drugs-tThe FDA's direct final rule swaps 'animal studies' for 'nonclinical studies' across its regulations. It eliminates no animal testing, moves no evidentiary bar, and sets up no program to prove the alternatives it now invites actually work.Tue, 22 Sep 2026 00:00:00 GMTdrugs-fdafdaanimal-testingnamsdrug-developmentregulationMarcus Chenhttps://thefirstcohort.com/articles/2026-09-22-even-the-vitamin-c-made-the-list-112-000-people-and-eight-everyday-preservativeshttps://thefirstcohort.com/articles/2026-09-22-even-the-vitamin-c-made-the-list-112-000-people-and-eight-everyday-preservativesAscorbic acid, citric acid, sodium nitrite: three of eight common food preservatives that a 112,000-person French cohort has now linked to higher blood pressure, with the researchers asking the FDA and EFSA to re-check them.Tue, 22 Sep 2026 00:00:00 GMTnutrition-foodfood-additivespreservativesblood-pressurecardiovascularultra-processed-foodfda-grasSarah Okonkwohttps://thefirstcohort.com/articles/2026-09-22-crash-diets-rewire-your-gut-to-sabotage-the-next-onehttps://thefirstcohort.com/articles/2026-09-22-crash-diets-rewire-your-gut-to-sabotage-the-next-oneIn mice, transplanting the gut microbes of weight-cycled animals into healthy ones handed over the bingeing with them. Crash dieting reshapes the gut, and the diet industry keeps selling you the fix for damage its last plan made.Tue, 22 Sep 2026 00:00:00 GMTmetabolic-weightgut-microbiomeweight-lossyo-yo-dietingglp-1metabolic-healthSarah Okonkwohttps://thefirstcohort.com/articles/2026-09-22-a-bendable-fiber-thinner-than-six-hairs-records-doses-and-stimulates-a-mouse-brahttps://thefirstcohort.com/articles/2026-09-22-a-bendable-fiber-thinner-than-six-hairs-records-doses-and-stimulates-a-mouse-braSilicon brain probes scar the tissue they're built to read. A soft optical fiber from Denmark records, doses, and stimulates neurons at once, in mice, with a pharma foundation and pending patents behind it.Tue, 22 Sep 2026 00:00:00 GMTbrain-agingneurotechnologybrain-implantepilepsymedical-devicespreclinicaldrug-deliverySarah Okonkwohttps://thefirstcohort.com/articles/2026-09-21-the-47th-human-blood-group-was-hiding-in-a-protein-almost-too-small-to-findhttps://thefirstcohort.com/articles/2026-09-21-the-47th-human-blood-group-was-hiding-in-a-protein-almost-too-small-to-findMore than 99.9% of us carry the AnWj antigen without knowing. For the rare few born without it, a routine transfusion can turn dangerous, and until now no genetic test could reliably identify them before the damage was done.Mon, 21 Sep 2026 00:00:00 GMTautoimmune-inflammationbloodgeneticscell-biologytransfusionrare-diseaseSarah Okonkwohttps://thefirstcohort.com/articles/2026-09-21-for-nineteen-years-bundibugyo-was-a-footnote-in-the-ebola-family-it-has-killed-mhttps://thefirstcohort.com/articles/2026-09-21-for-nineteen-years-bundibugyo-was-a-footnote-in-the-ebola-family-it-has-killed-mCongo confirmed a little-known Ebola cousin on May 15. By September it had reached 61 health zones, killed nearly half of its confirmed patients, and traveled abroad in infected and evacuated people, and the celebrated Ebola vaccine was never built to stop it.Mon, 21 Sep 2026 00:00:00 GMTinfectious-diseasebundibugyoebolafiloviruswhodrcoutbreakLena Marshallhttps://thefirstcohort.com/articles/2026-09-21-for-400-years-after-the-black-death-plague-kept-walking-back-into-europe-on-warhttps://thefirstcohort.com/articles/2026-09-21-for-400-years-after-the-black-death-plague-kept-walking-back-into-europe-on-warTwenty-six sets of medieval teeth trace Yersinia pestis splitting into three branches around 1500, with the later lineages tracking the roads armies and refugees traveled. The pattern points to repeated re-introductions, plus some strains that may have dug in locally.Mon, 21 Sep 2026 00:00:00 GMTinfectious-diseaseplagueancient-dnainfectious-diseaseyersinia-pestisepidemiologySarah Okonkwohttps://thefirstcohort.com/articles/2026-09-21-brain-on-fire-ottawa-s-vaccine-injury-program-spent-more-on-its-contractor-thanhttps://thefirstcohort.com/articles/2026-09-21-brain-on-fire-ottawa-s-vaccine-injury-program-spent-more-on-its-contractor-thanFifty injured Canadians testified in Ottawa over four days, and Health Canada did not show. The compensation program has spent more on its contractor's overhead than on the people it was built to pay.Mon, 21 Sep 2026 00:00:00 GMTinvestigationscovid-vaccinevaccine-injuryautoimmune-encephalitisneuroinflammationcanadaregulatory-captureMarcus Chenhttps://thefirstcohort.com/articles/2026-09-20-the-healing-cells-that-cheat-death-carry-a-catch-their-offspring-are-seven-timeshttps://thefirstcohort.com/articles/2026-09-20-the-healing-cells-that-cheat-death-carry-a-catch-their-offspring-are-seven-timesA radiation-blasted fruit fly rebuilt half its ruined tissue in two days, and the cells that pulled it off left descendants 7 times harder to kill, which may be close to how some tumors outlast the treatments meant to finish them.Sun, 20 Sep 2026 00:00:00 GMTcancercancercell-deathregenerationradiationoncologyLena Marshallhttps://thefirstcohort.com/articles/2026-09-20-the-fat-hiding-in-black-and-green-rice-is-a-cousin-of-the-body-s-own-blood-sugarhttps://thefirstcohort.com/articles/2026-09-20-the-fat-hiding-in-black-and-green-rice-is-a-cousin-of-the-body-s-own-blood-sugarHokkaido chemists screened 56 rice varieties and found the pigmented ones carry a lipid cousin of the body's own insulin-sensitizing fats. This study did not test it in people.Sun, 20 Sep 2026 00:00:00 GMTnutrition-foodmetabolicblood-sugarnutritionlipidsglp-1whole-foodsSarah Okonkwohttps://thefirstcohort.com/articles/2026-09-20-the-ebola-vaccine-2-000-congolese-frontline-workers-received-isn-t-known-to-workhttps://thefirstcohort.com/articles/2026-09-20-the-ebola-vaccine-2-000-congolese-frontline-workers-received-isn-t-known-to-workBundibugyo Ebola has no licensed vaccine, so the response is dosing frontline workers with Ervebo, approved only against a different strain, while the State Department fast-tracks $50 million to CEPI and a four-candidate portfolio that includes Moderna, in an outbreak the surveillance system missedSun, 20 Sep 2026 00:00:00 GMTinvestigationsebolavaccineswhomodernadrcMira Petrovhttps://thefirstcohort.com/articles/2026-09-20-czech-trust-in-government-fell-to-19-percent-eight-to-ten-weeks-later-the-deathhttps://thefirstcohort.com/articles/2026-09-20-czech-trust-in-government-fell-to-19-percent-eight-to-ten-weeks-later-the-deathA populist government overstated its testing, cycled through health ministers, and governed by press conference. Czechs stopped believing it, and a new analysis ties that collapse of faith to a death rate that ran roughly twice the European average.Sun, 20 Sep 2026 00:00:00 GMTinfectious-diseasecovid-19institutional-trustexcess-mortalitypublic-healthczech-republicMarcus Chenhttps://thefirstcohort.com/articles/2026-09-19-they-called-it-goodbrother-four-years-of-teaching-the-elderly-to-accept-camerashttps://thefirstcohort.com/articles/2026-09-19-they-called-it-goodbrother-four-years-of-teaching-the-elderly-to-accept-camerasThe project's own charter says the aim is to 'increase user acceptance' of audio and video monitoring in the homes of older and frail people. On World Patient Safety Day, they call that safety.Sat, 19 Sep 2026 00:00:00 GMTinvestigationssurveillanceelder-careprivacyai-monitoringdata-rightseuLena Marshallhttps://thefirstcohort.com/articles/2026-09-19-the-supplement-reverses-aging-headline-skips-the-brain-surgery-on-the-mousehttps://thefirstcohort.com/articles/2026-09-19-the-supplement-reverses-aging-headline-skips-the-brain-surgery-on-the-mouseThe mouse study now going around as an anti-aging supplement win leaves out the part where the real reversal took a virus carrying a gene, injected into the hypothalamus.Sat, 19 Sep 2026 00:00:00 GMTbrain-agingaginglongevitybraind-serinesupplementshypothalamusSarah Okonkwohttps://thefirstcohort.com/articles/2026-09-19-the-fda-approved-a-3-95-million-gene-therapy-it-rejected-fourteen-months-agohttps://thefirstcohort.com/articles/2026-09-19-the-fda-approved-a-3-95-million-gene-therapy-it-rejected-fourteen-months-agoIn July 2025 the FDA refused to approve this Sanfilippo gene therapy and faulted the factory, not the science. Fourteen months later it is the first treatment for a fatal childhood brain disease, cleared on 17 treated children against a comparison group the maker built, at $3.95 million a dose.Sat, 19 Sep 2026 00:00:00 GMTdrugs-fdagene-therapysanfilippofda-approvaldrug-pricingrare-diseaseLena Marshallhttps://thefirstcohort.com/articles/2026-09-19-mri-found-fat-marbled-inside-the-thigh-muscles-of-heavy-ultra-processed-eaters-ahttps://thefirstcohort.com/articles/2026-09-19-mri-found-fat-marbled-inside-the-thigh-muscles-of-heavy-ultra-processed-eaters-aMRI scans of 615 adults found more fat marbled inside the thigh muscle the more ultra-processed food people ate, and the link held after adjustment for calorie intake, exercise, and fat intake.Sat, 19 Sep 2026 00:00:00 GMTnutrition-foodultra-processed-foodmetabolic-healthmuscleosteoarthritisnutritionSarah Okonkwohttps://thefirstcohort.com/articles/2026-09-19-fifty-sworn-witnesses-1-400-who-applied-and-not-one-official-from-health-canadahttps://thefirstcohort.com/articles/2026-09-19-fifty-sworn-witnesses-1-400-who-applied-and-not-one-official-from-health-canadaA sitting MP put Canadians who say the COVID shots injured them under oath on Parliament Hill. Health Canada, which authorized the products and tracks their harms, sent no one.Sat, 19 Sep 2026 00:00:00 GMTinvestigationscoviddata-manipulationvaccine-injurypublic-healthcanadaregulatory-captureMarcus Chenhttps://thefirstcohort.com/articles/2026-09-19-an-a-for-the-air-outside-nearly-three-times-dirtier-insidehttps://thefirstcohort.com/articles/2026-09-19-an-a-for-the-air-outside-nearly-three-times-dirtier-insideThe EPA rated one Virginia region's outdoor air a clean 'A.' Inside the public-housing apartments of elderly and disabled residents, fine-particle pollution ran nearly three times higher, the air most long-term pollution studies miss.Sat, 19 Sep 2026 00:00:00 GMTinvestigationsair pollutionindoor airpublic healthregulationenvironmental healthSarah Okonkwohttps://thefirstcohort.com/articles/2026-09-18-the-mesothelioma-drug-in-this-month-s-headlines-was-tested-in-fifteen-peoplehttps://thefirstcohort.com/articles/2026-09-18-the-mesothelioma-drug-in-this-month-s-headlines-was-tested-in-fifteen-peopleThe scientist whose lab found the drug's target is also chief science officer of the company selling it, a conflict the breakthrough headlines tuck into a job title.Fri, 18 Sep 2026 00:00:00 GMTcancermesotheliomaasbestosclinical-trialsoncologyconflict-of-interestLena Marshallhttps://thefirstcohort.com/articles/2026-09-18-the-last-time-moderna-s-stock-soared-on-vaccine-news-insiders-sold-400-million-ihttps://thefirstcohort.com/articles/2026-09-18-the-last-time-moderna-s-stock-soared-on-vaccine-news-insiders-sold-400-million-iModerna's stock has run up 137 percent in a month on a melanoma-vaccine trial that has not released its detailed data or reported overall survival. As retail chased the rally, the CEO sold $28.7 million in shares two weeks before the readout, and the rest of the C-suite cashed out after the stock trFri, 18 Sep 2026 00:00:00 GMTinvestigationsmodernacancer-vaccineinsider-sellingmrnamelanomapharma-skepticismMarcus Chenhttps://thefirstcohort.com/articles/2026-09-18-the-data-on-the-first-sanfilippo-gene-therapy-were-ready-last-summer-the-fda-spehttps://thefirstcohort.com/articles/2026-09-18-the-data-on-the-first-sanfilippo-gene-therapy-were-ready-last-summer-the-fda-speThe FDA said Ultragenyx's clinical data were robust in July 2025, then rejected its Sanfilippo gene therapy over manufacturing questions. Approval came fourteen months later, for children who lose skills and die on a clock.Fri, 18 Sep 2026 00:00:00 GMTdrugs-fdagene-therapyfdasanfilipporare-diseaseultragenyxregulatory-delayLena Marshallhttps://thefirstcohort.com/articles/2026-09-18-seven-biologics-up-to-47-000-a-year-and-89-percent-of-europe-s-severe-asthmaticshttps://thefirstcohort.com/articles/2026-09-18-seven-biologics-up-to-47-000-a-year-and-89-percent-of-europe-s-severe-asthmaticsThe Lancet calls severe asthma an 'unmet need.' A 13,455-patient European registry shows most of those patients are already on the pricey biologics, and 89 percent still have active disease.Fri, 18 Sep 2026 00:00:00 GMTautoimmune-inflammationsevere-asthmabiologicscorticosteroidspharma-pricingconflict-of-interestSarah Okonkwohttps://thefirstcohort.com/articles/2026-09-18-freeze-a-brain-cell-fast-enough-and-its-bare-wires-turn-out-to-be-strings-of-peahttps://thefirstcohort.com/articles/2026-09-18-freeze-a-brain-cell-fast-enough-and-its-bare-wires-turn-out-to-be-strings-of-peaThe bumps along the brain's thinnest fibers were written off as damage for a century. Johns Hopkins froze the tissue fast enough to catch them intact, and to watch them swell when the neuron fires hard.Fri, 18 Sep 2026 00:00:00 GMTbrain-agingneuroscienceaxonscell-biologyneurologybrainSarah Okonkwohttps://thefirstcohort.com/articles/2026-09-18-donor-t-cells-cross-into-the-gut-lining-and-become-resident-killers-that-won-t-lhttps://thefirstcohort.com/articles/2026-09-18-donor-t-cells-cross-into-the-gut-lining-and-become-resident-killers-that-won-t-lColumbia researchers tracked more than 51,000 donor T-cell clones across two years and found the ones tied to the worst graft-versus-host disease change identity depending on where they land in the gut, and spike in the blood weeks before symptoms show.Fri, 18 Sep 2026 00:00:00 GMTautoimmune-inflammationgvhdt-cellstransplantsingle-cellimmunologySarah Okonkwohttps://thefirstcohort.com/articles/2026-09-17-younger-generations-are-testing-biologically-older-and-early-cancer-is-trackinghttps://thefirstcohort.com/articles/2026-09-17-younger-generations-are-testing-biologically-older-and-early-cancer-is-trackingBy a nine-marker blood panel, Americans born in the 1990s scored biologically older than those born in the late 1960s did at the same age, and Washington University researchers found that accelerated aging tracked a higher risk of early-onset cancer.Thu, 17 Sep 2026 00:00:00 GMTcancerearly-onset-cancerbiological-agingcancerepidemiologymetabolic-healthLena Marshallhttps://thefirstcohort.com/articles/2026-09-17-twenty-years-four-botanical-drugs-the-fda-wants-to-know-what-s-blocking-the-resthttps://thefirstcohort.com/articles/2026-09-17-twenty-years-four-botanical-drugs-the-fda-wants-to-know-what-s-blocking-the-restFour botanical drugs in two decades, under a framework built for single molecules. Now, inside RFK Jr.'s HHS, the agency that wrote those rules is asking what blocked the rest, and whether it means it.Thu, 17 Sep 2026 00:00:00 GMTdrugs-fdabotanical-drugsfdamahanatural-productsregulatoryMarcus Chenhttps://thefirstcohort.com/articles/2026-09-17-the-whole-grain-sweet-spot-is-4-to-6-servings-and-it-nudged-five-heart-risk-numbhttps://thefirstcohort.com/articles/2026-09-17-the-whole-grain-sweet-spot-is-4-to-6-servings-and-it-nudged-five-heart-risk-numb60 to 100 grams a day moved body weight, blood pressure, cholesterol, blood sugar and an inflammation marker together, the same cluster clinicians usually treat one number, and one prescription, at a time.Thu, 17 Sep 2026 00:00:00 GMTnutrition-foodwhole grainsheart healthnutritionmetabolicfiberSarah Okonkwohttps://thefirstcohort.com/articles/2026-09-17-the-cell-mistakes-its-own-broken-dna-for-a-virus-and-the-panic-helps-wreck-a-fashttps://thefirstcohort.com/articles/2026-09-17-the-cell-mistakes-its-own-broken-dna-for-a-virus-and-the-panic-helps-wreck-a-fasFor decades the broken DNA got the blame. In fast-aging fish carrying a DNA-repair disorder, a major driver turned out to be the cell's own inflammatory overreaction, and silencing the sensor eased the ruin.Thu, 17 Sep 2026 00:00:00 GMTbrain-agingagingcgas-stingdna-damageinflammationlongevitySarah Okonkwohttps://thefirstcohort.com/articles/2026-09-17-a-top-cancer-researcher-logged-333-tumor-reports-after-covid-shots-and-infectionhttps://thefirstcohort.com/articles/2026-09-17-a-top-cancer-researcher-logged-333-tumor-reports-after-covid-shots-and-infectionWafik El-Deiry helped map how the p53 gene guards against cancer. Now he has co-authored a review of 333 tumor reports that surfaced or came roaring back after COVID vaccination or infection, plus a blunt admission that no one has produced the population study to rule the vaccine link out.Thu, 17 Sep 2026 00:00:00 GMTcancermrna-vaccinescancerimmune-surveillanceigg4regulatory-capturecovidSarah Okonkwohttps://thefirstcohort.com/articles/2026-09-16-they-sniffed-dark-chocolate-on-an-empty-stomach-and-cranked-out-18-more-repshttps://thefirstcohort.com/articles/2026-09-16-they-sniffed-dark-chocolate-on-an-empty-stomach-and-cranked-out-18-more-repsTwenty-three fasted men sniffed 90 percent dark chocolate and did roughly 18 more leg-extension reps than on water, without feeling like they'd worked any harder.Wed, 16 Sep 2026 00:00:00 GMTmetabolic-weightmetabolicexercise-performanceappetitedark-chocolateresistance-trainingSarah Okonkwohttps://thefirstcohort.com/articles/2026-09-16-the-study-clearing-sucralose-was-co-written-by-the-company-that-makes-ithttps://thefirstcohort.com/articles/2026-09-16-the-study-clearing-sucralose-was-co-written-by-the-company-that-makes-itAn independent lab found sucralose's byproduct breaks chromosomes and loosens the gut wall in cell experiments. The rebuttal telling you it's fine was co-written by the company that manufactures sucralose.Wed, 16 Sep 2026 00:00:00 GMTnutrition-foodsucraloseartificial-sweetenersgut-healthgenotoxicityregulatory-capturefood-additivesSarah Okonkwohttps://thefirstcohort.com/articles/2026-09-16-the-fda-s-new-pilot-lets-a-drug-sponsor-choose-the-institution-helping-build-itshttps://thefirstcohort.com/articles/2026-09-16-the-fda-s-new-pilot-lets-a-drug-sponsor-choose-the-institution-helping-build-itsThe agency will select 8 to 10 sponsor-QRI pairs to co-develop first-in-human trial applications it reviews on a rolling basis, and its stated reason is that China and Australia get there faster.Wed, 16 Sep 2026 00:00:00 GMTdrugs-fdafdafirst-in-humandrug-developmentregulatory-capturerevolving-doorclinical-trialsLena Marshallhttps://thefirstcohort.com/articles/2026-09-16-same-genes-different-fold-a-fly-wing-regrows-only-when-distant-dna-toucheshttps://thefirstcohort.com/articles/2026-09-16-same-genes-different-fold-a-fly-wing-regrows-only-when-distant-dna-touchesDisturb the way the DNA folds after an injury, and the fruit fly still builds a normal wing but loses much of its power to repair one. The instructions to heal weren't only in the genes. They were in the shape.Wed, 16 Sep 2026 00:00:00 GMTbrain-aginggeneticsregenerationchromatindrosophilabasic-scienceLena Marshallhttps://thefirstcohort.com/articles/2026-09-15-usc-scanned-459-aging-brains-across-india-the-wiring-just-under-the-cortex-not-thttps://thefirstcohort.com/articles/2026-09-15-usc-scanned-459-aging-brains-across-india-the-wiring-just-under-the-cortex-not-tIn 459 older adults across India, healthier short-range wiring just beneath the cortex was tied to a weaker link between gray matter loss and cognition, and the tie was strongest in people with the least schooling.Tue, 15 Sep 2026 00:00:00 GMTbrain-agingbrain-agingcognitiondementiawhite-matterlongevityneuroscienceSarah Okonkwohttps://thefirstcohort.com/articles/2026-09-15-the-women-low-on-vitamin-d-were-three-times-as-likely-to-wake-from-a-mastectomyhttps://thefirstcohort.com/articles/2026-09-15-the-women-low-on-vitamin-d-were-three-times-as-likely-to-wake-from-a-mastectomyNinety-two breast cancer patients went into a mastectomy deficient in vitamin D; they were three times as likely to be in serious pain afterward and drew far more from the tramadol pump than the women whose levels were fine.Tue, 15 Sep 2026 00:00:00 GMTcancervitamin-dbreast-canceropioidspostoperative-painsupplementsLena Marshallhttps://thefirstcohort.com/articles/2026-09-15-the-sixteen-drug-companies-funding-britain-s-biggest-health-study-can-mine-datahttps://thefirstcohort.com/articles/2026-09-15-the-sixteen-drug-companies-funding-britain-s-biggest-health-study-can-mine-dataOur Future Health signed up 1.9 million volunteers on £354 million of public money and £180 million from 16 drug companies. Its own scientists now warn the sample skews wealthy and healthy, and cannot yet say how common any disease actually is.Tue, 15 Sep 2026 00:00:00 GMTinvestigationscohort-studiespharma-fundinghealth-dataselection-biasuk-biobankSarah Okonkwohttps://thefirstcohort.com/articles/2026-09-15-the-government-is-keeping-almost-all-of-abbott-s-385-million-formula-settlementhttps://thefirstcohort.com/articles/2026-09-15-the-government-is-keeping-almost-all-of-abbott-s-385-million-formula-settlementAbbott will pay $385 million over the plant tied to two infant deaths. Almost every dollar reimburses Washington's own nutrition programs, three whistleblowers split $69 million, and the families get nothing. The DOJ dropped the criminal case after Abbott gave $500,000 to the president's inaugural fTue, 15 Sep 2026 00:00:00 GMTinvestigationsinfant-formulaabbottfdafood-safetyregulatory-capturecronobacterSarah Okonkwohttps://thefirstcohort.com/articles/2026-09-15-scientists-quieted-aging-inflammation-in-mice-by-starving-zombie-cells-not-killihttps://thefirstcohort.com/articles/2026-09-15-scientists-quieted-aging-inflammation-in-mice-by-starving-zombie-cells-not-killiFor years the anti-aging plan was to hunt down and kill the senescent cells driving inflammation. A Mayo and Sanford Burnham team quieted that inflammation in mice instead, by blocking the carrier that feeds their mitochondria the acetyl-CoA used to pry open inflammatory genes.Tue, 15 Sep 2026 00:00:00 GMTbrain-agingagingsenescent-cellsinflammationmitochondrialongevitymetabolismSarah Okonkwohttps://thefirstcohort.com/articles/2026-09-15-a-fatal-brain-disease-in-children-finally-has-a-drug-and-it-lists-at-1-14-milliohttps://thefirstcohort.com/articles/2026-09-15-a-fatal-brain-disease-in-children-finally-has-a-drug-and-it-lists-at-1-14-millioIonis's zilganersen is the first therapy ever approved for Alexander disease, and it lists near $1.14 million a year. The same FDA approval handed Ionis a rare pediatric disease voucher, the transferable coupon that has resold for as much as $350 million.Tue, 15 Sep 2026 00:00:00 GMTdrugs-fdaalexander-diseaseantisenseionisrare-diseasedrug-pricingfdaMarcus Chenhttps://thefirstcohort.com/articles/2026-09-14-they-drew-blood-from-719-women-and-children-in-rural-bangladesh-every-sample-hadhttps://thefirstcohort.com/articles/2026-09-14-they-drew-blood-from-719-women-and-children-in-rural-bangladesh-every-sample-hadEvery one of 712 whole-blood samples from a cohort of 719 rural Bangladeshi women and children carried at least two mold toxins, and 84 percent of participants carried three or more, including one the liver converts into a carcinogen.Mon, 14 Sep 2026 00:00:00 GMTnutrition-foodmycotoxinsaflatoxinfood-safetychildrens-healthwomens-healthenvironmental-healthSarah Okonkwohttps://thefirstcohort.com/articles/2026-09-14-the-study-breaking-pancreatic-cancer-s-shield-was-co-written-by-the-drug-s-makerhttps://thefirstcohort.com/articles/2026-09-14-the-study-breaking-pancreatic-cancer-s-shield-was-co-written-by-the-drug-s-makerThe 'breakthrough' bought engineered mice eleven extra days, its headline human numbers come from a post-hoc subgroup, and one author is the chief scientist of the company that makes the drug.Mon, 14 Sep 2026 00:00:00 GMTcancerpancreatic-canceril1rapnadunolimabconflicts-of-interestimmunotherapyLena Marshallhttps://thefirstcohort.com/articles/2026-09-14-the-fda-approved-a-breast-cancer-drug-its-own-advisers-had-just-rejected-6-to-3https://thefirstcohort.com/articles/2026-09-14-the-fda-approved-a-breast-cancer-drug-its-own-advisers-had-just-rejected-6-to-3An FDA advisory panel voted 6 to 3 that AstraZeneca had not shown its breast cancer drug delivered a meaningful benefit. The agency approved it four months later anyway.Mon, 14 Sep 2026 00:00:00 GMTdrugs-fdafdabreast-canceraccelerated-approvalastrazenecaregulatory-captureoncologyLena Marshallhttps://thefirstcohort.com/articles/2026-09-14-the-escape-hatch-in-trump-s-drug-deal-26-companies-signed-their-way-out-of-the-phttps://thefirstcohort.com/articles/2026-09-14-the-escape-hatch-in-trump-s-drug-deal-26-companies-signed-their-way-out-of-the-pTwenty-six drugmakers have signed voluntary White House agreements that exempt them from the proposed mandatory Medicare price cuts, and an analysis finds the deals could erase as much as 80 percent of the projected savings.Mon, 14 Sep 2026 00:00:00 GMTinvestigationsdrug-pricingmedicaremost-favored-nationpharmatransparencytrumpLena Marshallhttps://thefirstcohort.com/articles/2026-09-14-four-in-five-men-have-never-heard-milk-is-tied-to-prostate-cancerhttps://thefirstcohort.com/articles/2026-09-14-four-in-five-men-have-never-heard-milk-is-tied-to-prostate-cancerA vegan advocacy group's survey says only 20% of men know the link. The growth-hormone mechanism is well-mapped, the relative risks are modest, and nobody in a white coat is walking men through either one.Mon, 14 Sep 2026 00:00:00 GMTnutrition-foodprostate-cancerdairynutritionigf-1mens-healthSarah Okonkwohttps://thefirstcohort.com/articles/2026-09-14-a-fat-brake-eased-pain-in-49-men-but-barely-touched-the-swellinghttps://thefirstcohort.com/articles/2026-09-14-a-fat-brake-eased-pain-in-49-men-but-barely-touched-the-swellingUCL researchers gave 49 healthy men a drug GlaxoSmithKline shelved after early trials. Pain resolved faster and a class of immune cells shrank, but the heat, redness, and swelling showed no significant change.Mon, 14 Sep 2026 00:00:00 GMTautoimmune-inflammationinflammationmonocytesdrug-repurposingepoxy-oxylipinsautoimmunepharmaSarah Okonkwohttps://thefirstcohort.com/articles/2026-09-13-the-zombie-papers-retracted-stem-cell-studies-still-feeding-the-unproven-cure-mahttps://thefirstcohort.com/articles/2026-09-13-the-zombie-papers-retracted-stem-cell-studies-still-feeding-the-unproven-cure-maA stem-cell paper retracted in November 2021 kept collecting citations for years, 72 by mid-2026, 27 of them after the notice went up, 15 since 2023 that never mention it. Two researchers counted, and named who is supposed to be cleaning up.Sun, 13 Sep 2026 00:00:00 GMTinvestigationsresearch-integrityretractionsstem-cellsscientific-publishingconflicts-of-interestMira Petrovhttps://thefirstcohort.com/articles/2026-09-13-the-heart-scan-sold-to-everyone-barely-beats-a-free-calculator-except-for-the-pahttps://thefirstcohort.com/articles/2026-09-13-the-heart-scan-sold-to-everyone-barely-beats-a-free-calculator-except-for-the-paThe scan barely moved the needle over a free calculator for most adults, but inside the muddy middle of risk, calcium separated a 1.9 percent ten-year danger from a 14.3 percent one.Sun, 13 Sep 2026 00:00:00 GMTmetabolic-weightheart-diseasecardiac-imagingcalcium-scorecardiovascular-riskstatinsMarcus Chenhttps://thefirstcohort.com/articles/2026-09-13-the-fast-every-type-1-diabetic-is-warned-against-held-up-in-a-six-month-trialhttps://thefirstcohort.com/articles/2026-09-13-the-fast-every-type-1-diabetic-is-warned-against-held-up-in-a-six-month-trialThirty-two obese adults with Type 1 diabetes ate only between noon and 8 p.m. for six months. No rise in severe lows, severe highs, or ketoacidosis, and their HbA1c fell 0.46 points against the calorie-cutting group.Sun, 13 Sep 2026 00:00:00 GMTmetabolic-weightintermittent-fastingtype-1-diabetestime-restricted-eatingblood-sugarmetabolic-healthSarah Okonkwohttps://thefirstcohort.com/articles/2026-09-13-ozempic-gave-old-mice-a-diet-s-longevity-payoff-without-slowing-their-metabolismhttps://thefirstcohort.com/articles/2026-09-13-ozempic-gave-old-mice-a-diet-s-longevity-payoff-without-slowing-their-metabolismSemaglutide added 12 percent to old mice's median lifespan and matched calorie restriction on aging measures without slowing their metabolism the way dieting does. It was also female mice only, three months of dosing, and zero human longevity data under the fountain-of-youth headlines.Sun, 13 Sep 2026 00:00:00 GMTmetabolic-weightglp-1longevitysemaglutideagingmetabolicSarah Okonkwohttps://thefirstcohort.com/articles/2026-09-13-md-anderson-made-the-case-for-radiation-cleanup-after-immunotherapy-then-its-ownhttps://thefirstcohort.com/articles/2026-09-13-md-anderson-made-the-case-for-radiation-cleanup-after-immunotherapy-then-its-ownIn the oligometastatic subgroup the strategy was built for, small and underpowered, the patients who added radiation trended the wrong way: median survival of 42 months against 75.8 for the drugs alone.Sun, 13 Sep 2026 00:00:00 GMTcancerlung-cancerimmunotherapyradiationclinical-trialsoncologyLena Marshallhttps://thefirstcohort.com/articles/2026-09-13-arsenic-s-detox-pathway-has-a-catch-the-workers-who-finished-it-had-higher-bloodhttps://thefirstcohort.com/articles/2026-09-13-arsenic-s-detox-pathway-has-a-catch-the-workers-who-finished-it-had-higher-bloodIn 393 young Central American farmworkers carrying arsenic in their urine, the men whose bodies most efficiently converted it to DMA had systolic pressure up to 7 mmHg higher. The textbook calls that step detoxification.Sun, 13 Sep 2026 00:00:00 GMTmetabolic-weightarsenicblood-pressureenvironmental-healthmesoamerican-nephropathyheavy-metalsSarah Okonkwohttps://thefirstcohort.com/articles/2026-09-12-ucla-can-grow-thousands-of-cancer-fighting-cell-doses-in-six-weeks-every-patienthttps://thefirstcohort.com/articles/2026-09-12-ucla-can-grow-thousands-of-cancer-fighting-cell-doses-in-six-weeks-every-patientThe lab put a $5,000-a-dose price on an off-the-shelf cancer therapy grown from cord blood that controlled tumors in mice with ovarian cancer and melanoma. No human has received it.Sat, 12 Sep 2026 00:00:00 GMTcancercell-therapyoncologycord-bloodtcr-tpreclinicalLena Marshallhttps://thefirstcohort.com/articles/2026-09-12-the-gene-that-derails-brain-development-is-also-a-brake-on-your-killer-t-cellshttps://thefirstcohort.com/articles/2026-09-12-the-gene-that-derails-brain-development-is-also-a-brake-on-your-killer-t-cellsThe same gene whose failure derails brain development in children sits like a brake on the CD8 T cells your body uses against chronic hepatitis B and cancer. Take the brake off in the lab, and their fate reroutes toward fighters that do not burn out.Sat, 12 Sep 2026 00:00:00 GMTcancerimmunologycd8-t-cellshepatitis-bcancer-immunotherapychromatint-cell-exhaustionSarah Okonkwohttps://thefirstcohort.com/articles/2026-09-12-sickle-cell-finally-has-a-cure-it-costs-2-2-million-and-has-reached-64-peoplehttps://thefirstcohort.com/articles/2026-09-12-sickle-cell-finally-has-a-cure-it-costs-2-2-million-and-has-reached-64-peopleCasgevy has kept Victoria Gray crisis-free for seven years. Getting it still means wiping out a patient's bone marrow with a chemo tied to infertility and malignancy warnings and paying about $3 million all in, and two years after approval only 64 people have been infused.Sat, 12 Sep 2026 00:00:00 GMTdrugs-fdagene-editingcrisprsickle-cellcasgevydrug-pricingfdaMarcus Chenhttps://thefirstcohort.com/articles/2026-09-12-four-times-the-odds-of-losing-bowel-control-an-adhd-gut-signal-tangled-up-with-thttps://thefirstcohort.com/articles/2026-09-12-four-times-the-odds-of-losing-bowel-control-an-adhd-gut-signal-tangled-up-with-tStimulants list constipation, nausea, and stomach pain among their common side effects. Most of the 23 studies pooling 1.9 million people never separated the medicated from the unmedicated, so the gut signal and the drug effect sit tangled together.Sat, 12 Sep 2026 00:00:00 GMTbrain-agingadhdgut-healthmicrobiomestimulantsgut-brain-axisSarah Okonkwohttps://thefirstcohort.com/articles/2026-09-12-a-journal-built-to-critique-capitalism-sold-for-360-000-its-fifteen-editors-readhttps://thefirstcohort.com/articles/2026-09-12-a-journal-built-to-critique-capitalism-sold-for-360-000-its-fifteen-editors-readA €360,000 sale, a €1,350 charge to publish, and a 25 percent fee to withdraw your own paper: the board of a journal built to critique capitalism read the new terms and resigned en masse.Sat, 12 Sep 2026 00:00:00 GMTinvestigationsresearch-integrityacademic-publishingpeer-reviewconflicts-of-interestpredatory-journalsMira Petrovhttps://thefirstcohort.com/articles/2026-09-11-the-fda-is-fighting-a-flesh-eating-parasite-we-eradicated-in-1966-with-a-flea-pihttps://thefirstcohort.com/articles/2026-09-11-the-fda-is-fighting-a-flesh-eating-parasite-we-eradicated-in-1966-with-a-flea-piNitenpyram was approved in 2000 to kill fleas. It is now the emergency tool against a parasite the United States wiped out in 1966, after the sterile-fly barrier that kept the screwworm out was breached in 2023.Fri, 11 Sep 2026 00:00:00 GMTinfectious-diseasescrewwormfdaeuaveterinarypublic-healthborderMarcus Chenhttps://thefirstcohort.com/articles/2026-09-11-the-coffee-and-bones-study-behind-the-scary-headline-found-no-significant-coffeehttps://thefirstcohort.com/articles/2026-09-11-the-coffee-and-bones-study-behind-the-scary-headline-found-no-significant-coffeeThe tea benefit was 0.003 grams per square centimeter, a number the authors themselves called too small to matter. The scary coffee result never cleared statistical significance.Fri, 11 Sep 2026 00:00:00 GMTnutrition-foodcoffeeteabone-densityosteoporosisnutritionscience-hypeSarah Okonkwohttps://thefirstcohort.com/articles/2026-09-11-the-bone-building-switch-is-back-in-the-headlines-it-was-tested-in-mice-and-onlyhttps://thefirstcohort.com/articles/2026-09-11-the-bone-building-switch-is-back-in-the-headlines-it-was-tested-in-mice-and-onlyA publicly funded Leipzig compound rebuilt bone in ovariectomized mice, 8 per treated group. More than a year later the same experiment is still being sold to readers as a way to keep their bones strong for life.Fri, 11 Sep 2026 00:00:00 GMTdrugs-fdaosteoporosisbonedrug-developmentpreclinicalgpr133agingLena Marshallhttps://thefirstcohort.com/articles/2026-09-11-sprouts-have-poisoned-thousands-for-a-quarter-century-the-wellness-world-still-ehttps://thefirstcohort.com/articles/2026-09-11-sprouts-have-poisoned-thousands-for-a-quarter-century-the-wellness-world-still-eSalmonella from Idaho broccoli sprouts has sickened 22 across four states, one more entry in a tally that logged 53 sprout outbreaks in two decades. The raw-is-best dogma is what keeps them coming.Fri, 11 Sep 2026 00:00:00 GMTnutrition-foodfood-safetysalmonellasproutssulforaphanefoodborne-illnessMarcus Chenhttps://thefirstcohort.com/articles/2026-09-11-a-kinesiologist-argues-aging-has-a-third-clock-and-it-fades-firsthttps://thefirstcohort.com/articles/2026-09-11-a-kinesiologist-argues-aging-has-a-third-clock-and-it-fades-firstGeorgia Southern's Li Li argues aging has a third clock, movement span, that starts narrowing before any disease shows up. A compelling reframe with one catch: it's an opinion paper carrying zero new data.Fri, 11 Sep 2026 00:00:00 GMTbrain-agingaginglongevitymovementhealthspanmobilitySarah Okonkwohttps://thefirstcohort.com/articles/2026-09-10-two-factories-make-the-starter-iv-nutrition-america-s-preemies-live-on-both-arehttps://thefirstcohort.com/articles/2026-09-10-two-factories-make-the-starter-iv-nutrition-america-s-preemies-live-on-both-areThe predominant source of starter IV nutrition for premature newborns is two outsourcing facilities, and both are permanently closing. The FDA's fix: let hospital pharmacies mix it themselves for 180 days, sending the most unforgiving product in medicine back into the loosely regulated compounding tThu, 10 Sep 2026 00:00:00 GMTdrugs-fdaneonatalparenteral-nutritionfdadrug-shortagecompoundingSarah Okonkwohttps://thefirstcohort.com/articles/2026-09-10-the-startup-selling-optimized-babies-just-paid-to-gene-edit-human-embryoshttps://thefirstcohort.com/articles/2026-09-10-the-startup-selling-optimized-babies-just-paid-to-gene-edit-human-embryosColumbia scientists rewrote cholesterol and sickle-cell genes in human embryos, reaching 100 percent in embryos edited before their first division. The funder sells parents 'optimized' babies, and a germline edit like this could be inherited by every generation that follows.Thu, 10 Sep 2026 00:00:00 GMTinvestigationsgene-editinggermlinebase-editingdesigner-babiesbiotechembryosMarcus Chenhttps://thefirstcohort.com/articles/2026-09-10-the-sea-squirt-that-reverses-aging-is-a-mouse-study-from-2022-the-capsules-are-ahttps://thefirstcohort.com/articles/2026-09-10-the-sea-squirt-that-reverses-aging-is-a-mouse-study-from-2022-the-capsules-are-aThe mice got 300 milligrams per kilogram by feeding tube, five days a week, for two months. The human trials used about a milligram a day, most were funded by the companies selling the capsules, and the largest could not beat placebo.Thu, 10 Sep 2026 00:00:00 GMTbrain-aginglongevitysupplementsplasmalogenbrain-agingwellnessSarah Okonkwohttps://thefirstcohort.com/articles/2026-09-10-a-blueberry-compound-pulled-fat-out-of-muscle-cells-by-saving-the-protein-that-bhttps://thefirstcohort.com/articles/2026-09-10-a-blueberry-compound-pulled-fat-out-of-muscle-cells-by-saving-the-protein-that-bPterostilbene didn't switch on fat-burning in muscle cells. It stopped them from destroying the protein that runs it, and the stored fat came apart. The catch: this happened in a dish, and you can't eat your way to the dose.Thu, 10 Sep 2026 00:00:00 GMTmetabolic-weightpterostilbenemetabolicmyosteatosisblueberriessupplementsSarah Okonkwohttps://thefirstcohort.com/articles/2026-09-10-a-2014-trial-warned-that-correcting-vaccine-fears-backfires-on-the-hesitant-publhttps://thefirstcohort.com/articles/2026-09-10-a-2014-trial-warned-that-correcting-vaccine-fears-backfires-on-the-hesitant-publA randomized trial found that correcting MMR-autism fears left the most hesitant parents less likely to vaccinate. A decade later, a panel of credentialed doctors in Sydney shows the trust cost of correcting harder anyway.Thu, 10 Sep 2026 00:00:00 GMTinfectious-diseasevaccinesmrnapublic-healthcovidtrustMarcus Chenhttps://thefirstcohort.com/articles/2026-09-10-97-000-sibling-sets-later-standard-air-pollution-birth-studies-overshot-one-riskhttps://thefirstcohort.com/articles/2026-09-10-97-000-sibling-sets-later-standard-air-pollution-birth-studies-overshot-one-riskComparing brothers and sisters born to the same mother stripped out many of the family-level confounders, and the scary preterm-birth links shrank while the growth-restriction link the conventional models kept underselling got stronger.Thu, 10 Sep 2026 00:00:00 GMTinvestigationsair-pollutionbirth-outcomesepidemiologyfetal-growthconfoundingwomens-healthSarah Okonkwohttps://thefirstcohort.com/articles/2026-09-09-the-fda-has-approved-4-plant-drugs-since-2004-now-it-s-asking-the-public-why-sohttps://thefirstcohort.com/articles/2026-09-09-the-fda-has-approved-4-plant-drugs-since-2004-now-it-s-asking-the-public-why-soA request for public input is not reform. After two decades of a pathway that produced four approvals, the question is whether the agency wants plant medicine or just wants to talk about it.Wed, 09 Sep 2026 00:00:00 GMTdrugs-fdafdabotanical-drugsmaharegulatoryplant-medicinecannabisMarcus Chenhttps://thefirstcohort.com/articles/2026-09-09-summit-s-500-million-lung-drug-split-the-curve-patients-can-t-feelhttps://thefirstcohort.com/articles/2026-09-09-summit-s-500-million-lung-drug-split-the-curve-patients-can-t-feelIvonescimab delayed tumor progression by 2.4 months in EGFR-mutated lung cancer, but its overall-survival curve never cleared statistical significance and serious treatment-related adverse events nearly doubled.Wed, 09 Sep 2026 00:00:00 GMTcancerlung-canceroncologyclinical-trialssurrogate-endpointsfdaLena Marshallhttps://thefirstcohort.com/articles/2026-09-09-statins-and-dementia-a-benefit-the-registries-keep-finding-and-the-trials-neverhttps://thefirstcohort.com/articles/2026-09-09-statins-and-dementia-a-benefit-the-registries-keep-finding-and-the-trials-neverA Danish registry of 132,000 diabetics reports early statin use lowers dementia risk by 15 percent. The randomized trials that could confirm it, covering tens of thousands of patients, found nothing.Wed, 09 Sep 2026 00:00:00 GMTbrain-agingstatinsdementiadiabetesobservational-studiespharmaLena Marshallhttps://thefirstcohort.com/articles/2026-09-09-rattlesnakes-carry-their-own-antivenom-in-their-blood-and-in-mice-a-cocktail-ofhttps://thefirstcohort.com/articles/2026-09-09-rattlesnakes-carry-their-own-antivenom-in-their-blood-and-in-mice-a-cocktail-ofRattlesnakes shrug off key parts of their own venom. Biologists found the blood proteins behind that trick, mixed them, and in mice the cocktail neutralized diamondback venom about 10 times better than the commercial antivenom.Wed, 09 Sep 2026 00:00:00 GMTinfectious-diseaseantivenomsnakebiterattlesnaketoxinologyneglected-tropical-diseaseSarah Okonkwohttps://thefirstcohort.com/articles/2026-09-09-fused-into-one-cell-a-neutrophil-and-a-macrophage-ate-tumors-two-wayshttps://thefirstcohort.com/articles/2026-09-09-fused-into-one-cell-a-neutrophil-and-a-macrophage-ate-tumors-two-waysCAR-macrophage therapy keeps stalling in solid tumors: it can't get in, and it can't finish. Fuse a neutrophil onto it and, in mice, one dose shrank the tumor and kept it from coming back.Wed, 09 Sep 2026 00:00:00 GMTcancercancerimmunotherapycar-macrophageneutrophilssolid-tumorsSarah Okonkwohttps://thefirstcohort.com/articles/2026-09-09-a-salsa-class-a-grocery-list-and-38-check-ins-beat-health-advice-on-memory-by-55https://thefirstcohort.com/articles/2026-09-09-a-salsa-class-a-grocery-list-and-38-check-ins-beat-health-advice-on-memory-by-55Across 11 Latin American countries, a coached program of exercise, an adapted MIND diet, and cognitive training improved older adults' thinking 55 percent more than periodic health advice, with no infusion chair and no $26,500-a-year drug.Wed, 09 Sep 2026 00:00:00 GMTbrain-agingdementiacognitive-declinelifestyle-medicinebrain-agingalzheimersSarah Okonkwohttps://thefirstcohort.com/articles/2026-09-08-the-breast-cancer-cells-that-hide-from-chemotherapy-were-already-there-before-thhttps://thefirstcohort.com/articles/2026-09-08-the-breast-cancer-cells-that-hide-from-chemotherapy-were-already-there-before-thBritish researchers mapped where dormant breast-tumor cells hide, inside protective pockets of immune and connective cells, and found cells resembling therapy-resistant survivors already parked there before treatment begins.Tue, 08 Sep 2026 00:00:00 GMTcancerbreast cancerdormancychemotherapy resistancetumor microenvironmentrecurrenceLena Marshallhttps://thefirstcohort.com/articles/2026-09-08-oxford-found-the-cells-that-may-mark-which-joints-rheumatoid-arthritis-attacks-thttps://thefirstcohort.com/articles/2026-09-08-oxford-found-the-cells-that-may-mark-which-joints-rheumatoid-arthritis-attacks-tThe joints rheumatoid arthritis attacks and the ones it spares are built differently in the womb, seeded with different cells before a single joint ever swells.Tue, 08 Sep 2026 00:00:00 GMTautoimmune-inflammationrheumatoid-arthritisautoimmunefibroblastsdevelopmental-biologyjointsSarah Okonkwohttps://thefirstcohort.com/articles/2026-09-08-in-1999-fifteen-reports-suspended-a-vaccine-within-weeks-the-spike-signal-has-wahttps://thefirstcohort.com/articles/2026-09-08-in-1999-fifteen-reports-suspended-a-vaccine-within-weeks-the-spike-signal-has-waSpike protein has turned up in the vessel-lining cells of vasculitic skin lesions 18 months after the shot, and adverse-event reports keep stacking up. The agencies that suspended a vaccine over fifteen reports in 1999 now call thousands a coincidence.Tue, 08 Sep 2026 00:00:00 GMTinfectious-diseasecovid-19vaccine-safetyspike-proteinvaersspikeopathymrnaMarcus Chenhttps://thefirstcohort.com/articles/2026-09-08-dirty-air-is-linked-to-16-percent-more-inflammation-in-your-blood-does-that-damahttps://thefirstcohort.com/articles/2026-09-08-dirty-air-is-linked-to-16-percent-more-inflammation-in-your-blood-does-that-damaEach step up in long-term fine-particle exposure is tied to nearly 16 percent higher inflammation in older adults' blood, and a CHARLS analysis asks whether that same signal is what wears down the aging brain.Tue, 08 Sep 2026 00:00:00 GMTbrain-agingair-pollutionneurodegenerationinflammationbrain-agingpm2.5Sarah Okonkwohttps://thefirstcohort.com/articles/2026-09-08-autistic-teenagers-are-bullied-three-times-as-often-and-we-have-barely-studied-hhttps://thefirstcohort.com/articles/2026-09-08-autistic-teenagers-are-bullied-three-times-as-often-and-we-have-barely-studied-hAutistic teenagers are bullied roughly three times as often as their peers, and the sexual-victimization risk that shadows them into adulthood is just as real, yet the research meant to protect them is small, scattered, and looking the other way.Tue, 08 Sep 2026 00:00:00 GMTbrain-agingautismadolescencebullyingsexual-abusemental-healthresearch-gapsSarah Okonkwohttps://thefirstcohort.com/articles/2026-09-08-at-the-dose-the-fda-calls-safe-two-sweeteners-reshaped-the-guts-of-mouse-grandpuhttps://thefirstcohort.com/articles/2026-09-08-at-the-dose-the-fda-calls-safe-two-sweeteners-reshaped-the-guts-of-mouse-grandpuChilean researchers fed mice sucralose and stevia at the doses the FDA calls safe. The metabolic marks showed up in grandpups that only drank water.Tue, 08 Sep 2026 00:00:00 GMTmetabolic-weightsucralosesteviagut-microbiomeblood-sugarmetabolic-healthSarah Okonkwohttps://thefirstcohort.com/articles/2026-09-07-your-gut-bacteria-decide-whether-sorbitol-is-harmless-or-a-liver-problemhttps://thefirstcohort.com/articles/2026-09-07-your-gut-bacteria-decide-whether-sorbitol-is-harmless-or-a-liver-problemSorbitol was sold for decades as the inert, guilt-free sugar swap. In zebrafish stripped of their gut bacteria, WashU researchers watched the intestine's own sorbitol reach the liver and feed the same fructose-metabolism pathway that packs on liver fat.Mon, 07 Sep 2026 00:00:00 GMTnutrition-foodsorbitolsugar-freefatty-livergut-microbiomesweetenersmetabolicSarah Okonkwohttps://thefirstcohort.com/articles/2026-09-07-weathered-plastic-in-the-water-grows-its-own-city-of-drug-resistant-bacteriahttps://thefirstcohort.com/articles/2026-09-07-weathered-plastic-in-the-water-grows-its-own-city-of-drug-resistant-bacteriaOn weathered plastic drifting from a lake into a river, researchers logged 102 new antibiotic-resistance gene subtypes moving into the surrounding water in five weeks.Mon, 07 Sep 2026 00:00:00 GMTinfectious-diseasemicroplasticsantibiotic-resistanceplastisphereenvironmental-healthmicrobiomeSarah Okonkwohttps://thefirstcohort.com/articles/2026-09-07-the-amino-acid-sold-for-focus-tracked-fewer-years-for-men-not-womenhttps://thefirstcohort.com/articles/2026-09-07-the-amino-acid-sold-for-focus-tracked-fewer-years-for-men-not-womenIn more than 270,000 people, men with higher blood tyrosine died sooner, by nearly a year on the genetic estimate. Women showed no clear lifespan signal. The amino acid is sold in capsules for focus.Mon, 07 Sep 2026 00:00:00 GMTbrain-agingtyrosinesupplementslongevitymendelian-randomizationmens-healthSarah Okonkwohttps://thefirstcohort.com/articles/2026-09-07-ionis-priced-the-first-alexander-disease-drug-at-1-14-million-a-year-and-got-a-fhttps://thefirstcohort.com/articles/2026-09-07-ionis-priced-the-first-alexander-disease-drug-at-1-14-million-a-year-and-got-a-fZilganersen is the first drug for Alexander disease, an antisense therapy designed to lower the toxic protein that drives a fatal brain disease. It also carries a $1.14 million annual price and a pediatric voucher Ionis can resell for more than $100 million.Mon, 07 Sep 2026 00:00:00 GMTdrugs-fdaalexander-diseasegfapantisenseionisorphan-drugsfdaMarcus Chenhttps://thefirstcohort.com/articles/2026-09-07-europe-wants-every-heart-patient-tested-for-kidney-disease-the-test-is-cheap-thehttps://thefirstcohort.com/articles/2026-09-07-europe-wants-every-heart-patient-tested-for-kidney-disease-the-test-is-cheap-theThe European Society of Cardiology now says screen every heart patient for kidney damage and start the drugs early. More than 80 percent of the guideline's authors report financial ties to industry.Mon, 07 Sep 2026 00:00:00 GMTmetabolic-weightcardiorenalchronic-kidney-diseasesglt2-inhibitorsesc-guidelinesconflicts-of-interestscreeningSarah Okonkwohttps://thefirstcohort.com/articles/2026-09-06-twenty-people-no-control-arm-and-a-startup-on-the-side-reading-the-pancreatic-cahttps://thefirstcohort.com/articles/2026-09-06-twenty-people-no-control-arm-and-a-startup-on-the-side-reading-the-pancreatic-caNinety percent of twenty volunteers made KRAS-specific T cells. None was shown to avoid cancer. Two of the investigators co-founded the company that licensed the shot from Johns Hopkins, which stands to collect royalties.Sun, 06 Sep 2026 00:00:00 GMTcancerpancreatic-cancerkrascancer-vaccineconflict-of-interestclinical-trialsLena Marshallhttps://thefirstcohort.com/articles/2026-09-06-they-didn-t-rewrite-the-memory-a-flinch-of-surprise-predicted-who-got-betterhttps://thefirstcohort.com/articles/2026-09-06-they-didn-t-rewrite-the-memory-a-flinch-of-surprise-predicted-who-got-betterPolish researchers had 180 young adults imagine a defender stepping into a painful childhood memory. The rewrite itself helped only modestly. What predicted who improved was an involuntary jolt of surprise, measured in the skin, when the expected blow never came.Sun, 06 Sep 2026 00:00:00 GMTbrain-agingimagery-rescriptingmental-healthfear-of-failurememoryneuroscienceSarah Okonkwohttps://thefirstcohort.com/articles/2026-09-06-the-immune-cells-that-calm-autoimmune-disease-can-also-ignite-it-one-protein-mayhttps://thefirstcohort.com/articles/2026-09-06-the-immune-cells-that-calm-autoimmune-disease-can-also-ignite-it-one-protein-mayRegulatory T cells keep autoimmune disease in check, but under inflammation they can shed their identity and turn inflammatory. In mice, researchers find a protein called TIF1γ restrains that defection by sending a runaway growth signal to be destroyed.Sun, 06 Sep 2026 00:00:00 GMTautoimmune-inflammationregulatory-t-cellsautoimmunecancer-immunotherapyimmunologytreg-plasticitySarah Okonkwohttps://thefirstcohort.com/articles/2026-09-06-the-hiv-reservoir-everyone-called-untouchable-has-natural-killer-cell-fingerprinhttps://thefirstcohort.com/articles/2026-09-06-the-hiv-reservoir-everyone-called-untouchable-has-natural-killer-cell-fingerprinIn 104 people on long-term HIV treatment, the ones whose natural killer cells were armed a certain way carried far fewer intact copies of the virus. The reservoir that defeats every cure turns out to carry the fingerprints of an immune fight nobody thought was happening.Sun, 06 Sep 2026 00:00:00 GMTinfectious-diseasehivnatural-killer-cellsimmunologycure-researchreservoirSarah Okonkwohttps://thefirstcohort.com/articles/2026-09-06-the-fda-approved-a-breast-cancer-drug-four-months-after-its-advisers-voted-nohttps://thefirstcohort.com/articles/2026-09-06-the-fda-approved-a-breast-cancer-drug-four-months-after-its-advisers-voted-noOn April 30 the FDA's oncology advisers voted 6 to 3 that AstraZeneca's camizestrant hadn't shown a clinically meaningful benefit. On September 4 the agency approved it anyway, conceding in its own approval that the benefit is "not yet confirmed."Sun, 06 Sep 2026 00:00:00 GMTdrugs-fdafdaaccelerated-approvalbreast-cancerastrazenecactdnaoncologyLena Marshallhttps://thefirstcohort.com/articles/2026-09-06-the-calm-down-breath-that-made-people-bet-biggerhttps://thefirstcohort.com/articles/2026-09-06-the-calm-down-breath-that-made-people-bet-biggerA 2-second inhale and an 8-second exhale slowed 41 people's hearts and, across the same sessions, made them more willing to take the risky bet. The pull came from the reward side, not from any loss of caution.Sun, 06 Sep 2026 00:00:00 GMTbrain-agingbreathworkneurosciencedecision-makingheart-rate-variabilitywellnessriskSarah Okonkwohttps://thefirstcohort.com/articles/2026-09-06-microfold-cells-got-filed-as-the-gut-s-mail-slot-they-were-organizing-its-defenshttps://thefirstcohort.com/articles/2026-09-06-microfold-cells-got-filed-as-the-gut-s-mail-slot-they-were-organizing-its-defensThe specialized cells that hand your gut bacteria to the immune system turn out to build the niche that keeps antimicrobial defense switched on, and the same signal that makes them wires in the brake.Sun, 06 Sep 2026 00:00:00 GMTautoimmune-inflammationgut-immunitym-cellsil-22innate-lymphoid-cellsmicrobiomeSarah Okonkwohttps://thefirstcohort.com/articles/2026-09-06-decades-of-cancer-warning-signs-and-still-no-proof-they-save-liveshttps://thefirstcohort.com/articles/2026-09-06-decades-of-cancer-warning-signs-and-still-no-proof-they-save-livesEngland's cancer-awareness campaigns sent more people to the doctor for a decade. The reviews still can't show they caught a single cancer earlier or cut deaths, while the cancers that kill fastest stay silent until it's already too late.Sun, 06 Sep 2026 00:00:00 GMTcancercancerearly-detectionscreeningoncologypublic-healthLena Marshallhttps://thefirstcohort.com/articles/2026-09-06-china-runs-more-drug-trials-than-america-the-fda-says-it-can-no-longer-trust-dathttps://thefirstcohort.com/articles/2026-09-06-china-runs-more-drug-trials-than-america-the-fda-says-it-can-no-longer-trust-datChina went from under 8 percent of the world's drug trials in 2010 to passing the United States by 2020. After three deaths in Chinese studies surfaced late, the FDA says it has sometimes been denied access to the very sites whose data underpins American approvals.Sun, 06 Sep 2026 00:00:00 GMTdrugs-fdafdaclinical-trialschinadrug-approvalsgene-therapyregulatoryLena Marshallhttps://thefirstcohort.com/articles/2026-09-06-beef-level-b12-in-spirulina-the-study-measured-the-tank-not-a-humanhttps://thefirstcohort.com/articles/2026-09-06-beef-level-b12-in-spirulina-the-study-measured-the-tank-not-a-humanAn Icelandic supplement maker's light-tuned spirulina tested at beef-level active B12. The reading was taken from the biomass in a reactor. No one has yet fed it to a person to see whether the body can absorb it.Sun, 06 Sep 2026 00:00:00 GMTnutrition-foodspirulinavitamin-b12supplementsnutritionfood-techLena Marshallhttps://thefirstcohort.com/articles/2026-09-06-an-ai-read-4-4-million-mother-and-baby-records-and-says-it-can-predict-illness-ihttps://thefirstcohort.com/articles/2026-09-06-an-ai-read-4-4-million-mother-and-baby-records-and-says-it-can-predict-illness-iMoChiAgent forecasts maternal and infant disease from hospital records at a scale no clinician could read. A cautionary predecessor, Epic's sepsis tool, caught only a third of the cases it promised to catch.Sun, 06 Sep 2026 00:00:00 GMTinvestigationsmedical-aimaternal-healthprediction-modelselectronic-health-recordsfoundation-modelsMarcus Chenhttps://thefirstcohort.com/articles/2026-09-05-what-probiotics-actually-do-for-autistic-kids-isn-t-what-the-label-promiseshttps://thefirstcohort.com/articles/2026-09-05-what-probiotics-actually-do-for-autistic-kids-isn-t-what-the-label-promisesA review pooling about 1,000 participants found the clearest probiotic effect in autistic children lands on the gut, not behavior. The supplement aisle sells the reverse.Sat, 05 Sep 2026 00:00:00 GMTnutrition-foodprobioticsautismmicrobiomegut-brain-axisnutritionsupplementsSarah Okonkwohttps://thefirstcohort.com/articles/2026-09-05-what-fluoride-does-once-it-gets-past-the-teethhttps://thefirstcohort.com/articles/2026-09-05-what-fluoride-does-once-it-gets-past-the-teethAs Washington fights over whether to keep fluoridating tap water, the sharpest evidence on childhood fluoride and cardiovascular risk comes from places where the dose dwarfs anything out of a U.S. tap. The whole argument is about how much.Sat, 05 Sep 2026 00:00:00 GMTmetabolic-weightfluoridecardiovascularchildrenwater-safetymetabolicSarah Okonkwohttps://thefirstcohort.com/articles/2026-09-05-the-gut-s-doorway-cells-have-a-second-job-landlord-to-its-barrier-defendershttps://thefirstcohort.com/articles/2026-09-05-the-gut-s-doorway-cells-have-a-second-job-landlord-to-its-barrier-defendersMicrofold cells were filed away as passive antigen samplers. In mice, they turn out to build and staff the niche that keeps the gut's IL-22 defenders alive, the cytokine that fortifies the intestinal barrier and keeps sampled bacteria contained inside its immune outposts.Sat, 05 Sep 2026 00:00:00 GMTautoimmune-inflammationgut-immunitymicrobiomeil-22ilc3barrier-functionautoimmuneSarah Okonkwohttps://thefirstcohort.com/articles/2026-09-05-the-government-calls-the-ama-s-codes-a-monopoly-the-government-made-them-mandatohttps://thefirstcohort.com/articles/2026-09-05-the-government-calls-the-ama-s-codes-a-monopoly-the-government-made-them-mandatoRoyalties bring the American Medical Association more than half its revenue, $301.4 million in 2024, and the code set behind them is one federal rules make mandatory. This summer, CMS asked the public what that arrangement costs.Sat, 05 Sep 2026 00:00:00 GMTinvestigationsamacpt-codesmedicareregulatory-capturerfk-jrMira Petrovhttps://thefirstcohort.com/articles/2026-09-05-the-cheapest-measurement-in-the-exam-room-beat-bmi-and-the-lancet-s-four-part-obhttps://thefirstcohort.com/articles/2026-09-05-the-cheapest-measurement-in-the-exam-room-beat-bmi-and-the-lancet-s-four-part-obBMI flagged 37 percent of the adults a body-fat scan called obese. On overall accuracy, a cloth tape around the waist caught far more and edged out the four-measurement framework built to fix BMI.Sat, 05 Sep 2026 00:00:00 GMTmetabolic-weightobesitybmimetabolic-healthvisceral-fatglp-1diagnosisSarah Okonkwohttps://thefirstcohort.com/articles/2026-09-05-a-stanford-lab-deleted-one-immune-receptor-and-its-old-mice-barely-agedhttps://thefirstcohort.com/articles/2026-09-05-a-stanford-lab-deleted-one-immune-receptor-and-its-old-mice-barely-agedStanford says it found one big reason we age. The proof is a genetically engineered mouse, no such drug exists for people, and the senior author already holds patents on inhibiting the receptor she wants blocked.Sat, 05 Sep 2026 00:00:00 GMTbrain-agingaginginflammationsenescencemacrophageslongevitymouse-studyLena Marshallhttps://thefirstcohort.com/articles/2026-09-04-your-immune-cells-remember-obesity-for-up-to-a-decade-after-the-weight-comes-offhttps://thefirstcohort.com/articles/2026-09-04-your-immune-cells-remember-obesity-for-up-to-a-decade-after-the-weight-comes-offCD4 T cells hold chemical marks of past obesity for an estimated five to ten years, which may help explain why the risk for diabetes and some cancers can linger long after the scale reads normal.Fri, 04 Sep 2026 00:00:00 GMTmetabolic-weightobesitymetabolicimmune-systemweight-lossepigeneticsglp-1Sarah Okonkwohttps://thefirstcohort.com/articles/2026-09-04-they-worried-a-pig-kidney-would-burn-the-bridge-to-a-human-one-in-the-first-twohttps://thefirstcohort.com/articles/2026-09-04-they-worried-a-pig-kidney-would-burn-the-bridge-to-a-human-one-in-the-first-twoA gene-edited pig kidney kept Tim Andrews off dialysis for a record 271 days before it failed and came out. The worry was that it would leave his immune system too sensitized for a human match. In the first two patients, it hasn't.Fri, 04 Sep 2026 00:00:00 GMTautoimmune-inflammationxenotransplantationkidney-transplantgene-editingorgan-shortageimmune-sensitizationSarah Okonkwohttps://thefirstcohort.com/articles/2026-09-04-the-fda-erased-its-ivermectin-posts-and-admitted-nothing-the-doctors-records-kephttps://thefirstcohort.com/articles/2026-09-04-the-fda-erased-its-ivermectin-posts-and-admitted-nothing-the-doctors-records-kepThe agency deleted its 'you are not a horse' posts to end a lawsuit, but by then Bowden had lost hospital privileges, Marik had resigned his university chair, and Apter had been referred to two state boards.Fri, 04 Sep 2026 00:00:00 GMTinvestigationsmedical-researchMira Petrovhttps://thefirstcohort.com/articles/2026-09-04-the-adhd-creativity-bump-is-modest-and-it-fades-right-where-the-symptoms-turn-clhttps://thefirstcohort.com/articles/2026-09-04-the-adhd-creativity-bump-is-modest-and-it-fades-right-where-the-symptoms-turn-clThe headlines sell the wandering ADHD mind as a hidden creative gift. The data underneath shows the edge is modest and flattens right as symptoms cross into the clinical range.Fri, 04 Sep 2026 00:00:00 GMTbrain-agingadhdcreativityneurodivergenceovermedicationbrainSarah Okonkwohttps://thefirstcohort.com/articles/2026-09-04-on-the-study-s-cleanest-test-the-doctors-12-billion-ai-only-tied-google-s-free-shttps://thefirstcohort.com/articles/2026-09-04-on-the-study-s-cleanest-test-the-doctors-12-billion-ai-only-tied-google-s-free-sIn June a Nature Medicine paper crowned general chatbots over the specialized AI that 40 percent of U.S. doctors use. Its biggest margins came from a public exam and a benchmark OpenAI built. On the one test made for the comparison, the expensive tool only matched a free Google box.Fri, 04 Sep 2026 00:00:00 GMTinvestigationsclinical-aibenchmarksopenevidencenature-medicinemedical-aiLena Marshallhttps://thefirstcohort.com/articles/2026-09-04-all-719-blood-samples-carried-mold-toxins-and-the-youngest-children-carried-thehttps://thefirstcohort.com/articles/2026-09-04-all-719-blood-samples-carried-mold-toxins-and-the-youngest-children-carried-theResearchers tested the blood of 719 women and young children in rural Bangladesh. Ochratoxin A turned up in every single one, and modeling put up to 99 percent of the children over the line toxicologists use to flag a cancer-risk exposure.Fri, 04 Sep 2026 00:00:00 GMTnutrition-foodmycotoxinsfood-safetyaflatoxinchildrens-healthenvironmental-healthSarah Okonkwohttps://thefirstcohort.com/articles/2026-09-03-the-coffee-weakens-bones-study-never-analyzed-a-single-fracturehttps://thefirstcohort.com/articles/2026-09-03-the-coffee-weakens-bones-study-never-analyzed-a-single-fractureNearly 10,000 older women, ten years of hip scans, and the coffee alarm that made headlines came from a spline curve that never cleared statistical significance.Thu, 03 Sep 2026 00:00:00 GMTnutrition-foodcoffeeteabone-densityosteoporosisnutritionstudy-spinSarah Okonkwohttps://thefirstcohort.com/articles/2026-09-03-pennsylvania-announced-two-measles-deaths-its-county-coroner-never-recordedhttps://thefirstcohort.com/articles/2026-09-03-pennsylvania-announced-two-measles-deaths-its-county-coroner-never-recordedPennsylvania classified two Lancaster County fatalities as measles-associated, including a newborn the county coroner says he certified as dying from a ruptured spleen and blood loss. The CDC won't add either to the national count until the record shows measles caused or contributed to the deaths.Thu, 03 Sep 2026 00:00:00 GMTinvestigationsmeaslescdcpublic-healthdata-integritypennsylvaniarfk-jrMarcus Chenhttps://thefirstcohort.com/articles/2026-09-03-high-blood-sugar-hands-cancer-cells-a-cloak-the-immune-system-can-t-see-throughhttps://thefirstcohort.com/articles/2026-09-03-high-blood-sugar-hands-cancer-cells-a-cloak-the-immune-system-can-t-see-throughGrown in a fluid built to mimic the human body, cancer cells used excess glucose to thicken a sugar coating that hid them from immune cells, an effect that never showed up in the standard lab dishes used across cancer biology.Thu, 03 Sep 2026 00:00:00 GMTcancercancerhigh-blood-sugarimmune-evasionmetabolic-healthhsf1glycocalyxLena Marshallhttps://thefirstcohort.com/articles/2026-09-03-chronic-money-trouble-showed-up-on-the-brain-scans-decades-laterhttps://thefirstcohort.com/articles/2026-09-03-chronic-money-trouble-showed-up-on-the-brain-scans-decades-laterIn a British cohort followed since birth, people who spent years in the bottom fifth of income had weaker verbal memory by their fifties and larger brain ventricles, a marker of brain aging, by their seventies, even after childhood and education were accounted for.Thu, 03 Sep 2026 00:00:00 GMTbrain-agingbrain-agingpovertychronic-stresscognitionlongevitySarah Okonkwohttps://thefirstcohort.com/articles/2026-09-02-the-pancreatic-cancer-pill-that-doubles-survival-39-800-a-month-and-a-fast-lanehttps://thefirstcohort.com/articles/2026-09-02-the-pancreatic-cancer-pill-that-doubles-survival-39-800-a-month-and-a-fast-laneRasonque roughly doubles median survival in metastatic pancreatic cancer. Revolution Medicines priced it at $477,600 a year, more than double Keytruda, and the FDA cleared it early through a voucher program lawmakers say Congress never authorized.Wed, 02 Sep 2026 00:00:00 GMTdrugs-fdapancreatic-cancerfdadrug-pricingras-inhibitoroncologyLena Marshallhttps://thefirstcohort.com/articles/2026-09-02-mindfulness-dropped-their-blood-pressure-7-6-points-diet-movement-and-pills-didhttps://thefirstcohort.com/articles/2026-09-02-mindfulness-dropped-their-blood-pressure-7-6-points-diet-movement-and-pills-didEighteen randomized trials found positive-psychology and mindfulness programs nudged blood pressure down within weeks. Look closely at the ones that worked best and the active ingredient was ordinary: coaching people to move more, eat better, and take their pills.Wed, 02 Sep 2026 00:00:00 GMTmetabolic-weightmedical-researchSarah Okonkwohttps://thefirstcohort.com/articles/2026-09-02-forty-years-of-calling-me-cfs-psychosomatic-taught-the-institutions-how-to-dismihttps://thefirstcohort.com/articles/2026-09-02-forty-years-of-calling-me-cfs-psychosomatic-taught-the-institutions-how-to-dismiImmune exhaustion ties ME/CFS to long COVID. A Yale preprint finds the same signatures in the vaccine-injured, plus spike protein still circulating 709 days after a COVID shot. The institutions that spent decades dismissing the first are dismissing the rest.Wed, 02 Sep 2026 00:00:00 GMTinfectious-diseasemedical-researchMarcus Chenhttps://thefirstcohort.com/articles/2026-08-27-the-executioner-s-second-job-a-death-enzyme-that-also-calls-nk-cells-to-the-tumohttps://thefirstcohort.com/articles/2026-08-27-the-executioner-s-second-job-a-death-enzyme-that-also-calls-nk-cells-to-the-tumoCaspase-3, the enzyme biology calls the executioner, turns out to carve a hidden, nucleus-bound form of interleukin-18 that summons NK cells to hunt tumors, a role the study says had gone unrecognized.Thu, 27 Aug 2026 00:00:00 GMTcanceril-18nk-cellscancer-immunologycaspase-3immunotherapySarah Okonkwohttps://thefirstcohort.com/articles/2026-08-27-in-mice-early-life-stress-writes-a-molecular-mark-onto-the-brain-s-reward-neuronhttps://thefirstcohort.com/articles/2026-08-27-in-mice-early-life-stress-writes-a-molecular-mark-onto-the-brain-s-reward-neuronEarly-life stress raises an enzyme called SETD7 in the brain's dopamine neurons, loosening the DNA around stress genes so they fire too easily into adulthood. When researchers blocked it in mice, the stressed animals did not develop the same anxiety-like stress sensitivity, and stayed as social andThu, 27 Aug 2026 00:00:00 GMTbrain-agingchildhood-traumaepigeneticsdopaminemental-healthneuroscienceSarah Okonkwohttps://thefirstcohort.com/articles/2026-08-27-gsk-bankrolled-the-study-that-turned-its-shingles-vaccine-into-a-dementia-headlihttps://thefirstcohort.com/articles/2026-08-27-gsk-bankrolled-the-study-that-turned-its-shingles-vaccine-into-a-dementia-headliThe academics who best isolated a shingles-vaccine effect on dementia used a natural experiment and no industry money. The study behind this month's headlines used a claims database and GlaxoSmithKline's checkbook.Thu, 27 Aug 2026 00:00:00 GMTinvestigationsshingles-vaccineshingrixdementiagskpharma-fundingobservationalLena Marshallhttps://thefirstcohort.com/articles/2026-08-27-a-pill-doubled-survival-in-advanced-pancreatic-cancer-six-months-to-thirteen-athttps://thefirstcohort.com/articles/2026-08-27-a-pill-doubled-survival-in-advanced-pancreatic-cancer-six-months-to-thirteen-atThe best result advanced pancreatic cancer has seen in a generation, and the FDA cleared it in about five weeks. For patients who have run out of chemo, it turns a median of six months into thirteen, at a list price of $39,800 a month.Thu, 27 Aug 2026 00:00:00 GMTdrugs-fdamedical-researchLena Marshallhttps://thefirstcohort.com/articles/2026-08-26-j-j-won-the-first-ever-drug-approval-for-warm-autoimmune-hemolytic-anemia-it-helhttps://thefirstcohort.com/articles/2026-08-26-j-j-won-the-first-ever-drug-approval-for-warm-autoimmune-hemolytic-anemia-it-helIt works by starving rogue antibodies of the recycling route that keeps them alive. Whether it beats the drugs doctors already reach for is the question the first-ever headlines skip.Wed, 26 Aug 2026 00:00:00 GMTdrugs-fdawaihafcrnnipocalimabautoimmunefda-approvalanemiaSarah Okonkwohttps://thefirstcohort.com/articles/2026-08-26-in-depressed-brains-the-new-neuron-supply-had-stalled-where-fresh-pain-gets-sorthttps://thefirstcohort.com/articles/2026-08-26-in-depressed-brains-the-new-neuron-supply-had-stalled-where-fresh-pain-gets-sortColumbia researchers mapped nearly 500,000 cells from postmortem brains and found the depressed ones showed a stalled supply of new hippocampal neurons, the cells thought to keep a fresh setback from merging with every old one.Wed, 26 Aug 2026 00:00:00 GMTbrain-agingdepressionneurogenesishippocampusmental-healthbrain-agingSarah Okonkwohttps://thefirstcohort.com/articles/2026-08-26-a-third-of-england-s-copd-patients-aren-t-diagnosed-until-a-hospital-admissionhttps://thefirstcohort.com/articles/2026-08-26-a-third-of-england-s-copd-patients-aren-t-diagnosed-until-a-hospital-admissionAcross 1.7 million patients and thirteen conditions, being diagnosed only after an emergency tracked with far higher odds of dying within a year, up to sevenfold for coeliac disease, in a health service whose own records held the story for two decades.Wed, 26 Aug 2026 00:00:00 GMTinvestigationsdiagnosisprimary-carenhscopdmortalityhealth-systemsLena Marshallhttps://thefirstcohort.com/articles/2026-08-26-a-new-cancer-weapon-that-has-only-ever-slowed-tumors-in-micehttps://thefirstcohort.com/articles/2026-08-26-a-new-cancer-weapon-that-has-only-ever-slowed-tumors-in-miceStanford's tissue-resident natural killer cells slowed melanoma and head-and-neck tumors in mice. John Sunwoo warned against reading too much into that. The coverage read plenty into it anyway.Wed, 26 Aug 2026 00:00:00 GMTcancernk-cellsimmunotherapysolid-tumorscancerstanfordpreclinicalLena Marshallhttps://thefirstcohort.com/articles/2026-08-25-your-gut-remembers-the-benzo-you-quit-three-years-agohttps://thefirstcohort.com/articles/2026-08-25-your-gut-remembers-the-benzo-you-quit-three-years-agoScreen 2,509 people's guts against their prescription records and the fingerprint lingers: benzodiazepines, antidepressants and acid-reducers stay linked to a shifted microbiome years after the last pill, some rivaling antibiotics.Tue, 25 Aug 2026 00:00:00 GMTmetabolic-weightgut-microbiomebenzodiazepinesantidepressantspolypharmacyproton-pump-inhibitorsSarah Okonkwohttps://thefirstcohort.com/articles/2026-08-25-the-standard-treatment-for-this-fatal-lung-disease-killed-more-patients-than-plahttps://thefirstcohort.com/articles/2026-08-25-the-standard-treatment-for-this-fatal-lung-disease-killed-more-patients-than-plaEight patients died on the drugs, one on placebo, and a government safety board halted the trial for harm. Now a Nature Immunology review argues three kinds of inflammation work together in the disease after all.Tue, 25 Aug 2026 00:00:00 GMTmetabolic-weightmedical-researchSarah Okonkwohttps://thefirstcohort.com/articles/2026-08-25-the-anti-mosquito-industry-sells-a-fix-for-something-your-skin-chemistry-settledhttps://thefirstcohort.com/articles/2026-08-25-the-anti-mosquito-industry-sells-a-fix-for-something-your-skin-chemistry-settledOne volunteer drew 100 times more mosquitoes than another, a difference set by skin acids that hold steady for years. The wristbands, ultrasonic gadgets and vitamin-B patches sold to stop the bites show no measurable protection.Tue, 25 Aug 2026 00:00:00 GMTinfectious-diseasemosquitoesskin-microbiomerepellentsconsumer-healthentomologyLena Marshallhttps://thefirstcohort.com/articles/2026-08-25-kennedy-reopens-the-federal-vaccine-rulebook-starting-with-the-words-that-decidehttps://thefirstcohort.com/articles/2026-08-25-kennedy-reopens-the-federal-vaccine-rulebook-starting-with-the-words-that-decideHHS is asking whether the three labels that decide which shots your child gets still work, and putting the COVID-era override of its own vaccine advisers on the record as the reason public trust cracked.Tue, 25 Aug 2026 00:00:00 GMTinvestigationsvaccineshhsacipvaccine-policyinformed-consentpublic-trustMarcus Chenhttps://thefirstcohort.com/articles/2026-08-25-in-abstinent-mice-a-deep-brain-region-more-than-doubles-its-activity-before-relahttps://thefirstcohort.com/articles/2026-08-25-in-abstinent-mice-a-deep-brain-region-more-than-doubles-its-activity-before-relaIn mice, a deep brain region more than doubled its activity after they quit drinking, before they touched a drop again. Relapse-like drinking may be a brain adaptation, not a failure of will.Tue, 25 Aug 2026 00:00:00 GMTbrain-agingalcoholaddictionneurosciencerelapsebrainSarah Okonkwohttps://thefirstcohort.com/articles/2026-08-24-the-vitamin-d-trials-that-found-no-brain-benefit-never-tested-this-dosehttps://thefirstcohort.com/articles/2026-08-24-the-vitamin-d-trials-that-found-no-brain-benefit-never-tested-this-doseFifty-four older adults with failing sleep and early memory loss, and the ones taking 5,000 IU of vitamin D a day scored 13 percent higher on a standard cognitive test. The major null trials never tested that dose.Mon, 24 Aug 2026 00:00:00 GMTbrain-agingvitamin-dcognitiondementiasupplementsnihLena Marshallhttps://thefirstcohort.com/articles/2026-08-24-new-york-let-its-poorest-mothers-breathe-bus-and-boiler-soot-for-decades-when-ithttps://thefirstcohort.com/articles/2026-08-24-new-york-let-its-poorest-mothers-breathe-bus-and-boiler-soot-for-decades-when-itColumbia followed more than a thousand poor New York kids for twenty years as soot from buses and heating oil fell, and their age-3 cognitive scores came in 26 percent higher. How much of that the air can actually claim is the open question, and the sharper evidence is buried underneath it.Mon, 24 Aug 2026 00:00:00 GMTmetabolic-weightmedical-researchSarah Okonkwohttps://thefirstcohort.com/articles/2026-08-24-how-fiber-teaches-a-self-erasing-gut-wall-to-remember-for-two-weekshttps://thefirstcohort.com/articles/2026-08-24-how-fiber-teaches-a-self-erasing-gut-wall-to-remember-for-two-weeksButyrate, the compound gut bacteria make from fiber, reprogrammed the intestinal lining of mice to keep raising IL-10 and blunting colitis for 2 weeks after the last dose, and the imprint held even in mice with no gut bacteria at all.Mon, 24 Aug 2026 00:00:00 GMTautoimmune-inflammationgut-microbiomebutyratefiberinflammationibdimmune-toleranceSarah Okonkwohttps://thefirstcohort.com/articles/2026-08-24-for-sixty-years-the-screwworm-was-gone-it-s-back-in-texas-and-the-fda-reached-fohttps://thefirstcohort.com/articles/2026-08-24-for-sixty-years-the-screwworm-was-gone-it-s-back-in-texas-and-the-fda-reached-foThe flesh-eating fly the US wiped out in 1966 has crossed the southern border into Texas, and Washington's answer leans on the same emergency law it used for COVID drugs, this time to slap an emergency label on Zoetis's best-selling dog pill.Mon, 24 Aug 2026 00:00:00 GMTinfectious-diseasescrewwormfdaemergency-use-authorizationzoetispublic-healthMarcus Chenhttps://thefirstcohort.com/articles/2026-08-24-berkeley-dusted-off-a-shelved-1970s-fat-compound-that-burns-energy-instead-of-aphttps://thefirstcohort.com/articles/2026-08-24-berkeley-dusted-off-a-shelved-1970s-fat-compound-that-burns-energy-instead-of-apGLP-1 drugs quiet your appetite, and along with the fat they can pull out a real chunk of muscle. A shelved acetyl-CoA carboxylase inhibitor from the 1970s went after the other lever, energy burned, and in obese mice it left the lean mass alone.Mon, 24 Aug 2026 00:00:00 GMTmetabolic-weightglp-1obesitymetabolismmusclediabetesfatty-liverSarah Okonkwohttps://thefirstcohort.com/articles/2026-08-23-the-exercise-paradox-lousy-for-losing-weight-your-best-bet-for-keeping-it-offhttps://thefirstcohort.com/articles/2026-08-23-the-exercise-paradox-lousy-for-losing-weight-your-best-bet-for-keeping-it-offA study of more than 1,100 people found activity did almost nothing for the pounds they shed, yet it was one of the strongest signals of whether that weight stayed gone.Sun, 23 Aug 2026 00:00:00 GMTmetabolic-weightmetabolicweight-lossexerciseglp-1obesitySarah Okonkwohttps://thefirstcohort.com/articles/2026-08-23-fluoride-and-kids-hearts-the-reassuring-study-tested-water-below-what-us-taps-arhttps://thefirstcohort.com/articles/2026-08-23-fluoride-and-kids-hearts-the-reassuring-study-tested-water-below-what-us-taps-arResearchers measured fluoride and heart risk in 161 Iranian children, and the main analysis found no significant link. But they drank water below the level US taps are told to add, and a different adjustment flipped the numbers.Sun, 23 Aug 2026 00:00:00 GMTmetabolic-weightfluoridecardiovascularchildrenwaterenvironmental-healthmetabolicSarah Okonkwohttps://thefirstcohort.com/articles/2026-08-23-a-chinese-registry-marked-the-trial-complete-it-never-mentioned-the-boy-who-diedhttps://thefirstcohort.com/articles/2026-08-23-a-chinese-registry-marked-the-trial-complete-it-never-mentioned-the-boy-who-diedA boy died in a Chinese gene-therapy trial in August 2025. Months later the registry marked the study 'complete' and never mentioned him. He is one of three deaths now pulling Congress toward the trial data U.S. drugmakers ship home from China, while American inspectors almost never see the sites thSun, 23 Aug 2026 00:00:00 GMTinvestigationschina-trialsfdagene-therapycrisprclinical-trial-oversightcongressMira Petrovhttps://thefirstcohort.com/articles/2026-08-23-a-brain-clock-says-your-fourth-language-is-worth-13-years-nobody-s-published-thehttps://thefirstcohort.com/articles/2026-08-23-a-brain-clock-says-your-fourth-language-is-worth-13-years-nobody-s-published-theThe 13-years-younger figure comes from a conference talk with no paper behind it, and the sturdier study underneath still can't tell you whether the languages did anything at all.Sun, 23 Aug 2026 00:00:00 GMTbrain-agingbrain-agingmultilingualismcognitive-reservedementianeuroscienceSarah Okonkwohttps://thefirstcohort.com/articles/2026-08-22-this-weight-loss-hormone-protected-mouse-livers-without-a-pound-lost-novo-nordishttps://thefirstcohort.com/articles/2026-08-22-this-weight-loss-hormone-protected-mouse-livers-without-a-pound-lost-novo-nordisThe hormone works through the same brainstem switch that makes weight-loss drugs nauseating, and the company developing it supplied the compound, funded the mouse study, and put two of its scientists on the author list.Sat, 22 Aug 2026 00:00:00 GMTmetabolic-weightgdf15livermetabolicnovo-nordiskmashobesity-drugsSarah Okonkwohttps://thefirstcohort.com/articles/2026-08-22-the-hunger-neurons-ozempic-was-meant-to-silence-are-the-ones-burning-your-fathttps://thefirstcohort.com/articles/2026-08-22-the-hunger-neurons-ozempic-was-meant-to-silence-are-the-ones-burning-your-fatSilence the hunger neurons and semaglutide keeps killing appetite, but in Yale's female mice the lost fat came back within 15 days.Sat, 22 Aug 2026 00:00:00 GMTmetabolic-weightozempicglp-1obesitymetabolicneuroscienceSarah Okonkwohttps://thefirstcohort.com/articles/2026-08-22-the-fda-is-building-an-on-ramp-for-medical-ai-that-can-hallucinatehttps://thefirstcohort.com/articles/2026-08-22-the-fda-is-building-an-on-ramp-for-medical-ai-that-can-hallucinateThe FDA has cleared more than 1,000 AI medical devices and not one large language model. Its new discussion paper starts building the pathway for the ones that can make things up, with faster delivery to market named as an agency priority.Sat, 22 Aug 2026 00:00:00 GMTdrugs-fdafdaartificial-intelligencemedical-devicesregulationgenerative-aiMarcus Chenhttps://thefirstcohort.com/articles/2026-08-22-arizona-state-s-ai-flags-healthy-people-as-weak-vaccine-responders-without-reporhttps://thefirstcohort.com/articles/2026-08-22-arizona-state-s-ai-flags-healthy-people-as-weak-vaccine-responders-without-reporArizona State's AI sorts roughly one in twenty healthy people into the 'weak responder' column. The clinical payoff, in the lead author's own words, is more doses. Nobody reported how often the model is right.Sat, 22 Aug 2026 00:00:00 GMTinfectious-diseasecovid-19vaccinesaidiagnosticsboostersLena Marshallhttps://thefirstcohort.com/articles/2026-08-21-lupus-hits-nine-women-for-every-man-and-the-reason-may-be-hiding-in-dna-both-sexhttps://thefirstcohort.com/articles/2026-08-21-lupus-hits-nine-women-for-every-man-and-the-reason-may-be-hiding-in-dna-both-sexScientists sequenced more than 1.25 million immune cells and found over 1,000 genetic switches set differently in men and women, with the female side tuned for stronger inflammation. It may help explain why lupus hits nine women for every man.Fri, 21 Aug 2026 00:00:00 GMTautoimmune-inflammationautoimmunelupuswomens-healthimmunologygeneticsprecision-medicineSarah Okonkwohttps://thefirstcohort.com/articles/2026-08-21-cut-the-fiber-and-your-gut-bacteria-start-eating-your-own-gut-lininghttps://thefirstcohort.com/articles/2026-08-21-cut-the-fiber-and-your-gut-bacteria-start-eating-your-own-gut-liningPrinceton isotope tracing found that when fiber runs short, gut bacteria strip protein off the mucus wall and churn out the same toxins that pile up in failing kidneys. Feed them whole plants and the chemistry flips.Fri, 21 Aug 2026 00:00:00 GMTnutrition-foodgut-microbiomefibernutritionmetabolic-healthplant-basedSarah Okonkwohttps://thefirstcohort.com/articles/2026-08-21-banned-in-1979-legacy-pcbs-are-now-tied-to-shorter-telomeres-in-childrenhttps://thefirstcohort.com/articles/2026-08-21-banned-in-1979-legacy-pcbs-are-now-tied-to-shorter-telomeres-in-childrenDioxin-like PCBs left American factories decades ago and never left children's bodies. New research traces how they may erode the protective caps on kids' chromosomes, and may help explain lower cognitive scores.Fri, 21 Aug 2026 00:00:00 GMTbrain-agingpcbstelomeresenvironmental-healthchildrens-healthcognitionendocrine-disruptorsSarah Okonkwohttps://thefirstcohort.com/articles/2026-08-21-a-peta-tied-doctors-group-is-suing-to-kill-rfk-jr-s-new-food-pyramidhttps://thefirstcohort.com/articles/2026-08-21-a-peta-tied-doctors-group-is-suing-to-kill-rfk-jr-s-new-food-pyramidThe Physicians Committee says a secret, industry-tied panel redirected the 2025-2030 dietary guidelines. The group crying capture spent years inside PETA's funding orbit.Fri, 21 Aug 2026 00:00:00 GMTnutrition-fooddietary-guidelinesfood-pyramidrfk-jrconflict-of-interestnutrition-policyLena Marshallhttps://thefirstcohort.com/articles/2026-08-21-a-2-7-million-gene-therapy-approved-because-patients-needed-less-cornstarchhttps://thefirstcohort.com/articles/2026-08-21-a-2-7-million-gene-therapy-approved-because-patients-needed-less-cornstarchUltragenyx's Genglycos won accelerated approval on a surrogate: a 31 percent cut in daily cornstarch. But the disease is low blood sugar, and by the company's own numbers the treated group spent slightly more time below 70 mg/dL, while liver enzymes spiked in 71 percent and every patient needed sterFri, 21 Aug 2026 00:00:00 GMTdrugs-fdagene-therapyfdaaccelerated-approvalrare-diseaseultragenyxLena Marshallhttps://thefirstcohort.com/articles/2026-08-20-two-words-open-fauci-s-pandemic-diary-game-onhttps://thefirstcohort.com/articles/2026-08-20-two-words-open-fauci-s-pandemic-diary-game-onAnthony Fauci's private diary greets the pandemic with 'GAME ON!!!' and, in the same January 2020 entry, records that the first infection traced to early December and that the Wuhan market was 'the amplifier,' not the source.Thu, 20 Aug 2026 00:00:00 GMTinvestigationsfaucicovid-originsfoialab-leakaccountabilityMira Petrovhttps://thefirstcohort.com/articles/2026-08-20-the-marmoset-under-salk-s-claim-that-brain-waves-build-the-reality-you-seehttps://thefirstcohort.com/articles/2026-08-20-the-marmoset-under-salk-s-claim-that-brain-waves-build-the-reality-you-seeA Salk lab says the electrical waves rolling across your cortex are a generative engine that builds what you see. The catch: the splashy new paper is a review, and the experiments under it are marmosets squinting at faint dots.Thu, 20 Aug 2026 00:00:00 GMTbrain-agingneuroscienceperceptionbrain-wavesvisual-cortexresearch-hypeSarah Okonkwohttps://thefirstcohort.com/articles/2026-08-20-how-244-people-cut-357-calories-a-day-without-eating-less-foodhttps://thefirstcohort.com/articles/2026-08-20-how-244-people-cut-357-calories-a-day-without-eating-less-foodThe people on the low-fat vegan diet didn't count calories or shrink portions. They ate the same weight of food and took in hundreds fewer calories a day. The group that ran the trial also has a stake in what you conclude.Thu, 20 Aug 2026 00:00:00 GMTmetabolic-weightweight lossnutritionenergy densityplant-basedmetabolicSarah Okonkwohttps://thefirstcohort.com/articles/2026-08-20-fauci-s-top-adviser-admitted-to-hiding-covid-emails-and-taking-wine-for-a-naturahttps://thefirstcohort.com/articles/2026-08-20-fauci-s-top-adviser-admitted-to-hiding-covid-emails-and-taking-wine-for-a-naturaDavid Morens pleaded guilty to conspiring to run NIH business through Gmail to dodge FOIA, and to taking wine as an illegal gratuity tied to a commentary declaring COVID had natural origins. Fauci was not charged.Thu, 20 Aug 2026 00:00:00 GMTinvestigationscovid-originsfoianiaidaccountabilitylab-leakLena Marshallhttps://thefirstcohort.com/articles/2026-08-20-canada-went-looking-for-the-forever-chemicals-nobody-tracks-and-found-a-dozen-ofhttps://thefirstcohort.com/articles/2026-08-20-canada-went-looking-for-the-forever-chemicals-nobody-tracks-and-found-a-dozen-ofScientists went hunting for the replacement and precursor PFAS almost nobody measures. In Canadian women's blood they found a dozen of them, riding alongside the 'banned' legacy chemicals that still turn up in nearly everyone.Thu, 20 Aug 2026 00:00:00 GMTinvestigationspfasforever-chemicalswomens-healthenvironmental-healthbiomonitoringSarah Okonkwohttps://thefirstcohort.com/articles/2026-08-19-uc-irvine-s-framework-for-safer-car-t-is-a-hypothesis-essay-not-a-studyhttps://thefirstcohort.com/articles/2026-08-19-uc-irvine-s-framework-for-safer-car-t-is-a-hypothesis-essay-not-a-studyThe senior author consults for Kite Pharma, whose Yescarta accounted for all 6 grade-5 neurotoxicity deaths in the cited review's real-world data, the exact harm the paper proposes to treat.Wed, 19 Aug 2026 00:00:00 GMTcancercar-toncologyicansdrug-repurposingconflict-of-interestLena Marshallhttps://thefirstcohort.com/articles/2026-08-19-kindergarten-vaccine-exemptions-doubled-in-five-years-the-number-is-a-verdict-onhttps://thefirstcohort.com/articles/2026-08-19-kindergarten-vaccine-exemptions-doubled-in-five-years-the-number-is-a-verdict-onExemptions climbed to a record 4.2 percent of kindergartners while medical exemptions never budged from 0.2 percent. The rise is not a medical event. It is five years of institutional credibility spent, showing up in the one column parents control.Wed, 19 Aug 2026 00:00:00 GMTinfectious-diseasevaccinescdcpublic-healthmedical-freedommeaslesMarcus Chenhttps://thefirstcohort.com/articles/2026-08-19-eight-infant-macaques-showed-no-hiv-rebound-for-a-year-the-third-drug-comes-fromhttps://thefirstcohort.com/articles/2026-08-19-eight-infant-macaques-showed-no-hiv-rebound-for-a-year-the-third-drug-comes-fromOHSU's triple regimen left no detectable virus in all eight infant macaques a year after treatment stopped, even after the harshest rebound test. Two of the authors hold a financial stake in the company behind the experimental third drug.Wed, 19 Aug 2026 00:00:00 GMTinfectious-diseasehivleronlimabcytodynconflict-of-interestprimate-studyLena Marshallhttps://thefirstcohort.com/articles/2026-08-19-a-jama-essay-says-the-doctor-makes-your-care-worse-three-of-its-four-authors-selhttps://thefirstcohort.com/articles/2026-08-19-a-jama-essay-says-the-doctor-makes-your-care-worse-three-of-its-four-authors-selThe Viewpoint predicts autonomous AI will run much of primary care by 2030, and that adding a human doctor can make the care worse. Its evidence is trained actors chatting over text, and three of its four authors sell or bankroll the AI.Wed, 19 Aug 2026 00:00:00 GMTinvestigationsai-in-medicineconflict-of-interestjamadiagnosismedical-establishmentSarah Okonkwohttps://thefirstcohort.com/articles/2026-08-18-thousands-of-genes-20-volunteers-no-control-group-the-viral-orange-juice-studyhttps://thefirstcohort.com/articles/2026-08-18-thousands-of-genes-20-volunteers-no-control-group-the-viral-orange-juice-studyThe juice came from a citrus-growers' group, the study had no comparison drink, and 'thousands of genes' rests on 20 people, arriving the same summer the FDA loosened what counts as orange juice.Tue, 18 Aug 2026 00:00:00 GMTnutrition-foodorange-juicenutrigenomicsmetabolic-healthsugarfdahesperidinSarah Okonkwohttps://thefirstcohort.com/articles/2026-08-18-the-neuroscientist-who-mapped-fear-in-the-brain-says-a-face-can-t-reliably-reveahttps://thefirstcohort.com/articles/2026-08-18-the-neuroscientist-who-mapped-fear-in-the-brain-says-a-face-can-t-reliably-reveaPeople scowl only about a third of the time they are angry. A multibillion-dollar industry sells software that assumes the other two-thirds are legible.Tue, 18 Aug 2026 00:00:00 GMTinfectious-diseasemedical-researchMarcus Chenhttps://thefirstcohort.com/articles/2026-08-18-the-cells-that-heal-wounds-are-feeding-breast-cancer-its-nerveshttps://thefirstcohort.com/articles/2026-08-18-the-cells-that-heal-wounds-are-feeding-breast-cancer-its-nervesUniversity of Oklahoma researchers blocked the protein in mice and triple-negative tumors grew far less. In patients, all they have is a correlation and a drug, already sold for something else, that has never been tried against breast cancer.Tue, 18 Aug 2026 00:00:00 GMTcancerbreast-cancertriple-negativemacrophagespreclinicaloncologyLena Marshallhttps://thefirstcohort.com/articles/2026-08-18-takeda-fixed-the-narcolepsy-drug-that-was-poisoning-livers-now-you-can-t-buy-ithttps://thefirstcohort.com/articles/2026-08-18-takeda-fixed-the-narcolepsy-drug-that-was-poisoning-livers-now-you-can-t-buy-itOveporexton is the first drug to replace the orexin signal narcolepsy destroys, instead of stimulating around a tired brain. At the higher dose it leaves 60 percent of patients newly insomniac, and it still has to clear DEA scheduling before it reaches a pharmacy shelf.Tue, 18 Aug 2026 00:00:00 GMTdrugs-fdanarcolepsyorexinfda-approvaltakedaneurologysleepSarah Okonkwohttps://thefirstcohort.com/articles/2026-08-18-a-lung-atlas-found-1-000-autoimmune-risk-genes-that-blood-studies-missedhttps://thefirstcohort.com/articles/2026-08-18-a-lung-atlas-found-1-000-autoimmune-risk-genes-that-blood-studies-missedFor two decades, geneticists mapped thousands of autoimmune-risk variants that sat silent in blood cells. A 1.1-million-cell lung atlas shows the effects switch on only in immune cells lodged in tissue.Tue, 18 Aug 2026 00:00:00 GMTautoimmune-inflammationautoimmunegeneticsimmune-cellslupusgwasSarah Okonkwohttps://thefirstcohort.com/articles/2026-08-17-the-screwworm-america-eradicated-with-sterile-flies-is-back-and-this-time-washinhttps://thefirstcohort.com/articles/2026-08-17-the-screwworm-america-eradicated-with-sterile-flies-is-back-and-this-time-washinDicyclanil, an Australian sheep-blowfly chemical with mouse liver tumors in its toxicology file, is now cleared for cattle, swine, goats and wildlife under section 564, the same emergency-use power heavily used for pandemic countermeasures.Mon, 17 Aug 2026 00:00:00 GMTdrugs-fdascrewwormfdaemergency-use-authorizationlivestockdicyclanilbiosecurityMarcus Chenhttps://thefirstcohort.com/articles/2026-08-17-the-123-percent-death-risk-number-in-the-vitamin-d-headlines-was-never-tested-ashttps://thefirstcohort.com/articles/2026-08-17-the-123-percent-death-risk-number-in-the-vitamin-d-headlines-was-never-tested-asAn observational study of 5,520 older Britons tied belly fat plus low vitamin D to a 123 percent higher death risk. Hand people the actual pill in a randomized trial and mortality drops about 5 percent, with nothing at all for the heart.Mon, 17 Aug 2026 00:00:00 GMTmetabolic-weightvitamin-dobesitymortalitysupplementsagingLena Marshallhttps://thefirstcohort.com/articles/2026-08-17-bracing-for-a-fall-that-hasn-t-happened-yet-the-bargain-the-aging-ankle-strikeshttps://thefirstcohort.com/articles/2026-08-17-bracing-for-a-fall-that-hasn-t-happened-yet-the-bargain-the-aging-ankle-strikesFalls kill more older Americans than any other injury, and a study of 107 walkers points at the body's own defense: the aging ankle appears to brace for stability, buying it with a shorter, slower, more tiring stride.Mon, 17 Aug 2026 00:00:00 GMTbrain-agingagingfallsmobilitygaitexerciseLena Marshallhttps://thefirstcohort.com/articles/2026-08-17-any-amount-of-midlife-movement-tracked-with-slower-brain-decline-most-clearly-inhttps://thefirstcohort.com/articles/2026-08-17-any-amount-of-midlife-movement-tracked-with-slower-brain-decline-most-clearly-inIn a San Antonio cohort followed since 1979, any physical activity in midlife tracked with slower brain decline, and the link showed up most clearly in the Mexican American adults Alzheimer's research keeps leaving out.Mon, 17 Aug 2026 00:00:00 GMTbrain-agingbrain-agingexercisecognitive-declinemetabolichealth-disparitiesSarah Okonkwohttps://thefirstcohort.com/articles/2026-08-16-the-fda-s-reviewers-called-this-melanoma-data-not-interpretable-nine-days-laterhttps://thefirstcohort.com/articles/2026-08-16-the-fda-s-reviewers-called-this-melanoma-data-not-interpretable-nine-days-laterTwice the FDA rejected Replimune's engineered-herpes melanoma therapy, its reviewers calling the single-arm trial not interpretable. The design never changed. A 10-3 advisory vote came anyway, and nine days after that memo, the accelerated approval.Sun, 16 Aug 2026 00:00:00 GMTdrugs-fdamelanomafdaoncolytic-virusaccelerated-approvalreplimuneLena Marshallhttps://thefirstcohort.com/articles/2026-08-16-the-craving-brake-nobody-mapped-how-glp-1-drugs-quiet-cravings-from-the-lateralhttps://thefirstcohort.com/articles/2026-08-16-the-craving-brake-nobody-mapped-how-glp-1-drugs-quiet-cravings-from-the-lateralThe anti-craving effect pushing people to use a diabetes shot off-label against drinking traces to a brain region built to inhibit, not to reward, and the human evidence is still just two small trials deep.Sun, 16 Aug 2026 00:00:00 GMTbrain-agingglp-1ozempicaddictionneurosciencealcoholcravingsSarah Okonkwohttps://thefirstcohort.com/articles/2026-08-16-lilly-turned-the-receptor-on-amgen-turned-it-off-and-both-strip-weight-the-map-chttps://thefirstcohort.com/articles/2026-08-16-lilly-turned-the-receptor-on-amgen-turned-it-off-and-both-strip-weight-the-map-cEli Lilly's tirzepatide switches the gut-hormone receptor on. Amgen's MariTide blocks it. Both drive weight loss, and until a publicly funded Cambridge mouse study, no one had cleanly mapped how one receptor works in both directions.Sun, 16 Aug 2026 00:00:00 GMTmetabolic-weightobesity-drugsgiprtirzepatideappetiteincretinsLena Marshallhttps://thefirstcohort.com/articles/2026-08-16-eighteen-years-and-250-million-later-human-limb-regrowth-is-still-a-salamander-thttps://thefirstcohort.com/articles/2026-08-16-eighteen-years-and-250-million-later-human-limb-regrowth-is-still-a-salamander-tA Northeastern lab showed exactly how an axolotl rebuilds an arm from the shoulder down, and humans carry the same genes. We can still regrow a lost fingertip as children. Everything past that we heal by scarring over, and $250 million of Pentagon money has not changed the math.Sun, 16 Aug 2026 00:00:00 GMTinvestigationsregenerative-medicinelimb-regenerationaxolotlretinoic-aciddarpa-fundingLena Marshallhttps://thefirstcohort.com/articles/2026-08-16-a-study-blames-the-rising-atmosphere-for-your-blood-chemistry-your-own-breath-ovhttps://thefirstcohort.com/articles/2026-08-16-a-study-blames-the-rising-atmosphere-for-your-blood-chemistry-your-own-breath-ovBlood bicarbonate climbed about 7 percent since 1999, and two researchers blame the rising atmosphere. But convert that 51 ppm into the pressure that reaches your lungs and it moves your blood by about 0.04 millimeters of mercury, roughly a thousand times too small to matter.Sun, 16 Aug 2026 00:00:00 GMTmetabolic-weightco2blood-chemistryclimate-healthnhanesacid-baseSarah Okonkwohttps://thefirstcohort.com/articles/2026-08-15-no-falsification-jama-keeps-a-purdue-funded-opioid-paper-its-own-retraction-rulehttps://thefirstcohort.com/articles/2026-08-15-no-falsification-jama-keeps-a-purdue-funded-opioid-paper-its-own-retraction-ruleCourt records from a 2007 federal case show Purdue had flagged 8 possible-withdrawal cases a year before its 2000 study called withdrawal rare. The journal says that isn't falsification, so the paper stays in print.Sat, 15 Aug 2026 00:00:00 GMTinvestigationsopioidspurdue-pharmaretractionresearch-integrityjamaoxycontinMira Petrovhttps://thefirstcohort.com/articles/2026-08-15-for-twenty-years-women-were-warned-that-estrogen-raised-their-dementia-risk-stanhttps://thefirstcohort.com/articles/2026-08-15-for-twenty-years-women-were-warned-that-estrogen-raised-their-dementia-risk-stanA randomized federal trial spent two decades warning that hormone therapy raised older women's dementia risk. A Stanford autopsy study just found the opposite association. The catch: both studied women who started the drug far too late to settle it.Sat, 15 Aug 2026 00:00:00 GMTbrain-aginghormone-therapyalzheimersmenopausewomens-healthbrain-agingLena Marshallhttps://thefirstcohort.com/articles/2026-08-15-for-thirty-years-doctors-here-were-taught-north-carolina-had-no-lyme-the-ticks-dhttps://thefirstcohort.com/articles/2026-08-15-for-thirty-years-doctors-here-were-taught-north-carolina-had-no-lyme-the-ticks-dNearly 40 percent of the adult blacklegged ticks sampled in one western North Carolina town carried the Lyme bacterium, in a state where doctors were trained for thirty years that the disease barely exists.Sat, 15 Aug 2026 00:00:00 GMTinfectious-diseaselyme diseaseticksnorth carolinainfectious diseasepublic healthSarah Okonkwohttps://thefirstcohort.com/articles/2026-08-15-a-brain-protein-made-female-mice-overeat-fat-and-the-441-000-obesity-drug-workedhttps://thefirstcohort.com/articles/2026-08-15-a-brain-protein-made-female-mice-overeat-fat-and-the-441-000-obesity-drug-workedDietary fat switches on an appetite-protecting brain protein in male mice but not females. Delete it and the females overeat fat, gain more weight, and setmelanotide, the $441,000-a-year MC4R obesity drug, loses much of its appetite-suppressing punch on them.Sat, 15 Aug 2026 00:00:00 GMTmetabolic-weightobesitymetabolicmc4rsex-differencessetmelanotideSarah Okonkwohttps://thefirstcohort.com/articles/2026-08-14-your-antibodies-are-still-fighting-the-2020-virushttps://thefirstcohort.com/articles/2026-08-14-your-antibodies-are-still-fighting-the-2020-virusFor two years the message was that another ancestral booster would keep pace with the virus. The immunology says the opposite can happen: repeated shots against the 2020 strain can lock your antibodies onto a version of SARS-CoV-2 that stopped circulating, and in 2023 the WHO named immune imprintingFri, 14 Aug 2026 00:00:00 GMTinfectious-diseaseimmune-imprintingcovid-vaccinesimmunologymrnaoriginal-antigenic-sinSarah Okonkwohttps://thefirstcohort.com/articles/2026-08-14-warmer-saltier-fed-on-sewage-why-a-flesh-eating-bacterium-is-getting-meaner-as-ihttps://thefirstcohort.com/articles/2026-08-14-warmer-saltier-fed-on-sewage-why-a-flesh-eating-bacterium-is-getting-meaner-as-iVibrio vulnificus kills roughly one in five people it infects, and its northern edge has climbed about 30 miles a year since 1998. The big paper this week reached instead for grief and eco-anxiety.Fri, 14 Aug 2026 00:00:00 GMTinfectious-diseasevibriomarine-heatwavesalgal-bloomsseafood-safetyinfectious-diseaseSarah Okonkwohttps://thefirstcohort.com/articles/2026-08-14-the-peptide-boom-hides-one-divide-human-trials-on-a-few-rodent-data-and-case-rephttps://thefirstcohort.com/articles/2026-08-14-the-peptide-boom-hides-one-divide-human-trials-on-a-few-rodent-data-and-case-repSemaglutide and tirzepatide erased up to 22 percent of body weight in trials with thousands of patients. The research-only peptides sold beside them, like BPC-157, have not completed a single published human efficacy trial. A popular 2026 guide lists them as equals.Fri, 14 Aug 2026 00:00:00 GMTmetabolic-weightpeptidesglp-1weight-lossfdabpc-157Sarah Okonkwohttps://thefirstcohort.com/articles/2026-08-14-the-fda-put-an-emergency-label-on-a-zoetis-dog-pill-for-a-screwworm-america-erashttps://thefirstcohort.com/articles/2026-08-14-the-fda-put-an-emergency-label-on-a-zoetis-dog-pill-for-a-screwworm-america-erasThe sterile-fly barrier that kept the flesh-eating screwworm out of America for sixty years gave way, and Washington's answer has been a run of emergency drug authorizations, the newest for a Zoetis dog pill whose maker's own release cites no efficacy data against the parasite.Fri, 14 Aug 2026 00:00:00 GMTinfectious-diseasescrewwormfdaemergency-use-authorizationzoetisparasitespublic-healthMarcus Chenhttps://thefirstcohort.com/articles/2026-08-14-for-forty-years-they-said-skim-the-fat-this-trial-fed-people-full-fat-dairy-andhttps://thefirstcohort.com/articles/2026-08-14-for-forty-years-they-said-skim-the-fat-this-trial-fed-people-full-fat-dairy-andIn a 74-adult trial, the group assigned three servings of full-fat dairy a day for twelve weeks held steady on weight, body fat, cholesterol and insulin resistance, and their blood pressure improved, against advice the guidelines have pushed since 1980.Fri, 14 Aug 2026 00:00:00 GMTnutrition-fooddairynutritiondietary-guidelinescholesterolmetabolic-healthfull-fatSarah Okonkwohttps://thefirstcohort.com/articles/2026-08-13-why-anti-tnf-keeps-failing-so-many-crohn-s-patients-the-drug-never-reached-the-chttps://thefirstcohort.com/articles/2026-08-13-why-anti-tnf-keeps-failing-so-many-crohn-s-patients-the-drug-never-reached-the-cAnti-TNF biologics have muzzled the immune system for 25 years, and up to 46 percent of Crohn's patients still fail them. A single-cell atlas points at the structural cells of the gut wall, epigenetically rewired into a state the drugs were never built to reach.Thu, 13 Aug 2026 00:00:00 GMTautoimmune-inflammationcrohns-diseaseautoimmunefibroblastsanti-tnfepigeneticsSarah Okonkwohttps://thefirstcohort.com/articles/2026-08-13-the-checklist-drove-icu-infections-to-zero-the-federal-ethics-office-halted-thehttps://thefirstcohort.com/articles/2026-08-13-the-checklist-drove-icu-infections-to-zero-the-federal-ethics-office-halted-theA five-step checklist cut central-line infections 66 percent and was credited with 1,500 lives saved in Michigan ICUs. Then the federal office that guards research ethics ordered it halted, because the hospitals had never run it past an institutional review board.Thu, 13 Aug 2026 00:00:00 GMTinvestigationsresearch-ethicsirbpatient-safetymedical-bureaucracyregulatory-captureSarah Okonkwohttps://thefirstcohort.com/articles/2026-08-13-nih-said-its-cervical-cancer-ai-beat-human-doctors-six-years-later-its-own-authohttps://thefirstcohort.com/articles/2026-08-13-nih-said-its-cervical-cancer-ai-beat-human-doctors-six-years-later-its-own-authoIn 2019, NIH announced an algorithm that read cervix photos better than doctors, an AUC of 0.91. Its senior author has since written that the number came from overfitting and that the follow-on projects failed. Nature Medicine is now calling the same idea the 'missing piece.'Thu, 13 Aug 2026 00:00:00 GMTdrugs-fdamedical-researchLena Marshallhttps://thefirstcohort.com/articles/2026-08-13-king-s-college-london-turned-sheep-s-wool-into-a-bone-scaffold-and-called-it-a-mhttps://thefirstcohort.com/articles/2026-08-13-king-s-college-london-turned-sheep-s-wool-into-a-bone-scaffold-and-called-it-a-mThe wool membrane grew more organized bone than collagen in a rat's skull. Collagen still grew more of it, the sample size never made the press release, and no one has put the material in a person.Thu, 13 Aug 2026 00:00:00 GMTinvestigationsbiomaterialskeratinbone-regenerationdentistrypreclinicalLena Marshallhttps://thefirstcohort.com/articles/2026-08-13-a-sauna-floods-your-blood-with-immune-cells-it-s-a-flush-not-a-boosthttps://thefirstcohort.com/articles/2026-08-13-a-sauna-floods-your-blood-with-immune-cells-it-s-a-flush-not-a-boostFifty-one Finns sat in a 73°C sauna for half an hour, and every white blood cell type poured into their blood. Half an hour later the neutrophils and lymphocytes were back to baseline, and the immune system's chemical alarm had barely rung.Thu, 13 Aug 2026 00:00:00 GMTinfectious-diseasesaunaimmune-systemwellnesslongevityheat-therapySarah Okonkwohttps://thefirstcohort.com/articles/2026-08-12-this-week-s-autism-breakthrough-a-rare-mutation-an-injection-into-mice-and-not-ohttps://thefirstcohort.com/articles/2026-08-12-this-week-s-autism-breakthrough-a-rare-mutation-an-injection-into-mice-and-not-oAn injection that silences one gene rescued social behavior in mutant mice and a dish of human cells. The headlines called it an autism therapy. No autistic person has received it, and the gene it targets is mutated in a small fraction of cases.Wed, 12 Aug 2026 00:00:00 GMTbrain-agingautismnmda-receptorantisense-oligonucleotidepreclinicalshank3drug-developmentLena Marshallhttps://thefirstcohort.com/articles/2026-08-12-they-measured-the-forever-chemicals-in-the-umbilical-cord-itself-the-babies-withhttps://thefirstcohort.com/articles/2026-08-12-they-measured-the-forever-chemicals-in-the-umbilical-cord-itself-the-babies-withScientists skipped the usual stand-in and measured the forever chemicals in the umbilical cord blood itself. By age two, the babies carrying more of them scored lower on communication and motor development, and the companies that made these chemicals knew the risk for decades.Wed, 12 Aug 2026 00:00:00 GMTbrain-agingpfasneurodevelopmentpregnancyforever-chemicalsfolateenvironmental-healthSarah Okonkwohttps://thefirstcohort.com/articles/2026-08-12-the-stress-hormone-was-already-high-before-daily-cannabis-users-woke-uphttps://thefirstcohort.com/articles/2026-08-12-the-stress-hormone-was-already-high-before-daily-cannabis-users-woke-upOregon State measured the morning stress hormone in 39 daily users and 43 non-users. The people reaching for cannabis to unwind started every day with cortisol already running higher, and it tracked with the cannabis-related consequences they reported.Wed, 12 Aug 2026 00:00:00 GMTbrain-agingcannabiscortisolstresshpa-axisendocannabinoidmental-healthSarah Okonkwohttps://thefirstcohort.com/articles/2026-08-12-the-juice-industry-paid-for-the-study-telling-you-a-daily-glass-lowers-depressiohttps://thefirstcohort.com/articles/2026-08-12-the-juice-industry-paid-for-the-study-telling-you-a-daily-glass-lowers-depressioIn a 42-person trial, the group that added a daily glass of juice improved on depression scores while the group that added only whole fruits and vegetables didn't, and the European juice trade body paid for the whole thing.Wed, 12 Aug 2026 00:00:00 GMTmetabolic-weightmedical-researchSarah Okonkwohttps://thefirstcohort.com/articles/2026-08-12-the-finest-immune-map-of-the-sarcoid-lung-explains-why-its-targeted-drugs-keep-fhttps://thefirstcohort.com/articles/2026-08-12-the-finest-immune-map-of-the-sarcoid-lung-explains-why-its-targeted-drugs-keep-fNational Jewish Health charted more than 150,000 immune cells from sixteen sarcoidosis patients and found a disease with too many moving parts for any single drug to switch off. The targeted therapy that got furthest had already failed Phase 3 and erased 83 percent of its maker's value.Wed, 12 Aug 2026 00:00:00 GMTautoimmune-inflammationsarcoidosissingle-cell-sequencingpharma-conflictsfdaautoimmunelung-diseaseLena Marshallhttps://thefirstcohort.com/articles/2026-08-12-the-fda-approved-moderna-s-mrna-flu-shot-for-seniors-without-proving-it-works-inhttps://thefirstcohort.com/articles/2026-08-12-the-fda-approved-moderna-s-mrna-flu-shot-for-seniors-without-proving-it-works-inIn February the FDA's own vaccine chief refused to even review it. One week later the agency reversed course, and the trial data never changed.Wed, 12 Aug 2026 00:00:00 GMTdrugs-fdamrna vaccineflu vaccinefdamodernaaccelerated approvalregulatory captureMarcus Chenhttps://thefirstcohort.com/articles/2026-08-12-seven-weeks-345-people-sick-and-not-one-recall-notice-with-a-lot-codehttps://thefirstcohort.com/articles/2026-08-12-seven-weeks-345-people-sick-and-not-one-recall-notice-with-a-lot-codeThe FDA said the outbreak jalapeños did not reach grocery stores directly. Two days later the USDA named eighteen grocery products made with them, sold in 23 states. Seven weeks in, not one recall notice carries a lot code.Wed, 12 Aug 2026 00:00:00 GMTinfectious-diseasemedical-researchMarcus Chenhttps://thefirstcohort.com/articles/2026-08-12-rfk-jr-promised-radical-transparency-his-hhs-gutted-the-staff-who-release-fda-inhttps://thefirstcohort.com/articles/2026-08-12-rfk-jr-promised-radical-transparency-his-hhs-gutted-the-staff-who-release-fda-inThe FDA, CDC, and NIH fielded more than 15,000 records requests in 2024. In April 2025 HHS fired the staff who answer them, rehired some FDA workers a month later under legal pressure, and by August 2026 the federal records backlog had only grown.Wed, 12 Aug 2026 00:00:00 GMTinvestigationsfoiatransparencyhhsfdacdcMira Petrovhttps://thefirstcohort.com/articles/2026-08-12-one-protein-keeps-your-immune-system-s-peacekeeper-cells-from-switching-sideshttps://thefirstcohort.com/articles/2026-08-12-one-protein-keeps-your-immune-system-s-peacekeeper-cells-from-switching-sidesRegulatory T cells are supposed to be the immune system's off switch. Strip out a protein called TIF1γ and, under inflammation, they lose that identity, start producing an inflammatory cytokine, and join the attack.Wed, 12 Aug 2026 00:00:00 GMTautoimmune-inflammationtregsautoimmunitycell-biologyinflammationimmunologySarah Okonkwohttps://thefirstcohort.com/articles/2026-08-12-one-irish-plant-releases-both-of-sanofi-s-pompe-enzymes-in-june-the-fda-called-ihttps://thefirstcohort.com/articles/2026-08-12-one-irish-plant-releases-both-of-sanofi-s-pompe-enzymes-in-june-the-fda-called-iOne Irish plant runs the final release for both of Sanofi's lifelong Pompe enzymes. It just failed an FDA inspection on that exact step, and now the company says the fix could take months while patients confirm their next shipments.Wed, 12 Aug 2026 00:00:00 GMTinvestigationspompe-diseaseenzyme-replacementdrug-shortagesanofifdarare-diseaseSarah Okonkwohttps://thefirstcohort.com/articles/2026-08-12-months-before-officials-told-pregnant-women-the-covid-shot-was-safe-fauci-privathttps://thefirstcohort.com/articles/2026-08-12-months-before-officials-told-pregnant-women-the-covid-shot-was-safe-fauci-privatSenators Ron Johnson and Rand Paul pulled the first messages off Fauci's government iPhone: a January 2021 chain in which he privately flagged a theoretical first-trimester miscarriage risk, months before official guidance told pregnant women the shot carried no such concern.Wed, 12 Aug 2026 00:00:00 GMTinvestigationsfaucicovid-19mrna-vaccinespregnancyregulatory-captureaccountabilityMarcus Chenhttps://thefirstcohort.com/articles/2026-08-12-feed-these-bacteria-a-splash-of-glycerol-and-95-of-the-uranium-leaves-the-waterhttps://thefirstcohort.com/articles/2026-08-12-feed-these-bacteria-a-splash-of-glycerol-and-95-of-the-uranium-leaves-the-waterMicrobes in a flooded German uranium mine turned 95 percent of the dissolved metal into an iron compound that held together when oxygen returned, the exact failure that has always defeated standard cleanup.Wed, 12 Aug 2026 00:00:00 GMTinvestigationsuraniumbioremediationenvironmental-healthwater-contaminationmicrobiomeSarah Okonkwohttps://thefirstcohort.com/articles/2026-08-12-britain-france-and-germany-don-t-put-covid-shots-on-the-childhood-schedule-a-ushttps://thefirstcohort.com/articles/2026-08-12-britain-france-and-germany-don-t-put-covid-shots-on-the-childhood-schedule-a-usBritain, France, and Germany already keep routine COVID shots off the schedule for healthy children. When a US executive order moved the same way, the AMA, Paul Offit, and the press answered with 'zero data' instead of a debate.Wed, 12 Aug 2026 00:00:00 GMTinfectious-diseasemedical-researchMarcus Chenhttps://thefirstcohort.com/articles/2026-08-12-a-brown-fat-gene-turns-out-to-be-the-dial-between-a-heart-cell-dividing-and-growhttps://thefirstcohort.com/articles/2026-08-12-a-brown-fat-gene-turns-out-to-be-the-dial-between-a-heart-cell-dividing-and-growTurn PRDM16 down and lab-grown heart cells start dividing again but stay weak. Turn it up and they mature but quit the cell cycle. It's the same gene that decides whether a cell becomes calorie-burning brown fat.Wed, 12 Aug 2026 00:00:00 GMTmetabolic-weightheart-regenerationprdm16stem-cellscardiomyocytesbrown-fatcell-biologySarah Okonkwohttps://thefirstcohort.com/articles/2026-08-09-the-study-telling-you-not-to-bother-cutting-sweet-foods-was-co-funded-by-the-sodhttps://thefirstcohort.com/articles/2026-08-09-the-study-telling-you-not-to-bother-cutting-sweet-foods-was-co-funded-by-the-sodThe Sweet Tooth Trial found no reason to reduce sweet-tasting foods. Its private funders include the soda industry's trade group and the International Sweeteners Association.Sun, 09 Aug 2026 00:00:00 GMTnutrition-foodsugarsweetenersconflict-of-interestnutritioncravingsmetabolicSarah Okonkwohttps://thefirstcohort.com/articles/2026-08-09-the-screwworm-america-eradicated-is-back-and-the-fda-s-first-move-was-an-unapprohttps://thefirstcohort.com/articles/2026-08-09-the-screwworm-america-eradicated-is-back-and-the-fda-s-first-move-was-an-unapproThe fly the US drove off the continent in 1966 has crossed the border again, and the FDA's emergency answer is a wound spray that never cleared its own approval process. The method that actually won the war is the sterile fly, and Texas is racing to rebuild the factory it let die.Sun, 09 Aug 2026 00:00:00 GMTinfectious-diseasemedical-researchMarcus Chenhttps://thefirstcohort.com/articles/2026-08-09-the-fda-said-no-to-moderna-s-mrna-flu-shot-in-february-by-august-the-two-men-whohttps://thefirstcohort.com/articles/2026-08-09-the-fda-said-no-to-moderna-s-mrna-flu-shot-in-february-by-august-the-two-men-whoThe FDA refused to even review Moderna's mRNA flu shot in February because it was never tested against the enhanced vaccines seniors are steered toward. The two officials who objected are gone, and the agency approved it anyway, for the oldest patients, on a promise to prove it works later.Sun, 09 Aug 2026 00:00:00 GMTdrugs-fdamrnaflu-vaccinefdamodernaregulatory-capturerfkMarcus Chenhttps://thefirstcohort.com/articles/2026-08-09-the-fda-approved-narcolepsy-s-first-orexin-agonist-takeda-s-last-one-was-pulledhttps://thefirstcohort.com/articles/2026-08-09-the-fda-approved-narcolepsy-s-first-orexin-agonist-takeda-s-last-one-was-pulledTakeda's oveporexton switches on the orexin receptor that narcolepsy type 1 patients can no longer signal. The company's last orexin drug was halted in 2021 after patients crossed serious liver-injury thresholds.Sun, 09 Aug 2026 00:00:00 GMTdrugs-fdanarcolepsyorexinfda-approvaltakedadrug-safetyMarcus Chenhttps://thefirstcohort.com/articles/2026-08-09-the-cancer-trials-that-buried-vitamin-c-never-put-it-in-a-veinhttps://thefirstcohort.com/articles/2026-08-09-the-cancer-trials-that-buried-vitamin-c-never-put-it-in-a-veinMayo's famous trials gave advanced cancer patients vitamin C by mouth and found nothing. A randomized trial that delivered it by IV, at a dose pills cannot reach, doubled survival in metastatic pancreatic cancer.Sun, 09 Aug 2026 00:00:00 GMTcancervitamin-cpancreatic-cancerclinical-trialsascorbateoncologyLena Marshallhttps://thefirstcohort.com/articles/2026-08-09-the-body-s-own-brake-on-inflammation-mapped-in-2015-still-not-in-a-pillhttps://thefirstcohort.com/articles/2026-08-09-the-body-s-own-brake-on-inflammation-mapped-in-2015-still-not-in-a-pillA kinase called MST4 rides the brake on TRAF6, the protein that lets inflammation spiral, doing gently from inside the cell what broad autoimmune drugs force from the outside. Researchers mapped it in 2015. No pill uses it yet.Sun, 09 Aug 2026 00:00:00 GMTautoimmune-inflammationinflammationautoimmunetraf6cell-biologydrug-targetsSarah Okonkwohttps://thefirstcohort.com/articles/2026-08-09-for-years-the-muscle-aches-were-called-a-nocebo-effect-a-mcmaster-lab-found-stathttps://thefirstcohort.com/articles/2026-08-09-for-years-the-muscle-aches-were-called-a-nocebo-effect-a-mcmaster-lab-found-statAn estimated 7 to 29 percent of statin users report muscle pain. The flagship trial called most of it a placebo response. In mouse and human muscle cells, a McMaster team has now traced a cholesterol-independent pathway by which statins damage muscle directly.Sun, 09 Aug 2026 00:00:00 GMTdrugs-fdastatinsmuscle-paincholesterolnlrp3drug-safetyLena Marshallhttps://thefirstcohort.com/articles/2026-08-09-europe-s-wildfire-smoke-has-a-second-blast-radius-stopped-hearts-and-mood-disordhttps://thefirstcohort.com/articles/2026-08-09-europe-s-wildfire-smoke-has-a-second-blast-radius-stopped-hearts-and-mood-disordWhen California's wildfire PM2.5 climbed, depression ED visits rose 15 percent and mood-disorder visits 29 percent up to a week later, and per microgram that smoke was tied to larger health effects than ordinary city smog.Sun, 09 Aug 2026 00:00:00 GMTbrain-agingwildfire smokeair pollutionmental healthcardiovascularpm2.5public healthSarah Okonkwohttps://thefirstcohort.com/articles/2026-08-09-chemists-cracked-unsorted-plastic-into-hydrogen-with-lye-and-trapped-three-quarthttps://thefirstcohort.com/articles/2026-08-09-chemists-cracked-unsorted-plastic-into-hydrogen-with-lye-and-trapped-three-quartMost plastic never gets recycled. It gets burned or buried, and polyethylene keeps turning up in human brain tissue. A UCLA and Ewha team cracked mixed, unsorted trash into more than 90 percent pure hydrogen at low heat and trapped 75 percent of the carbon instead of letting it escape.Sun, 09 Aug 2026 00:00:00 GMTbrain-agingmicroplasticsplastic-wastehydrogenenvironmental-healthrecyclingbrainSarah Okonkwohttps://thefirstcohort.com/articles/2026-08-08-they-gave-ptsd-patients-thc-drops-at-bedtime-more-than-a-third-stopped-having-nihttps://thefirstcohort.com/articles/2026-08-08-they-gave-ptsd-patients-thc-drops-at-bedtime-more-than-a-third-stopped-having-niDronabinol beat placebo on the nightmare symptom the VA's longtime standby flunked, and the company that sells dronabinol helped fund the trial that found it worked.Sat, 08 Aug 2026 00:00:00 GMTmetabolic-weightmedical-researchSarah Okonkwohttps://thefirstcohort.com/articles/2026-08-08-the-fda-twice-called-this-melanoma-trial-uninterpretable-then-it-approved-the-drhttps://thefirstcohort.com/articles/2026-08-08-the-fda-twice-called-this-melanoma-trial-uninterpretable-then-it-approved-the-drFederal reviewers rejected Replimune's melanoma therapy twice, faulting a single-arm trial they called not adequate and well-controlled and its results uninterpretable. No new controlled data ever answered them. After a 10-3 advisory vote, the FDA approved it anyway, at $450,000 a course.Sat, 08 Aug 2026 00:00:00 GMTdrugs-fdamelanomafdaimmunotherapyaccelerated-approvalreplimuneoncologyLena Marshallhttps://thefirstcohort.com/articles/2026-08-08-mexican-jalape-os-sickened-1-400-americans-in-2008-eighteen-years-later-a-differhttps://thefirstcohort.com/articles/2026-08-08-mexican-jalape-os-sickened-1-400-americans-in-2008-eighteen-years-later-a-differSalmonella Javiana in jalapeños from Sinaloa has sickened 345 people across 27 states. It is the second time in eighteen years that imported Mexican peppers have done this, and the FDA still physically inspects only about 1 to 2 percent of the food crossing the border.Sat, 08 Aug 2026 00:00:00 GMTinfectious-diseasesalmonellafood-safetyproduce-importsfoodborne-illnessfdaantibiotic-resistanceMarcus Chenhttps://thefirstcohort.com/articles/2026-08-08-cancer-drugs-starve-tumors-of-arginine-a-rockefeller-lab-says-the-immune-systemhttps://thefirstcohort.com/articles/2026-08-08-cancer-drugs-starve-tumors-of-arginine-a-rockefeller-lab-says-the-immune-systemSome cancer therapies deliberately strip arginine from the body to starve tumors. Rockefeller researchers found that in mice the same depletion can hide tumors, flu, and SARS-CoV-2 from the immune system.Sat, 08 Aug 2026 00:00:00 GMTnutrition-foodarginineimmune-systemcancerviral-infectionsupplementsamino-acidsSarah Okonkwohttps://thefirstcohort.com/articles/2026-08-08-arkansas-cut-18-000-eligible-people-from-medicaid-over-paperwork-and-the-2027-fihttps://thefirstcohort.com/articles/2026-08-08-arkansas-cut-18-000-eligible-people-from-medicaid-over-paperwork-and-the-2027-fiA federal work requirement hits ACA Medicaid on January 1, 2027. Health-policy academics propose using AI to verify, screen, and manage the rollout, and the paper's lead author admits the system will "100% reproduce" the biases baked into the data.Sat, 08 Aug 2026 00:00:00 GMTinvestigationsmedicaidhealth-policyartificial-intelligencework-requirementsregulatoryMarcus Chenhttps://thefirstcohort.com/articles/2026-08-08-a-map-of-1-1-million-lung-immune-cells-finds-the-genetic-risk-for-autoimmune-dishttps://thefirstcohort.com/articles/2026-08-08-a-map-of-1-1-million-lung-immune-cells-finds-the-genetic-risk-for-autoimmune-disResearchers at La Jolla mapped genetic activity in 1.1 million lung immune cells and found about 1,000 genes whose activity is tuned by disease-risk variants only inside tissue, plus 1,700 that read differently in women than in men.Sat, 08 Aug 2026 00:00:00 GMTautoimmune-inflammationautoimmunelupuswomens-healthgeneticsimmunologySarah Okonkwohttps://thefirstcohort.com/articles/2026-08-07-christof-koch-bet-a-case-of-wine-that-science-would-find-consciousness-in-the-brhttps://thefirstcohort.com/articles/2026-08-07-christof-koch-bet-a-case-of-wine-that-science-would-find-consciousness-in-the-brAt a symposium in Portugal, the neuroscientist who spent 25 years hunting consciousness inside the brain conceded the field's central promise is still unpaid, and floated that consciousness might be fundamental to reality rather than manufactured by neurons.Fri, 07 Aug 2026 00:00:00 GMTbrain-agingconsciousnessneuroscienceintegrated-information-theoryterminal-luciditymindSarah Okonkwohttps://thefirstcohort.com/articles/2026-08-06-the-prescription-vitamin-d-added-to-protect-failing-kidneys-made-them-decline-fohttps://thefirstcohort.com/articles/2026-08-06-the-prescription-vitamin-d-added-to-protect-failing-kidneys-made-them-decline-foChasing a parathyroid-hormone target, doctors added active vitamin D to a kidney drug. The hormone dropped 35 percent, and the kidneys declined four times faster.Thu, 06 Aug 2026 00:00:00 GMTmetabolic-weightvitamin-dkidney-diseasefgf23overtreatmentpharma-fundingSarah Okonkwohttps://thefirstcohort.com/articles/2026-08-06-the-lungs-may-be-where-rheumatoid-arthritis-actually-startshttps://thefirstcohort.com/articles/2026-08-06-the-lungs-may-be-where-rheumatoid-arthritis-actually-startsAcross Italy, South Korea, and California, higher fine-particle pollution tracks more RA flares and more new cases, and the biology keeps pointing at the airway, not the knee.Thu, 06 Aug 2026 00:00:00 GMTautoimmune-inflammationrheumatoid-arthritisair-pollutionautoimmunepm2.5environmental-healthinflammationSarah Okonkwohttps://thefirstcohort.com/articles/2026-08-06-the-fat-rebound-pediatricians-watch-for-at-age-six-measure-the-waist-and-it-turnhttps://thefirstcohort.com/articles/2026-08-06-the-fat-rebound-pediatricians-watch-for-at-age-six-measure-the-waist-and-it-turnWaist-to-height ratio tracks body fat with about 90 percent accuracy. In 2,410 American kids it kept falling straight through the age when BMI says the fat comes roaring back.Thu, 06 Aug 2026 00:00:00 GMTmetabolic-weightchildhood-obesitybmimetabolicobesity-diagnosisnovo-nordiskSarah Okonkwohttps://thefirstcohort.com/articles/2026-08-06-gilead-priced-its-near-perfect-hiv-shot-out-of-the-countries-where-the-virus-ishttps://thefirstcohort.com/articles/2026-08-06-gilead-priced-its-near-perfect-hiv-shot-out-of-the-countries-where-the-virus-isLenacapavir drove new HIV infections to nearly zero across two Gilead trials and a year-long extension. Gilead lists it at $28,218 a year in America; researchers estimate generics could be made for as little as $25, and the fastest-growing epidemics were left off the cheap-generic map.Thu, 06 Aug 2026 00:00:00 GMTdrugs-fdamedical-researchLena Marshallhttps://thefirstcohort.com/articles/2026-08-06-chemo-surviving-ovarian-cancer-cells-release-fructose-to-loosen-the-tumor-next-dhttps://thefirstcohort.com/articles/2026-08-06-chemo-surviving-ovarian-cancer-cells-release-fructose-to-loosen-the-tumor-next-dThe same cholesterol-starving mechanism that loosens tumor cells implicates statins, the pills 39 million Americans take, yet the researchers who found it say keep taking them anyway.Thu, 06 Aug 2026 00:00:00 GMTcancerovarian-cancerfructosemetastasisstatinssenescencechemotherapyLena Marshallhttps://thefirstcohort.com/articles/2026-08-05-your-fat-cells-remember-being-fat-and-that-memory-outlasts-the-weight-losshttps://thefirstcohort.com/articles/2026-08-05-your-fat-cells-remember-being-fat-and-that-memory-outlasts-the-weight-lossYour body defends its heaviest weight for years after you lose it, which is why the rebound isn't weak willpower and why the injection only works while you keep paying for it.Wed, 05 Aug 2026 00:00:00 GMTmetabolic-weightweight-regainglp-1metabolismobesityepigeneticsSarah Okonkwohttps://thefirstcohort.com/articles/2026-08-05-u-s-special-operators-carried-french-freeze-dried-plasma-for-15-years-before-thehttps://thefirstcohort.com/articles/2026-08-05-u-s-special-operators-carried-french-freeze-dried-plasma-for-15-years-before-theAllied militaries and U.S. commandos have relied on freeze-dried plasma for years. Washington licensed its own version this week, decades after an American doctor first invented the powder.Wed, 05 Aug 2026 00:00:00 GMTdrugs-fdafreeze-dried-plasmafdatraumatransfusionmilitary-medicinehemorrhageSarah Okonkwohttps://thefirstcohort.com/articles/2026-08-05-they-doubled-the-recommended-protein-this-year-350-studies-say-that-s-backwardshttps://thefirstcohort.com/articles/2026-08-05-they-doubled-the-recommended-protein-this-year-350-studies-say-that-s-backwardsFederal guidance now tells you to eat nearly twice the protein it used to. A University of Wisconsin review of more than 350 studies argues that for people who don't train hard, the extra may be speeding up the aging they're trying to outrun.Wed, 05 Aug 2026 00:00:00 GMTnutrition-foodproteinlongevitymetabolismagingnutritionfgf21Sarah Okonkwohttps://thefirstcohort.com/articles/2026-08-05-the-licensed-ebola-vaccine-was-never-proven-to-stop-the-strain-now-killing-congohttps://thefirstcohort.com/articles/2026-08-05-the-licensed-ebola-vaccine-was-never-proven-to-stop-the-strain-now-killing-congoBundibugyo virus has driven the fastest-growing Ebola outbreak on record, with 1,707 deaths across eastern Congo and nearly 90 percent of cases in Ituri, and the WHO's own experts say the one licensed Ebola vaccine should not be used against it.Wed, 05 Aug 2026 00:00:00 GMTinfectious-diseaseebolabundibugyocongooutbreakpublic-healthvaccinesMarcus Chenhttps://thefirstcohort.com/articles/2026-08-05-mit-put-an-ai-skin-doctor-in-front-of-776-people-its-friendliest-feature-fooledhttps://thefirstcohort.com/articles/2026-08-05-mit-put-an-ai-skin-doctor-in-front-of-776-people-its-friendliest-feature-fooled623 lay people and 153 doctors used the same AI to read skin conditions. The doctors shrugged off its bad advice. Everyone else trusted it more the more fluently it explained itself.Wed, 05 Aug 2026 00:00:00 GMTinvestigationsmedical-aiexplainable-aidermatologyautomation-biasskin-cancerSarah Okonkwohttps://thefirstcohort.com/articles/2026-08-04-vitamin-k-shot-refusals-nearly-doubled-since-2017-a-cancer-scare-refuted-twentyhttps://thefirstcohort.com/articles/2026-08-04-vitamin-k-shot-refusals-nearly-doubled-since-2017-a-cancer-scare-refuted-twentyRefusal of the newborn vitamin K shot has nearly doubled since 2017. The injection all but erases a bleed that kills roughly one in five infants it reaches, and the cancer scare still shadowing it was refuted twenty years ago. The institutions losing these parents will not even count the damage.Tue, 04 Aug 2026 00:00:00 GMTinvestigationsvitamin-knewborn-healthvkdbpublic-trustrefusal-trendMira Petrovhttps://thefirstcohort.com/articles/2026-08-04-two-vaccine-injury-programs-one-country-covid-claims-landed-in-the-one-that-almohttps://thefirstcohort.com/articles/2026-08-04-two-vaccine-injury-programs-one-country-covid-claims-landed-in-the-one-that-almoThe federal fund for routine vaccine injuries has paid $5.2 billion to nearly 10,000 people. The program COVID shots were routed into has compensated 34 claims, and RFK Jr. wants to change the math.Tue, 04 Aug 2026 00:00:00 GMTinvestigationscovid-vaccinevaccine-injurycicprfk-jrprep-actMarcus Chenhttps://thefirstcohort.com/articles/2026-08-04-two-scientists-nominated-fauci-for-cash-prizes-then-his-agency-funded-them-by-thhttps://thefirstcohort.com/articles/2026-08-04-two-scientists-nominated-fauci-for-cash-prizes-then-his-agency-funded-them-by-thThe emails Rand Paul released July 24 show Fauci's taxpayer-funded staff drafting his award nominations, and two scientists who submitted them going on to draw large NIAID grants.Tue, 04 Aug 2026 00:00:00 GMTinvestigationsfaucinihconflicts-of-interestcovid-originsaccountabilityMira Petrovhttps://thefirstcohort.com/articles/2026-08-04-the-reason-immunotherapy-bounces-off-prostate-cancer-tumors-chew-off-a-genetic-thttps://thefirstcohort.com/articles/2026-08-04-the-reason-immunotherapy-bounces-off-prostate-cancer-tumors-chew-off-a-genetic-tProstate tumors overproduce a protein that destroys the immune system's docking targets. A CRISPR tool that blocks the trick made checkpoint drugs work again, so far only in mice.Tue, 04 Aug 2026 00:00:00 GMTcancerprostate-cancerimmunotherapycrisproncologycheckpoint-inhibitorsLena Marshallhttps://thefirstcohort.com/articles/2026-08-04-the-genes-driving-cancer-s-growth-are-the-same-ones-it-keeps-breakinghttps://thefirstcohort.com/articles/2026-08-04-the-genes-driving-cancer-s-growth-are-the-same-ones-it-keeps-breakingThe same super-enhancers that make a tumor grow keep snapping its DNA, and the botched repairs are where the next mutations come from. The finding is real, careful, and already a year old.Tue, 04 Aug 2026 00:00:00 GMTcancercancerdna-damagesuper-enhancersgenomic-instabilityoncologyLena Marshallhttps://thefirstcohort.com/articles/2026-08-04-the-fda-cleared-a-crispr-cure-for-two-year-olds-whose-own-trial-enrolled-no-onehttps://thefirstcohort.com/articles/2026-08-04-the-fda-cleared-a-crispr-cure-for-two-year-olds-whose-own-trial-enrolled-no-oneCasgevy's pediatric trials enrolled 11 children aged five and up, yet the FDA extended the $2.2 million therapy down to age two, where the conditioning chemo can permanently sterilize a child too young to bank eggs or sperm.Tue, 04 Aug 2026 00:00:00 GMTdrugs-fdagene-therapysickle-cellfdacrisprfertilitycasgevyLena Marshallhttps://thefirstcohort.com/articles/2026-08-04-the-fat-molecule-that-rides-from-your-waistline-to-your-brain-and-feeds-alzheimehttps://thefirstcohort.com/articles/2026-08-04-the-fat-molecule-that-rides-from-your-waistline-to-your-brain-and-feeds-alzheimeIn obese mice, a membrane fat called phosphatidylethanolamine packed into tiny vesicles, rode to the brain, and sabotaged the immune cells that clear amyloid. An investigational drug reversed it, in mice.Tue, 04 Aug 2026 00:00:00 GMTbrain-agingalzheimersobesitymetabolic-healthlipidsmicroglianeuroinflammationSarah Okonkwohttps://thefirstcohort.com/articles/2026-08-04-scientists-watched-the-flu-dissolve-structures-inside-the-nucleus-in-every-cellhttps://thefirstcohort.com/articles/2026-08-04-scientists-watched-the-flu-dissolve-structures-inside-the-nucleus-in-every-cellInfluenza reaches into the nucleus and takes apart droplets that may be part of the cell's own defense. Scientists have now mapped how. The drug targets that map supposedly unlocks are still hypothetical.Tue, 04 Aug 2026 00:00:00 GMTinfectious-diseaseinfluenzavirologycell-biologyparaspecklesantiviralsLena Marshallhttps://thefirstcohort.com/articles/2026-08-04-rare-but-real-the-autoimmune-hepatitis-after-mrna-that-vaers-was-built-to-misshttps://thefirstcohort.com/articles/2026-08-04-rare-but-real-the-autoimmune-hepatitis-after-mrna-that-vaers-was-built-to-missTwenty-seven biopsy-confirmed cases of autoimmune hepatitis after an mRNA dose, jaundice and an ALT of 1,092 that resolved on steroids. The disproportionality math found 'no safety signal.' It was measuring a reporting system, not the liver.Tue, 04 Aug 2026 00:00:00 GMTautoimmune-inflammationcovid-19vaccine-safetyautoimmune-hepatitisvaersmolecular-mimicrymrnaMarcus Chenhttps://thefirstcohort.com/articles/2026-08-04-in-tuberculosis-the-cell-we-called-neutral-is-the-one-torching-the-lunghttps://thefirstcohort.com/articles/2026-08-04-in-tuberculosis-the-cell-we-called-neutral-is-the-one-torching-the-lungIn the people whose latent TB roared into active disease, the airways filled with neutrophils, half of them flipping on an interferon alarm, while their T cells were pushed to exhaustion and death.Tue, 04 Aug 2026 00:00:00 GMTinfectious-diseasetuberculosisimmunologyneutrophilsinfectious-diseaselungSarah Okonkwohttps://thefirstcohort.com/articles/2026-08-04-in-2021-creatine-spread-cancer-in-mice-this-week-a-ucla-lab-said-it-fights-ithttps://thefirstcohort.com/articles/2026-08-04-in-2021-creatine-spread-cancer-in-mice-this-week-a-ucla-lab-said-it-fights-itA UCLA study found creatine energized cancer-fighting immune cells in mice and lab dishes. It was never tested in a patient, and a separate line of research says the same supplement feeds metastasis.Tue, 04 Aug 2026 00:00:00 GMTcancercreatinecancerimmunotherapysupplementsdendritic-cellspreclinicalLena Marshallhttps://thefirstcohort.com/articles/2026-08-04-glioblastoma-craves-sugar-oregon-state-coated-a-gene-therapy-in-it-and-rode-strahttps://thefirstcohort.com/articles/2026-08-04-glioblastoma-craves-sugar-oregon-state-coated-a-gene-therapy-in-it-and-rode-straGlioblastoma overexpresses the same sugar transporter that guards the brain. Oregon State researchers used that greed to smuggle a tumor-suppressor gene into tumors, and mouse survival rose 50 percent.Tue, 04 Aug 2026 00:00:00 GMTcancerglioblastomabrain-cancernanoparticlesgene-therapyblood-brain-barriermrnaSarah Okonkwohttps://thefirstcohort.com/articles/2026-08-04-built-to-find-nothing-merck-tested-gardasil-s-safety-against-its-own-aluminum-adhttps://thefirstcohort.com/articles/2026-08-04-built-to-find-nothing-merck-tested-gardasil-s-safety-against-its-own-aluminum-adIn ten of eleven pivotal trials, Merck's Gardasil 'placebo' was 225 micrograms of the same aluminum adjuvant that is in the vaccine, and serious harms counted only inside a 14-day window.Tue, 04 Aug 2026 00:00:00 GMTinvestigationsgardasilmerckhpv-vaccineclinical-trialsregulatory-capturealuminum-adjuvantMira Petrovhttps://thefirstcohort.com/articles/2026-08-04-a-toxicologist-mapped-800-shared-causes-across-4-000-diseases-his-protocol-treathttps://thefirstcohort.com/articles/2026-08-04-a-toxicologist-mapped-800-shared-causes-across-4-000-diseases-his-protocol-treatRonald Kostoff argues chronic and infectious disease grow from the same toxic soil, a damaged immune system, and that removing the cause has to come before any drug can work.Tue, 04 Aug 2026 00:00:00 GMTinfectious-diseasechronic-diseaseinfectious-diseasetoxicologyimmune-systemexposomepreventionMarcus Chenhttps://thefirstcohort.com/articles/2026-07-31-the-phone-radiation-study-everyone-called-a-debunking-was-too-small-to-find-thehttps://thefirstcohort.com/articles/2026-07-31-the-phone-radiation-study-everyone-called-a-debunking-was-too-small-to-find-theJapan and Korea spent two years 'validating' the NIH finding that cell-phone radiation gave rats heart tumors. They used one dose, one sex, and too few animals to detect it. Korea's rats grew the tumor anyway.Fri, 31 Jul 2026 00:00:00 GMTinvestigationsrf-radiationcell-phonescarcinogenicityntpregulatory-capturecancerSarah Okonkwohttps://thefirstcohort.com/articles/2026-07-31-a-week-instead-of-a-month-the-faster-prostate-radiation-was-only-as-safe-on-thehttps://thefirstcohort.com/articles/2026-07-31-a-week-instead-of-a-month-the-faster-prostate-radiation-was-only-as-safe-on-thePACE-C put five-fraction radiation against the four-week course in 1,208 men. On the old grading scale they matched. On the finer one the short course logged 17 percent bowel toxicity against 10 percent, and the trial still can't say whether the shorter beam controls cancer as well.Fri, 31 Jul 2026 00:00:00 GMTcancerprostate-cancerradiotherapysbrtclinical-trialsoncologyLena Marshallhttps://thefirstcohort.com/articles/2026-07-31-a-microwave-can-fry-a-potato-that-soaks-up-less-oil-that-isn-t-the-same-as-a-heahttps://thefirstcohort.com/articles/2026-07-31-a-microwave-can-fry-a-potato-that-soaks-up-less-oil-that-isn-t-the-same-as-a-heaUniversity of Illinois engineers made French fries that hold less oil by frying them from the inside. Nobody ran a taste test, nobody measured the acrylamide, and the pitch was aimed at food manufacturers.Fri, 31 Jul 2026 00:00:00 GMTnutrition-foodnutritionfood-processingacrylamidefryingmetabolicSarah Okonkwohttps://thefirstcohort.com/articles/2026-07-31-a-gene-editing-trial-killed-a-six-year-old-the-only-official-penalty-was-a-3-500https://thefirstcohort.com/articles/2026-07-31-a-gene-editing-trial-killed-a-six-year-old-the-only-official-penalty-was-a-3-500Xinhua Hospital paid about 24,000 yuan in September 2025. The death it was fined over stayed out of the medical literature for another ten months, and out of the Nature paper entirely.Fri, 31 Jul 2026 00:00:00 GMTinvestigationsgene-editingresearch-integritychinacrisprregulatory-captureaccountabilityMira Petrovhttps://thefirstcohort.com/articles/2026-07-31-a-30-minute-sauna-floods-the-blood-with-immune-cells-and-the-heat-isn-t-what-trihttps://thefirstcohort.com/articles/2026-07-31-a-30-minute-sauna-floods-the-blood-with-immune-cells-and-the-heat-isn-t-what-triFinnish researchers put 51 people in a 73-degree sauna and watched every class of white blood cell surge, then found the surge had almost nothing to do with how hot anyone actually got.Fri, 31 Jul 2026 00:00:00 GMTautoimmune-inflammationsaunaimmune-systeminflammationlongevitywellnessfinlandSarah Okonkwohttps://thefirstcohort.com/articles/2026-07-30-same-diet-same-15-pounds-only-the-women-who-ate-in-an-8-hour-window-got-sharperhttps://thefirstcohort.com/articles/2026-07-30-same-diet-same-15-pounds-only-the-women-who-ate-in-an-8-hour-window-got-sharperTwo groups of older women cut the same calories and lost the same 15 pounds over six months. The ones who packed eating into an 8-hour window still scored better on problem-solving, from a 47-person pilot that hasn't been peer-reviewed.Thu, 30 Jul 2026 00:00:00 GMTbrain-agingtime-restricted-eatingcognitive-declinelongevitymetabolic-healthwomens-healthSarah Okonkwohttps://thefirstcohort.com/articles/2026-07-30-rice-chemists-taught-an-enzyme-to-recycle-drug-synthesis-s-most-expensive-ingredhttps://thefirstcohort.com/articles/2026-07-30-rice-chemists-taught-an-enzyme-to-recycle-drug-synthesis-s-most-expensive-ingredThe chemistry that builds drugs like Spinraza just got cheaper. The $125,000 price tag never had much to do with the chemistry.Thu, 30 Jul 2026 00:00:00 GMTdrugs-fdadrug-synthesisantisense-oligonucleotidesbiocatalysisdrug-pricingenzymesSarah Okonkwohttps://thefirstcohort.com/articles/2026-07-30-no-one-guards-the-toddler-food-aisle-81-percent-of-its-foods-are-ultra-processedhttps://thefirstcohort.com/articles/2026-07-30-no-one-guards-the-toddler-food-aisle-81-percent-of-its-foods-are-ultra-processedParents assume the baby aisle is vetted. It isn't. No US rule makes toddler food meet a nutrient standard, and an Austin audit of 2,783 products marketed for 6-to-36-month-olds found 81 percent ultra-processed and nearly half failing a WHO benchmark.Thu, 30 Jul 2026 00:00:00 GMTnutrition-foodultra-processed foodstoddler nutritionadded sugarfood industryregulationmicrobiomeSarah Okonkwohttps://thefirstcohort.com/articles/2026-07-30-histamine-was-always-the-wrong-target-for-the-eczema-itchhttps://thefirstcohort.com/articles/2026-07-30-histamine-was-always-the-wrong-target-for-the-eczema-itchEczema itch runs on cytokines, not mainly histamine, which is why the pills in the allergy aisle keep failing the trials, and a network meta-analysis just said so one more time.Thu, 30 Jul 2026 00:00:00 GMTautoimmune-inflammationeczemaatopic-dermatitisantihistaminesitchdermatologyevidenceMarcus Chenhttps://thefirstcohort.com/articles/2026-07-28-the-same-cancer-mutation-opposite-effects-what-581-mouse-tumors-say-about-who-gehttps://thefirstcohort.com/articles/2026-07-28-the-same-cancer-mutation-opposite-effects-what-581-mouse-tumors-say-about-who-geCambridge and Yale gave four strains of mice one identical dose of a carcinogen. The tumors converged on the same pathway but took four different genetic routes to get there, and today's screening ignores the reason.Tue, 28 Jul 2026 00:00:00 GMTcancercanceroncologygeneticsscreeningprecision-medicineLena Marshallhttps://thefirstcohort.com/articles/2026-07-28-the-nih-weighed-every-meal-to-a-tenth-of-a-gram-four-ai-calorie-apps-undercountehttps://thefirstcohort.com/articles/2026-07-28-the-nih-weighed-every-meal-to-a-tenth-of-a-gram-four-ai-calorie-apps-undercounteIn a locked NIH metabolic kitchen where every ingredient was weighed to 0.1 grams, MyFitnessPal, Lose It!, CalAI, and Appediet each read a plate and undercounted it by a quarter to a third, missing the fat most of all.Tue, 28 Jul 2026 00:00:00 GMTnutrition-foodcalorie-trackingai-appsnutritionweight-lossketometabolicSarah Okonkwohttps://thefirstcohort.com/articles/2026-07-28-the-fda-approved-the-first-cholesterol-pill-of-its-kind-before-its-trial-could-shttps://thefirstcohort.com/articles/2026-07-28-the-fda-approved-the-first-cholesterol-pill-of-its-kind-before-its-trial-could-sLipfendra lowers LDL cholesterol by up to 60 percent. The 14,550-patient trial that would show whether that prevents heart attacks or deaths does not finish until November 2029, and Merck is charging roughly $3,800 a year in the meantime.Tue, 28 Jul 2026 00:00:00 GMTdrugs-fdamedical-researchLena Marshallhttps://thefirstcohort.com/articles/2026-07-28-pregnant-women-s-blood-pressure-registers-every-smoke-day-a-federal-rule-lets-sthttps://thefirstcohort.com/articles/2026-07-28-pregnant-women-s-blood-pressure-registers-every-smoke-day-a-federal-rule-lets-stOn heavy smoke days, adults' systolic pressure ran nearly 4 mmHg higher; across eight southwestern states, gestational smoke exposure raised the odds of gestational hypertension 12 percent. Since 2016, regulators have won EPA approval to erase wildfire smoke from the Clean Air Act record in more thaTue, 28 Jul 2026 00:00:00 GMTinvestigationswildfire-smokematernal-healthair-pollutionpregnancyepaSarah Okonkwohttps://thefirstcohort.com/articles/2026-07-28-a-daily-scoop-of-chicory-fiber-eased-knee-arthritis-and-it-moved-the-same-gut-hohttps://thefirstcohort.com/articles/2026-07-28-a-daily-scoop-of-chicory-fiber-eased-knee-arthritis-and-it-moved-the-same-gut-hoTwenty grams of chicory fiber a day matched a physiotherapy app for knee arthritis pain, and only one person in the fiber group quit. The hormone it nudged is the one Ozempic is built to imitate.Tue, 28 Jul 2026 00:00:00 GMTnutrition-foodknee osteoarthritisinulinprebiotic fiberglp-1gut microbiomeSarah Okonkwohttps://thefirstcohort.com/articles/2026-07-27-the-american-diabetes-association-had-police-remove-the-editor-of-its-own-journahttps://thefirstcohort.com/articles/2026-07-27-the-american-diabetes-association-had-police-remove-the-editor-of-its-own-journaSteven Kahn edits the ADA's own journal. In June its meeting had state police walk him out for handing out one of its editorials. In July it refused to print the response he and his colleagues wrote. He calls it what it is: pure censorship.Mon, 27 Jul 2026 00:00:00 GMTinvestigationscensorshipdiabetesacademic-freedominstitutional-capturenih-fundingfree-speechLena Marshallhttps://thefirstcohort.com/articles/2026-07-27-bpa-sits-in-90-of-us-the-cancer-studies-sample-it-with-a-method-that-was-never-ghttps://thefirstcohort.com/articles/2026-07-27-bpa-sits-in-90-of-us-the-cancer-studies-sample-it-with-a-method-that-was-never-gBisphenol A shows up in more than nine of ten Americans, yet California's reviewers just called the cancer evidence 'inadequate,' because the studies measure a chemical the body clears in hours from a single urine sample.Mon, 27 Jul 2026 00:00:00 GMTinvestigationsbpaendocrine-disruptorscancerchemical-regulationexposure-assessmentSarah Okonkwohttps://thefirstcohort.com/articles/2026-07-26-the-evolutionary-fix-for-drug-resistance-works-best-on-a-tumor-too-small-to-findhttps://thefirstcohort.com/articles/2026-07-26-the-evolutionary-fix-for-drug-resistance-works-best-on-a-tumor-too-small-to-findCity St George's mathematicians say hitting a tumor at its weakest moment can drive it extinct. Their own model clears 95 percent only below 7 million cells, far smaller than any tumor a scan can find.Sun, 26 Jul 2026 00:00:00 GMTcancercanceroncologydrug-resistanceevolutionary-therapyclinical-trialsLena Marshallhttps://thefirstcohort.com/articles/2026-07-26-pepsi-paid-1-95-billion-for-poppi-in-a-category-that-averages-as-much-sugar-as-fhttps://thefirstcohort.com/articles/2026-07-26-pepsi-paid-1-95-billion-for-poppi-in-a-category-that-averages-as-much-sugar-as-fUNC researchers read the labels on 108 prebiotic sodas and found roughly 5 grams of fiber, 5 grams of sugar, and, in most cans, a non-nutritive sweetener. Poppi agreed to an $8.9 million settlement over its gut-health claims; months later Pepsi paid $1.95 billion for it.Sun, 26 Jul 2026 00:00:00 GMTnutrition-foodprebiotic sodagut healthfood labelinghealth halopoppiLena Marshallhttps://thefirstcohort.com/articles/2026-07-26-orforglipron-reaches-deep-into-the-brain-s-reward-circuit-and-turns-the-dopaminehttps://thefirstcohort.com/articles/2026-07-26-orforglipron-reaches-deep-into-the-brain-s-reward-circuit-and-turns-the-dopamineIn mice engineered with human GLP-1 receptors, the new oral pills reached the central amygdala, a deep reward hub, and thinned the dopamine payoff of eating for pleasure. The government's addiction institute is already watching.Sun, 26 Jul 2026 00:00:00 GMTmetabolic-weightglp-1orforgliprondopamineobesityaddictionbrain-rewardSarah Okonkwohttps://thefirstcohort.com/articles/2026-07-26-a-gene-editing-trial-killed-a-6-year-old-nature-published-the-science-and-left-hhttps://thefirstcohort.com/articles/2026-07-26-a-gene-editing-trial-killed-a-6-year-old-nature-published-the-science-and-left-hHer parents paid $860,000 to base-edit their daughter's brain. She died of an immune reaction within a week, the trial's fatal outcome was never disclosed, and the Nature paper built on the same work never names her.Sun, 26 Jul 2026 00:00:00 GMTinvestigationsgene-editingbase-editingresearch-integrityregulatory-oversightchinaMira Petrovhttps://thefirstcohort.com/articles/2026-07-25-the-fruit-juice-sold-to-parents-as-the-healthy-choice-tracks-with-higher-blood-phttps://thefirstcohort.com/articles/2026-07-25-the-fruit-juice-sold-to-parents-as-the-healthy-choice-tracks-with-higher-blood-pOne daily glass of orange juice tracked with 20 percent higher blood pressure risk. The whole fruit tracked with nothing.Sat, 25 Jul 2026 00:00:00 GMTnutrition-foodfruit juicehypertensionchildhood nutritionfructosemetabolic healthSarah Okonkwohttps://thefirstcohort.com/articles/2026-07-25-the-fda-revoked-two-petroleum-dyes-that-industry-abandoned-before-most-americanshttps://thefirstcohort.com/articles/2026-07-25-the-fda-revoked-two-petroleum-dyes-that-industry-abandoned-before-most-americansOrange B was last certified in 1978. Citrus Red No. 2 has painted Florida oranges since 1959. The six petroleum dyes actually in the food supply remain on a voluntary timeline no manufacturer has publicly signed.Sat, 25 Jul 2026 00:00:00 GMTnutrition-foodfood-dyesfdamahapetroleum-dyesfood-safetycitrus-red-2Marcus Chenhttps://thefirstcohort.com/articles/2026-07-25-a-chinese-bark-compound-reached-the-black-box-arthritis-drugs-pathway-from-upstrhttps://thefirstcohort.com/articles/2026-07-25-a-chinese-bark-compound-reached-the-black-box-arthritis-drugs-pathway-from-upstrIn rats, a compound from the bark of the Amur cork tree reached the same JAK-STAT pathway as Xeljanz and its black-box cousins, but by rebalancing the cell's fat metabolism instead of blocking the pathway directly.Sat, 25 Jul 2026 00:00:00 GMTautoimmune-inflammationrheumatoid-arthritisautoimmunenatural-compoundsjak-inhibitorsmetabolismSarah Okonkwohttps://thefirstcohort.com/articles/2026-07-23-the-sweeteners-sold-to-diabetics-as-the-safe-swap-tracked-with-faster-brain-aginhttps://thefirstcohort.com/articles/2026-07-23-the-sweeteners-sold-to-diabetics-as-the-safe-swap-tracked-with-faster-brain-aginBrazilian researchers followed 12,772 adults for eight years. The ones consuming the most artificial sweeteners, about a diet soda's worth a day, showed cognitive decline equal to 1.6 extra years of brain aging, and diabetics fared worst.Thu, 23 Jul 2026 00:00:00 GMTbrain-agingartificial-sweetenerscognitive-declinediabetesgut-brain-axisaspartamemetabolic-healthSarah Okonkwohttps://thefirstcohort.com/articles/2026-07-23-the-glp-1s-that-barely-move-the-scale-don-t-cause-hair-loss-and-that-s-the-cluehttps://thefirstcohort.com/articles/2026-07-23-the-glp-1s-that-barely-move-the-scale-don-t-cause-hair-loss-and-that-s-the-clueWomen on semaglutide shed hair at about twice the rate of men, and the weakest GLP-1s show almost no signal, which points the cause away from the follicle and straight at how fast the weight comes off.Thu, 23 Jul 2026 00:00:00 GMTmetabolic-weightglp-1semaglutidehair-lossweight-losswomens-healthmetabolicSarah Okonkwohttps://thefirstcohort.com/articles/2026-07-23-the-aha-says-coffee-is-safe-to-five-cups-a-day-the-energy-shot-s-problem-isn-t-thttps://thefirstcohort.com/articles/2026-07-23-the-aha-says-coffee-is-safe-to-five-cups-a-day-the-energy-shot-s-problem-isn-t-tUp to 400 mg a day, roughly three to five cups of regular black coffee, is generally safe for most adults and may be linked to lower cardiovascular risk. The concentrated shot in the gym-bag can is a different animal, and the reason isn't the caffeine.Thu, 23 Jul 2026 00:00:00 GMTnutrition-foodcaffeinecoffeeenergy-drinksheart-healthblood-pressurenutritionSarah Okonkwohttps://thefirstcohort.com/articles/2026-07-23-in-the-lab-coffee-flipped-an-anti-aging-switch-the-caffeine-barely-didhttps://thefirstcohort.com/articles/2026-07-23-in-the-lab-coffee-flipped-an-anti-aging-switch-the-caffeine-barely-didStephen Safe's lab reported that coffee's polyphenols, more than its caffeine, switch on a cellular stress-defense receptor. Every experiment ran in a dish, and the anti-aging headline traveled a great deal further than the data.Thu, 23 Jul 2026 00:00:00 GMTnutrition-foodcoffeepolyphenolsagingnr4a1cell-studyLena Marshallhttps://thefirstcohort.com/articles/2026-07-14-a-petri-dish-of-angry-immune-cells-a-little-ultrasound-and-a-very-big-headlinehttps://thefirstcohort.com/articles/2026-07-14-a-petri-dish-of-angry-immune-cells-a-little-ultrasound-and-a-very-big-headlineUAH researchers used sound waves to shift immune cells from attack mode toward repair. The press release said 'stop arthritis before it starts.' The experiment never touched a joint.Tue, 14 Jul 2026 00:00:00 GMTautoimmune-inflammationultrasoundmacrophagesinflammationosteoarthritisjoint-healthpreclinicalSarah Okonkwohttps://thefirstcohort.com/articles/2026-07-13-the-mice-ate-more-and-got-leaner-the-switch-was-one-amino-acid-turned-downhttps://thefirstcohort.com/articles/2026-07-13-the-mice-ate-more-and-got-leaner-the-switch-was-one-amino-acid-turned-downUSC mice on a low-protein, methionine-tuned diet ate as many calories as the junk-food group and still lost fat, while their own bodies pumped out more GLP-1. The scientist behind it also owns the company selling longevity diets.Mon, 13 Jul 2026 00:00:00 GMTmetabolic-weightlongevitymetabolicmethionineglp-1dietproteinSarah Okonkwohttps://thefirstcohort.com/articles/2026-07-13-anti-tau-alzheimer-s-drugs-keep-hitting-their-target-and-missing-the-diseasehttps://thefirstcohort.com/articles/2026-07-13-anti-tau-alzheimer-s-drugs-keep-hitting-their-target-and-missing-the-diseaseTau is the new headliner at the Alzheimer's conference, but the anti-tau antibodies keep proving they bind the protein while doing nothing for patients. The clearest win so far is a blood test.Mon, 13 Jul 2026 00:00:00 GMTbrain-agingalzheimerstaublood-testbiomarkerspharmaneurologySarah Okonkwohttps://thefirstcohort.com/articles/2026-07-13-a-gut-microbe-was-feeding-ammonia-to-sick-livers-a-michigan-peptide-cut-off-thehttps://thefirstcohort.com/articles/2026-07-13-a-gut-microbe-was-feeding-ammonia-to-sick-livers-a-michigan-peptide-cut-off-theThe compound reversed severe fatty liver in monkeys by starving one ammonia-making gut bacterium. It also comes from a company its lead inventor founded, and no human has taken it for this.Mon, 13 Jul 2026 00:00:00 GMTmetabolic-weightfatty-livermashgut-microbiomemetabolicliverpreclinicalSarah Okonkwohttps://thefirstcohort.com/articles/2026-07-12-your-first-pregnancy-rewires-the-brain-for-one-baby-your-second-rewires-it-for-thttps://thefirstcohort.com/articles/2026-07-12-your-first-pregnancy-rewires-the-brain-for-one-baby-your-second-rewires-it-for-tAmsterdam researchers scanned 110 women and found each pregnancy leaves its own mark, and the brain changes tied to maternal depression showed up months earlier the second time around.Sun, 12 Jul 2026 00:00:00 GMTbrain-agingpregnancymaternal-brainneuroscienceperipartum-depressionwomens-healthSarah Okonkwohttps://thefirstcohort.com/articles/2026-07-12-the-blue-light-over-your-fish-tank-is-now-building-drug-moleculeshttps://thefirstcohort.com/articles/2026-07-12-the-blue-light-over-your-fish-tank-is-now-building-drug-moleculesUniversity at Buffalo chemists swapped harsh UV for a soft blue LED and got something the old chemistry rarely gives: two modifications to a molecule from a single reaction step.Sun, 12 Jul 2026 00:00:00 GMTdrugs-fdaphotochemistrydrug-discoverymedicinal-chemistrynih-fundingchemistrySarah Okonkwohttps://thefirstcohort.com/articles/2026-07-12-the-anti-inflammatory-worm-that-only-works-if-you-feed-it-fiberhttps://thefirstcohort.com/articles/2026-07-12-the-anti-inflammatory-worm-that-only-works-if-you-feed-it-fiberFeed a rat plenty of fiber and a harmless tapeworm reaches full size and quiets the immune system. Cut the fiber to Western levels and the same worm shrinks, stops reproducing, and its anti-inflammatory power switches off.Sun, 12 Jul 2026 00:00:00 GMTautoimmune-inflammationmicrobiomefiberhelminth-therapyautoimmunegut-healthinflammationSarah Okonkwohttps://thefirstcohort.com/articles/2026-07-12-a-pharma-funded-nonprofit-is-lobbying-the-fda-to-kill-seven-peptides-it-can-t-sehttps://thefirstcohort.com/articles/2026-07-12-a-pharma-funded-nonprofit-is-lobbying-the-fda-to-kill-seven-peptides-it-can-t-seThe Partnership for Safe Medicines has deep ties to the drug lobby. Now it's urging the FDA to permanently block BPC-157, MOTS-c and five other off-patent peptides that compounding pharmacies sell cheap.Sun, 12 Jul 2026 00:00:00 GMTinvestigationspeptidesbpc-157compoundingfdabig-pharmalongevitySarah Okonkwohttps://thefirstcohort.com/articles/2026-07-11-the-allergy-cell-everyone-wanted-dead-turns-out-to-run-your-gut-lining-and-yourhttps://thefirstcohort.com/articles/2026-07-11-the-allergy-cell-everyone-wanted-dead-turns-out-to-run-your-gut-lining-and-yourEosinophils were the villain of asthma and allergy, the cell whole-body drugs are built to erase. A decade of tissue biology says they also seal your gut, feed your antibodies, and tune your fat, and the trials never measured any of it.Sat, 11 Jul 2026 00:00:00 GMTautoimmune-inflammationeosinophilsgut-healthmetabolismimmunologyasthma-biologicsmicrobiomeSarah Okonkwohttps://thefirstcohort.com/articles/2026-07-11-for-years-a-foreign-factory-could-put-the-active-ingredient-in-your-medicine-andhttps://thefirstcohort.com/articles/2026-07-11-for-years-a-foreign-factory-could-put-the-active-ingredient-in-your-medicine-andThe FDA led with a paperwork convenience for manufacturers. Buried underneath was the admission that it can't always trace where a drug's active ingredient was made, a blind spot Congress had to order it to close.Sat, 11 Jul 2026 00:00:00 GMTdrugs-fdafdadrug-supply-chainactive-pharmaceutical-ingredientsmanufacturingchinaregulationLena Marshallhttps://thefirstcohort.com/articles/2026-07-11-berlin-physicists-bolted-a-metamaterial-to-a-7-tesla-mri-and-the-living-eye-camehttps://thefirstcohort.com/articles/2026-07-11-berlin-physicists-bolted-a-metamaterial-to-a-7-tesla-mri-and-the-living-eye-cameIt clips onto a 7-tesla scanner a hospital already owns, draws no extra power, and lifted the signal inside a living human eye by up to half.Sat, 11 Jul 2026 00:00:00 GMTbrain-agingmriimagingmetamaterialsophthalmologyneuroimagingmedical-devicesSarah Okonkwohttps://thefirstcohort.com/articles/2026-07-10-scientists-measured-the-salt-in-39-takeaways-nearly-half-had-more-than-the-labelhttps://thefirstcohort.com/articles/2026-07-10-scientists-measured-the-salt-in-39-takeaways-nearly-half-had-more-than-the-labelChemists at the University of Reading ran 39 takeaway dishes through a mass spectrometer. Almost half the labeled ones held more salt than the menu admitted, and one pasta dish carried nearly two days' worth.Fri, 10 Jul 2026 00:00:00 GMTnutrition-foodsaltsodiumtakeawayblood-pressurefood-labelingpublic-healthSarah Okonkwohttps://thefirstcohort.com/articles/2026-07-10-for-thirty-years-the-model-said-blue-cones-drift-out-of-sharp-vision-they-were-thttps://thefirstcohort.com/articles/2026-07-10-for-thirty-years-the-model-said-blue-cones-drift-out-of-sharp-vision-they-were-tJohns Hopkins researchers grew human retinas in a dish and watched blue cones convert into the red and green cones behind sharp central vision. The three-decade-old migration model was wrong.Fri, 10 Jul 2026 00:00:00 GMTbrain-agingvisionretinaorganoidsvitamin-athyroid-hormonedevelopmental-biologyLena Marshallhttps://thefirstcohort.com/articles/2026-07-10-a-440-000-drug-proved-this-obesity-was-never-about-willpowerhttps://thefirstcohort.com/articles/2026-07-10-a-440-000-drug-proved-this-obesity-was-never-about-willpowerBrain-tumor surgery can wreck the hypothalamus and leave hunger permanently switched on. Setmelanotide restored the missing signal in a real placebo-controlled trial, then arrived priced near half a million dollars a year.Fri, 10 Jul 2026 00:00:00 GMTdrugs-fdasetmelanotidehypothalamic-obesitydrug-pricingfda-approvalrare-diseaseLena Marshallhttps://thefirstcohort.com/articles/2026-07-09-nearly-half-of-america-s-er-substance-use-visits-involve-someone-the-justice-syshttps://thefirstcohort.com/articles/2026-07-09-nearly-half-of-america-s-er-substance-use-visits-involve-someone-the-justice-sysForty-four percent of Americans who go to an emergency room for substance use have a booking in their past. A survey of 139,524 people measured how much the jail and the ER share a population.Thu, 09 Jul 2026 00:00:00 GMTinvestigationsemergency-medicinesubstance-usemental-healthcriminal-justicepublic-healthLena Marshallhttps://thefirstcohort.com/articles/2026-07-09-both-groups-lost-the-same-seven-kilos-only-the-calorie-counters-had-to-white-knuhttps://thefirstcohort.com/articles/2026-07-09-both-groups-lost-the-same-seven-kilos-only-the-calorie-counters-had-to-white-knuIn an 18-month Adelaide trial, fasting and daily calorie-cutting stripped off the same seven kilos, but for the counters part of that loss ran on constant conscious restraint the fasters' scores never showed.Thu, 09 Jul 2026 00:00:00 GMTmetabolic-weightintermittent-fastingweight-lossmetaboliceating-behaviorobesityglp-1Sarah Okonkwohttps://thefirstcohort.com/articles/2026-07-08-your-retina-starts-failing-before-any-scan-can-see-it-now-someone-wants-to-turnhttps://thefirstcohort.com/articles/2026-07-08-your-retina-starts-failing-before-any-scan-can-see-it-now-someone-wants-to-turnDelayed dark adaptation flagged people who would develop early macular degeneration three years later. Now an optometrist has folded that finding into a 'retinal reserve' framework, bloodwork and all, that no trial has tested.Wed, 08 Jul 2026 00:00:00 GMTbrain-agingretinal reservedark adaptationmacular degenerationearly detectionfunctional testingLena Marshallhttps://thefirstcohort.com/articles/2026-07-08-pregnancy-stations-killer-t-cells-in-the-milk-ducts-and-a-decade-later-they-havehttps://thefirstcohort.com/articles/2026-07-08-pregnancy-stations-killer-t-cells-in-the-milk-ducts-and-a-decade-later-they-haveMelbourne researchers found that pregnancy stations killer T cells in the milk ducts, where they persist for at least a decade and track with better breast cancer outcomes. Now the race is on to summon them with a hormone shot instead of a pregnancy.Wed, 08 Jul 2026 00:00:00 GMTcancercancerbreast-cancerpregnancyimmunologywomens-healthSarah Okonkwohttps://thefirstcohort.com/articles/2026-07-08-for-forty-years-he-said-the-standard-cholesterol-target-was-wrong-a-computer-finhttps://thefirstcohort.com/articles/2026-07-08-for-forty-years-he-said-the-standard-cholesterol-target-was-wrong-a-computer-finA Northwestern model projects that the little-used apoB test would prevent more heart attacks and strokes than the LDL number your doctor chases. And non-HDL, a number already printed free on your standard lab report, beat LDL too. No trial has tested any of it on a patient.Wed, 08 Jul 2026 00:00:00 GMTmetabolic-weightcholesterolapobheart-diseasestatinspreventionLena Marshallhttps://thefirstcohort.com/articles/2026-07-08-david-ho-s-lab-built-an-antibody-to-neutralize-nearly-every-strain-of-hiv-its-fihttps://thefirstcohort.com/articles/2026-07-08-david-ho-s-lab-built-an-antibody-to-neutralize-nearly-every-strain-of-hiv-its-fiFifty-four volunteers, nine with HIV, and just three with virus still in their blood. The engineered antibody drove their viral load down as much as ninetyfold, then lost the ground within a week as it drained away.Wed, 08 Jul 2026 00:00:00 GMTinfectious-diseasehivbroadly-neutralizing-antibodiesclinical-trialsdrug-developmentnih-fundingLena Marshallhttps://thefirstcohort.com/articles/2026-07-08-a-brain-full-of-plaques-and-a-mind-that-held-the-cells-that-may-explain-alzheimehttps://thefirstcohort.com/articles/2026-07-08-a-brain-full-of-plaques-and-a-mind-that-held-the-cells-that-may-explain-alzheimeAbout a third of people whose brains show the full pathology of Alzheimer's never develop dementia. Dutch researchers say the difference may not be how many young neurons they have, but whether those cells switch on a survival program instead of dying.Wed, 08 Jul 2026 00:00:00 GMTbrain-agingalzheimersneurosciencebrain-agingneurogenesiscognitive-resilienceSarah Okonkwohttps://thefirstcohort.com/articles/2026-07-07-whether-a-t-cell-keeps-killing-cancer-or-quits-is-written-in-how-its-genome-foldhttps://thefirstcohort.com/articles/2026-07-07-whether-a-t-cell-keeps-killing-cancer-or-quits-is-written-in-how-its-genome-foldExhausted CD8 T cells are why checkpoint drugs and CAR-T so often stall. New maps of the 3D genome show their fate is set by how the DNA is physically folded, and by CTCF, the protein that does the folding.Tue, 07 Jul 2026 00:00:00 GMTcancerimmunotherapyt-cell-exhaustionepigeneticscancercell-biologycar-tSarah Okonkwohttps://thefirstcohort.com/articles/2026-07-07-the-nose-spray-tb-vaccine-in-your-feed-this-week-has-only-ever-worked-in-micehttps://thefirstcohort.com/articles/2026-07-07-the-nose-spray-tb-vaccine-in-your-feed-this-week-has-only-ever-worked-in-miceJohns Hopkins fused two genes into a nasal spray, added it to a drug cocktail, and cleared tuberculosis faster in mice. DNA vaccines have dazzled mice for thirty years and disappointed humans nearly every time. This one has not been in a person yet.Tue, 07 Jul 2026 00:00:00 GMTinfectious-diseasetuberculosisdna-vaccinepreclinicaljohns-hopkinsinfectious-diseasevaccine-hypeLena Marshallhttps://thefirstcohort.com/articles/2026-07-07-the-kratom-crackdown-its-biggest-trade-defenders-wantedhttps://thefirstcohort.com/articles/2026-07-07-the-kratom-crackdown-its-biggest-trade-defenders-wantedA concentrated 7-OH compound reported at up to 40 times morphine's receptor potency is sold in gas stations as herbal kratom. The plant's biggest trade defenders are cheering the DEA for banning it.Tue, 07 Jul 2026 00:00:00 GMTmetabolic-weightmedical-researchSarah Okonkwohttps://thefirstcohort.com/articles/2026-07-07-old-muscle-forgets-how-to-clean-itself-a-gene-called-deaf1-is-why-and-exercise-shttps://thefirstcohort.com/articles/2026-07-07-old-muscle-forgets-how-to-clean-itself-a-gene-called-deaf1-is-why-and-exercise-sIn aging muscle one gene keeps the growth pathway jammed on and the cleanup crew locked out. Exercise suppresses it in flies and mice, no pill required.Tue, 07 Jul 2026 00:00:00 GMTmetabolic-weightmuscle agingexerciselongevitymtorc1sarcopeniaautophagySarah Okonkwohttps://thefirstcohort.com/articles/2026-07-07-in-mice-early-stress-drinking-corroded-a-brain-region-a-long-sobriety-couldn-t-rhttps://thefirstcohort.com/articles/2026-07-07-in-mice-early-stress-drinking-corroded-a-brain-region-a-long-sobriety-couldn-t-rIn mice, pairing alcohol with stress in early adulthood damaged a tiny noradrenaline hub in the brainstem, and a prolonged stretch of abstinence didn't reverse it. The cognitive cost surfaced in middle age.Tue, 07 Jul 2026 00:00:00 GMTbrain-agingalcoholbrain-agingstresscognitive-declineneuroscienceSarah Okonkwohttps://thefirstcohort.com/articles/2026-07-06-nejm-retracted-the-study-that-approved-amgen-s-vasculitis-drug-it-had-never-donehttps://thefirstcohort.com/articles/2026-07-06-nejm-retracted-the-study-that-approved-amgen-s-vasculitis-drug-it-had-never-doneThe FDA says the drug's superiority result came from re-scoring nine patients after the trial was unblinded. It is still on U.S. shelves while Amgen fights the withdrawal.Mon, 06 Jul 2026 00:00:00 GMTinvestigationsretractionfdaemaclinical-trialsdata-integritypharmaMira Petrovhttps://thefirstcohort.com/articles/2026-07-06-longevity-clinics-sell-growth-hormone-by-the-vial-in-deep-sleep-your-brain-makeshttps://thefirstcohort.com/articles/2026-07-06-longevity-clinics-sell-growth-hormone-by-the-vial-in-deep-sleep-your-brain-makesThe muscle-building, fat-burning hormone that anti-aging clinics inject at a premium is the same one your hypothalamus releases every night you reach deep sleep. Berkeley mapped how, in mice, and the headline is already running ahead of the biology.Mon, 06 Jul 2026 00:00:00 GMTbrain-agingsleepgrowth hormonemetabolismneurosciencelongevitySarah Okonkwohttps://thefirstcohort.com/articles/2026-07-06-a-michigan-lab-grew-a-living-skull-joint-that-wouldn-t-fuse-in-mice-it-heldhttps://thefirstcohort.com/articles/2026-07-06-a-michigan-lab-grew-a-living-skull-joint-that-wouldn-t-fuse-in-mice-it-heldCraniosynostosis surgery reopens a fused infant skull; in some of the hardest cases it fuses right back and the child goes under the knife again. A triphasic scaffold kept the joint open in mice.Mon, 06 Jul 2026 00:00:00 GMTbrain-agingcraniosynostosistissue-engineeringregenerative-medicinestem-cellspediatric-surgeryskullLena Marshallhttps://thefirstcohort.com/articles/2026-07-05-the-box-and-banana-test-was-built-for-apes-a-bumble-bee-worked-it-out-on-its-ownhttps://thefirstcohort.com/articles/2026-07-05-the-box-and-banana-test-was-built-for-apes-a-bumble-bee-worked-it-out-on-its-ownResearchers in Finland trained bumble bees on two unrelated facts, a flower with sugar and a ball that rolls. With the flower moved out of reach, the bees combined the two into a solution nobody had shown them, on a task built for apes.Sun, 05 Jul 2026 00:00:00 GMTbrain-agingcognitionneuroscienceanimal-intelligenceproblem-solvinginsectsSarah Okonkwohttps://thefirstcohort.com/articles/2026-07-05-five-years-after-covid-japan-is-still-dying-at-pandemic-rates-and-confirmed-covihttps://thefirstcohort.com/articles/2026-07-05-five-years-after-covid-japan-is-still-dying-at-pandemic-rates-and-confirmed-coviJapan's excess deaths peaked at 7.55 percent in 2022 and still ran at 5.76 percent through 2023, after Tokyo downgraded COVID to a routine infectious disease, in one of the most heavily mRNA-dosed countries on earth.Sun, 05 Jul 2026 00:00:00 GMTinfectious-diseasecovidexcess-mortalityjapanmrna-vaccinespublic-healthMarcus Chenhttps://thefirstcohort.com/articles/2026-07-05-australia-switched-off-social-media-for-a-generation-of-kids-nepal-already-ran-thttps://thefirstcohort.com/articles/2026-07-05-australia-switched-off-social-media-for-a-generation-of-kids-nepal-already-ran-tThe ban is sold as youth mental-health protection, but its own university researchers call the harm evidence overblown, and the one nation that already banned a platform got ID checks and VPN workarounds, not healthier kids.Sun, 05 Jul 2026 00:00:00 GMTinvestigationssocial-media-banyouth-mental-healthage-verificationdigital-idaustraliaLena Marshallhttps://thefirstcohort.com/articles/2026-07-04-the-last-time-washington-went-after-hospital-drug-markups-the-supreme-court-blochttps://thefirstcohort.com/articles/2026-07-04-the-last-time-washington-went-after-hospital-drug-markups-the-supreme-court-blocIn 2018 the Supreme Court blocked CMS from cutting the markup 340B hospitals charge Medicare for discounted drugs, because the agency skipped a required survey. CMS ran the survey this time, and found seniors paying co-pays bigger than what the hospital paid for the drug.Sat, 04 Jul 2026 00:00:00 GMTdrugs-fdamedicare340bdrug-pricinghospitalscmspart-bMarcus Chenhttps://thefirstcohort.com/articles/2026-07-04-switch-off-one-protein-called-mitch-and-cells-start-eating-their-own-fathttps://thefirstcohort.com/articles/2026-07-04-switch-off-one-protein-called-mitch-and-cells-start-eating-their-own-fatWomen with obesity carry more of it. Disable it in mice and they turn lean and muscular at once, the opposite of what the injectable weight-loss drugs do to your body.Sat, 04 Jul 2026 00:00:00 GMTmetabolic-weightobesityglp-1mitochondriametabolismmuscleweight-lossSarah Okonkwohttps://thefirstcohort.com/articles/2026-07-04-for-decades-they-treated-this-stroke-like-a-clog-the-arteries-were-actually-toohttps://thefirstcohort.com/articles/2026-07-04-for-decades-they-treated-this-stroke-like-a-clog-the-arteries-were-actually-tooPeople with widened brain arteries were four times more likely to have had a lacunar stroke, the type doctors have treated for decades as if it were a clog.Sat, 04 Jul 2026 00:00:00 GMTbrain-agingstrokesmall-vessel-diseasebrain-agingdementiageneric-drugsneurologySarah Okonkwohttps://thefirstcohort.com/articles/2026-07-04-against-omicron-a-second-covid-dose-added-almost-nothing-for-kids-who-were-alreahttps://thefirstcohort.com/articles/2026-07-04-against-omicron-a-second-covid-dose-added-almost-nothing-for-kids-who-were-alreaIn Austria's own registry, one dose protected previously infected people slightly better than two; in children against the omicron they actually faced, the second dose's benefit could not be told apart from zero. The guidance never moved.Sat, 04 Jul 2026 00:00:00 GMTinfectious-diseasecovid-19natural immunitychildrenhybrid immunityvaccine policyMarcus Chenhttps://thefirstcohort.com/articles/2026-07-03-two-journals-that-buried-the-lab-leak-question-now-warn-of-a-gilded-age-in-amerihttps://thefirstcohort.com/articles/2026-07-03-two-journals-that-buried-the-lab-leak-question-now-warn-of-a-gilded-age-in-ameriThe Lancet and Science marked America's 250th by casting the administration's research cuts as vandalism. Both journals spent the public trust they now invoke, and the editorials never mention how.Fri, 03 Jul 2026 00:00:00 GMTinvestigationsnihscience-fundinglancetcovid-originsregulatory-capturepublic-trustMarcus Chenhttps://thefirstcohort.com/articles/2026-07-03-the-fda-cleared-a-sickle-cell-cure-for-two-year-olds-in-53-days-it-starts-with-chttps://thefirstcohort.com/articles/2026-07-03-the-fda-cleared-a-sickle-cell-cure-for-two-year-olds-in-53-days-it-starts-with-cCasgevy is a real advance against a brutal disease. It is also a $2.2 million therapy that requires sterilizing chemotherapy, saw a child die in trials, and reached toddlers on a 53-day review Makary's FDA hands out as a favor.Fri, 03 Jul 2026 00:00:00 GMTdrugs-fdasickle-cellgene-therapyfdacasgevycrisprregulatory-voucherLena Marshallhttps://thefirstcohort.com/articles/2026-07-02-one-protein-keeps-your-t-cells-in-the-fight-the-same-protein-feeds-autoimmune-dihttps://thefirstcohort.com/articles/2026-07-02-one-protein-keeps-your-t-cells-in-the-fight-the-same-protein-feeds-autoimmune-diIn mice, deleting the LEF1 gene collapsed the reserve T cells that sustain the fight against chronic infection and cancer. The same deletion protected against autoimmune diabetes.Thu, 02 Jul 2026 00:00:00 GMTcancert-cellsimmunotherapycar-tautoimmunitycancerMarcus Chenhttps://thefirstcohort.com/articles/2026-07-02-obesity-stopped-denting-older-adults-metabolic-numbers-in-the-young-it-s-bitinghttps://thefirstcohort.com/articles/2026-07-02-obesity-stopped-denting-older-adults-metabolic-numbers-in-the-young-it-s-bitingFor middle-aged and older adults, extra weight no longer tracks with the cardiovascular damage it once did. For the young, the same fat is biting harder and earlier. The lab panels converged; the fat didn't.Thu, 02 Jul 2026 00:00:00 GMTmetabolic-weightobesitymetabolic-healthbmivisceral-fatcardiovascular-riskglp-1Sarah Okonkwohttps://thefirstcohort.com/articles/2026-07-02-kennedy-ended-the-covid-emergency-authorizations-the-document-that-blocks-injuryhttps://thefirstcohort.com/articles/2026-07-02-kennedy-ended-the-covid-emergency-authorizations-the-document-that-blocks-injuryThe emergency use authorizations wind down within a year. The liability shield that routes injured people to a program denying more than 98% of claims runs untouched through 2029.Thu, 02 Jul 2026 00:00:00 GMTinvestigationsprep-actcovidliabilityvaccine-injurycicprfk-jrMira Petrovhttps://thefirstcohort.com/articles/2026-07-02-alzheimer-s-hitches-a-ride-on-a-virus-your-neurons-tamed-for-memoryhttps://thefirstcohort.com/articles/2026-07-02-alzheimer-s-hitches-a-ride-on-a-virus-your-neurons-tamed-for-memoryIn mice and in human Alzheimer's brains, toxic tau rides a protein called Arc, a virus your neurons domesticated for memory, from sick cells into healthy ones. Delete Arc and the spread nearly stops.Thu, 02 Jul 2026 00:00:00 GMTbrain-agingalzheimerstauneurosciencebrain-agingextracellular-vesiclesarcSarah Okonkwohttps://thefirstcohort.com/articles/2026-07-02-a-juice-company-built-a-department-inside-a-japanese-university-its-scientists-jhttps://thefirstcohort.com/articles/2026-07-02-a-juice-company-built-a-department-inside-a-japanese-university-its-scientists-jKagome, Japan's largest vegetable-juice maker, funded the work, employs two of its authors, and measured the vitamin itself. The gray-matter correlation it reported is real, and small enough to miss.Thu, 02 Jul 2026 00:00:00 GMTbrain-agingvitamin cbrain agingconflict of interestnutritionobservational studyLena Marshallhttps://thefirstcohort.com/articles/2026-07-01-senescence-built-your-hands-before-it-ever-aged-your-skinhttps://thefirstcohort.com/articles/2026-07-01-senescence-built-your-hands-before-it-ever-aged-your-skinCellular senescence, the process blamed for aging and disease, is also how an embryo sculpts fingers and clears its own tissue. That double life scrambles the anti-aging industry's tidy 'kill the zombie cells' pitch.Wed, 01 Jul 2026 00:00:00 GMTbrain-agingsenescenceembryologyagingfertilitycell-biologylongevitySarah Okonkwohttps://thefirstcohort.com/articles/2026-07-01-no-gene-editing-no-catheter-into-the-skull-a-pediatric-brain-cancer-t-cell-trialhttps://thefirstcohort.com/articles/2026-07-01-no-gene-editing-no-catheter-into-the-skull-a-pediatric-brain-cancer-t-cell-trialChildren with diffuse pontine glioma rarely live past a year. A first-in-human trial infused 33 young patients with pediatric brain tumors, including DIPG, with T cells trained on three tumor proteins, no genetic engineering, and reported one complete response and three survivors still alive years lWed, 01 Jul 2026 00:00:00 GMTcancerpediatric-oncologydipgcell-therapyimmunotherapybrain-tumorsclinical-trialsLena Marshallhttps://thefirstcohort.com/articles/2026-07-01-lead-strips-dopamine-from-the-exact-brain-circuit-adhd-drugs-are-built-to-rescuehttps://thefirstcohort.com/articles/2026-07-01-lead-strips-dopamine-from-the-exact-brain-circuit-adhd-drugs-are-built-to-rescueChildhood lead keeps landing on the same target: the striatal dopamine circuit that ADHD drugs are built to rescue. A Philadelphia cohort just tied it to real diagnoses, not test scores.Wed, 01 Jul 2026 00:00:00 GMTbrain-agingleadadhdchildrenneurotoxicitydopamineenvironmental-healthSarah Okonkwohttps://thefirstcohort.com/articles/2026-06-30-the-fda-office-that-vets-gene-therapy-has-run-through-its-entire-top-tier-in-a-yhttps://thefirstcohort.com/articles/2026-06-30-the-fda-office-that-vets-gene-therapy-has-run-through-its-entire-top-tier-in-a-yThe office that decides whether gene therapies reach patients has lost its director, her deputy, and the man brought in to replace them, all inside twelve months.Tue, 30 Jun 2026 00:00:00 GMTdrugs-fdafdagene-therapyregulatory-capturecberdrug-safetysareptaLena Marshallhttps://thefirstcohort.com/articles/2026-06-30-group-mindfulness-beat-standard-back-pain-care-for-a-full-year-no-prescription-rhttps://thefirstcohort.com/articles/2026-06-30-group-mindfulness-beat-standard-back-pain-care-for-a-full-year-no-prescription-rBoston researchers taught 451 patients to work with their pain instead of medicating it, and the gains outlasted the program. The university's press release skipped the part where the edge over usual care fell short of the bar the team set for itself.Tue, 30 Jun 2026 00:00:00 GMTbrain-agingchronic-painmindfulnessback-painnon-pharmacologicalnih-fundingSarah Okonkwohttps://thefirstcohort.com/articles/2026-06-30-a-road-made-from-recycled-fishing-nets-shed-less-microplastic-than-the-tires-rolhttps://thefirstcohort.com/articles/2026-06-30-a-road-made-from-recycled-fishing-nets-shed-less-microplastic-than-the-tires-rolHawaii scientists laid ocean-net plastic into a real Oahu street, then measured what came off. The recycled plastic barely registered. Tire wear, the source almost nobody regulates, swamped it by orders of magnitude.Tue, 30 Jun 2026 00:00:00 GMTinvestigationsmicroplasticstire-wearocean-plasticrecyclingenvironmental-health6ppdSarah Okonkwohttps://thefirstcohort.com/articles/2026-06-30-a-federally-backed-trial-got-high-dose-fish-oil-into-the-brain-fluid-the-memoryhttps://thefirstcohort.com/articles/2026-06-30-a-federally-backed-trial-got-high-dose-fish-oil-into-the-brain-fluid-the-memoryDHA in the spinal fluid climbed 17 percent. Cognitive scores rose 2.76 points on fish oil, 2.67 on placebo. Two years of high-dose pills bought a rounding error.Tue, 30 Jun 2026 00:00:00 GMTbrain-agingomega-3fish-oilalzheimersbrain-agingsupplementsdhaSarah Okonkwohttps://thefirstcohort.com/articles/2026-06-29-twenty-years-of-nothing-on-brain-cancer-and-the-best-new-lead-is-a-vitamin-nobodhttps://thefirstcohort.com/articles/2026-06-29-twenty-years-of-nothing-on-brain-cancer-and-the-best-new-lead-is-a-vitamin-nobodA University of Calgary trial added high-dose niacin to standard glioblastoma treatment and reported 82% of 24 patients progression-free at six months. The design is single-arm and early, but the molecule is a cheap, unpatentable vitamin.Mon, 29 Jun 2026 00:00:00 GMTcancerglioblastomaniacinimmunotherapybrain-cancerclinical-trialsLena Marshallhttps://thefirstcohort.com/articles/2026-06-29-the-standard-treatment-for-nerve-damage-was-never-built-to-repair-a-nervehttps://thefirstcohort.com/articles/2026-06-29-the-standard-treatment-for-nerve-damage-was-never-built-to-repair-a-nerveGabapentin is the seventh most prescribed drug in America, handed out for neuropathy it was never shown to reverse. A retired researcher's drug-free protocol asks the question the pharmacy aisle can't: what if you removed the cause instead?Mon, 29 Jun 2026 00:00:00 GMTdrugs-fdaperipheral-neuropathygabapentindiabetic-neuropathymetforminroot-causedrug-freeLena Marshallhttps://thefirstcohort.com/articles/2026-06-29-the-same-system-now-racing-to-test-a-bundibugyo-ebola-vaccine-had-nineteen-yearshttps://thefirstcohort.com/articles/2026-06-29-the-same-system-now-racing-to-test-a-bundibugyo-ebola-vaccine-had-nineteen-yearsBundibugyo Ebola was identified in 2007. By the time this year's outbreak passed 1,200 cases there was still no licensed vaccine and none in clinical development. Now roughly $75 million is moving to test three experimental shots on the people dying from it.Mon, 29 Jun 2026 00:00:00 GMTinfectious-diseaseebolabundibugyovaccinesbardaoutbreak-preparednesspublic-healthMarcus Chenhttps://thefirstcohort.com/articles/2026-06-29-the-fda-s-fix-for-a-10-billion-flood-of-chinese-vapes-is-a-form-the-smugglers-wihttps://thefirstcohort.com/articles/2026-06-29-the-fda-s-fix-for-a-10-billion-flood-of-chinese-vapes-is-a-form-the-smugglers-wiForeign manufacturers ship most of America's vapes and falsify the customs forms to do it. Washington's answer is to ask them to register with the agency they already evade.Mon, 29 Jun 2026 00:00:00 GMTdrugs-fdatobaccoe-cigarettesfdachinayouth-vapingregulationMarcus Chenhttps://thefirstcohort.com/articles/2026-06-29-the-fda-pulled-infigratinib-as-a-cancer-drug-in-2024-it-just-passed-phase-3-in-chttps://thefirstcohort.com/articles/2026-06-29-the-fda-pulled-infigratinib-as-a-cancer-drug-in-2024-it-just-passed-phase-3-in-cThe FDA pulled infigratinib as a failed cancer drug in 2024. Now its maker says the same pill grows children with dwarfism faster, on a surrogate no one has yet shown reaches adulthood.Mon, 29 Jun 2026 00:00:00 GMTdrugs-fdaachondroplasiainfigratinibfgfr3surrogate-endpointsbridgebiodrug-repurposingLena Marshallhttps://thefirstcohort.com/articles/2026-06-29-for-twenty-years-a-vitamin-b12-cancer-drug-has-worked-in-mice-dogs-and-rats-it-shttps://thefirstcohort.com/articles/2026-06-29-for-twenty-years-a-vitamin-b12-cancer-drug-has-worked-in-mice-dogs-and-rats-it-sNitrosylcobalamin crossed the blood-brain barrier and pooled in a rat's brain tumor. This study didn't shrink one, the synergy ran in a petri dish, and the scientist behind the headlines holds the patents.Mon, 29 Jun 2026 00:00:00 GMTcancerglioblastomavitamin-b12brain-cancerpreclinicalresearch-hypeLena Marshallhttps://thefirstcohort.com/articles/2026-06-29-europe-called-medical-ai-high-risk-and-still-gave-patients-no-right-to-refuse-ithttps://thefirstcohort.com/articles/2026-06-29-europe-called-medical-ai-high-risk-and-still-gave-patients-no-right-to-refuse-itAn algorithm once cut the extra care flagged for Black patients by more than half, and ran for years before anyone noticed. A commentary in the Journal of the Royal Society of Medicine says the rules now governing medical AI would not have caught it.Mon, 29 Jun 2026 00:00:00 GMTinvestigationsmedical-aiai-regulationpatient-rightsalgorithmic-biaseu-ai-actMarcus Chenhttps://thefirstcohort.com/articles/2026-06-29-a-federal-court-put-this-pesticide-back-on-your-food-ucla-just-showed-it-more-thhttps://thefirstcohort.com/articles/2026-06-29-a-federal-court-put-this-pesticide-back-on-your-food-ucla-just-showed-it-more-thChlorpyrifos was pulled from American homes in 2001 and ordered off food crops in 2021. A manufacturer sued, won, and it's back on apples and strawberries while the science against it gets stronger.Mon, 29 Jun 2026 00:00:00 GMTbrain-agingparkinsonschlorpyrifospesticidesdopamineautophagyepaSarah Okonkwohttps://thefirstcohort.com/articles/2026-06-28-your-brain-has-170-billion-cells-and-no-blueprint-here-s-how-one-cell-pulls-it-ohttps://thefirstcohort.com/articles/2026-06-28-your-brain-has-170-billion-cells-and-no-blueprint-here-s-how-one-cell-pulls-it-oFor fifty years the textbook said chemical gradients tell brain cells where to go. A new model says cells inherit their address from their family tree instead.Sun, 28 Jun 2026 00:00:00 GMTbrain-agingneurosciencebrain-developmentcell-biologyneuronsdevelopmental-biologySarah Okonkwohttps://thefirstcohort.com/articles/2026-06-28-the-who-invented-osteopenia-for-statisticians-merck-turned-it-into-34-million-pahttps://thefirstcohort.com/articles/2026-06-28-the-who-invented-osteopenia-for-statisticians-merck-turned-it-into-34-million-paThe man who chaired the 1992 WHO meeting says they never imagined osteopenia would be treated as a disease. Three years later Merck launched Fosamax and started putting bone scanners in doctors' offices.Sun, 28 Jun 2026 00:00:00 GMTinvestigationsosteopeniabone-densitydisease-mongeringmerckfosamaxbisphosphonatesLena Marshallhttps://thefirstcohort.com/articles/2026-06-28-the-gut-lining-starves-salmonella-of-iron-a-trick-we-thought-only-immune-cells-khttps://thefirstcohort.com/articles/2026-06-28-the-gut-lining-starves-salmonella-of-iron-a-trick-we-thought-only-immune-cells-kSalmonella sickens more than a million Americans a year. University of Vermont researchers found the cells it invades fight back by withholding the iron and manganese the bacteria need, a defense the textbooks credited mainly to immune cells.Sun, 28 Jun 2026 00:00:00 GMTinfectious-diseasesalmonellanutritional-immunityinfectious-diseaseironfood-safetyMarcus Chenhttps://thefirstcohort.com/articles/2026-06-28-the-belly-fat-you-gain-after-40-comes-from-a-cell-that-barely-existed-in-your-twhttps://thefirstcohort.com/articles/2026-06-28-the-belly-fat-you-gain-after-40-comes-from-a-cell-that-barely-existed-in-your-twTransplant old fat stem cells into a young mouse and they keep churning out fat; young ones in an old mouse stay quiet. In mice, the fat-making program travels with the cell, not the body around it.Sun, 28 Jun 2026 00:00:00 GMTmetabolic-weightbelly fatagingmetabolicstem cellslongevityobesitySarah Okonkwohttps://thefirstcohort.com/articles/2026-06-28-same-calories-different-wiring-why-fructose-leaves-your-hunger-neurons-runninghttps://thefirstcohort.com/articles/2026-06-28-same-calories-different-wiring-why-fructose-leaves-your-hunger-neurons-runningGlucose flips off the brain cells that drive hunger. Fructose barely nudges them, and the corn-syrup blend in your soda quiets them even better, which is exactly why it's so easy to keep drinking.Sun, 28 Jun 2026 00:00:00 GMTmetabolic-weightfructosehigh-fructose-corn-syrupmetabolicgut-brain-axisappetiteobesitySarah Okonkwohttps://thefirstcohort.com/articles/2026-06-28-for-forty-years-margarine-was-the-healthy-choice-the-chemistry-was-never-on-itshttps://thefirstcohort.com/articles/2026-06-28-for-forty-years-margarine-was-the-healthy-choice-the-chemistry-was-never-on-itsThe spread your doctor pushed for decades delivered trans fats, then got rebuilt with a modified fat that raised fasting glucose 22 percent in one trial. Butter, the supposed villain, turned out roughly neutral for your heart.Sun, 28 Jun 2026 00:00:00 GMTnutrition-foodmargarinebutterseed-oilsultraprocessedtrans-fatssaturated-fatSarah Okonkwohttps://thefirstcohort.com/articles/2026-06-28-fibrolamellar-carcinoma-hides-immune-cells-in-scar-tissue-a-drug-approved-in-200https://thefirstcohort.com/articles/2026-06-28-fibrolamellar-carcinoma-hides-immune-cells-in-scar-tissue-a-drug-approved-in-200Fibrolamellar carcinoma mostly kills young adults, and checkpoint immunotherapy bounces off it. Researchers found the tumor herds T cells into fibrous bands, and a drug shelved for stem-cell work since 2008 freed them in patient tissue. No human trial has started.Sun, 28 Jun 2026 00:00:00 GMTcancerfibrolamellar-carcinomaliver-cancerimmunotherapydrug-repurposingplerixaforcxcr4Lena Marshallhttps://thefirstcohort.com/articles/2026-06-26-they-told-older-adults-the-pill-was-fake-their-memory-got-better-anywayhttps://thefirstcohort.com/articles/2026-06-26-they-told-older-adults-the-pill-was-fake-their-memory-got-better-anywayA 90-person Italian trial gave older adults inert pills and told one group flat-out they were fake. That group improved as much as the deceived one. Here is what that does and doesn't prove.Fri, 26 Jun 2026 00:00:00 GMTbrain-agingplacebolongevitycognitionagingmind-bodySarah Okonkwohttps://thefirstcohort.com/articles/2026-06-26-they-call-it-aging-sometimes-it-s-a-vitamin-your-doctor-forgot-to-checkhttps://thefirstcohort.com/articles/2026-06-26-they-call-it-aging-sometimes-it-s-a-vitamin-your-doctor-forgot-to-checkNew Cornell research explains how B12 deficiency starves muscle of energy, and why the standard test your doctor orders can call the problem aging.Fri, 26 Jun 2026 00:00:00 GMTnutrition-foodvitamin-b12agingmitochondrianutritionmuscleLena Marshallhttps://thefirstcohort.com/articles/2026-06-26-the-immune-system-s-guardrails-were-too-rare-to-study-a-bonn-lab-just-grew-themhttps://thefirstcohort.com/articles/2026-06-26-the-immune-system-s-guardrails-were-too-rare-to-study-a-bonn-lab-just-grew-themA German lab built a way to grow follicular regulatory T cells from precursors in a dish, opening a notoriously hard-to-study brake on antibody production to direct experiment.Fri, 26 Jun 2026 00:00:00 GMTdrugs-fdamedical-researchLena Marshallhttps://thefirstcohort.com/articles/2026-06-26-most-people-s-bodies-quietly-beat-tb-the-ones-who-lose-are-drowning-their-own-thttps://thefirstcohort.com/articles/2026-06-26-most-people-s-bodies-quietly-beat-tb-the-ones-who-lose-are-drowning-their-own-tA new single-cell study of the airways of TB-exposed people finds that progression to disease tracks with a neutrophil flood that smothers protective T cells, with type I interferon as the switch.Fri, 26 Jun 2026 00:00:00 GMTinfectious-diseasetuberculosisimmunologyneutrophilsinterferoninfectious-diseaset-cellsSarah Okonkwohttps://thefirstcohort.com/articles/2026-06-26-most-of-these-ebola-patients-aren-t-bleeding-that-s-why-it-s-spreadinghttps://thefirstcohort.com/articles/2026-06-26-most-of-these-ebola-patients-aren-t-bleeding-that-s-why-it-s-spreadingA Bundibugyo virus outbreak in DRC and Uganda has topped 1,100 confirmed cases, yet roughly nine in ten patients show no bleeding, the symptom everyone is trained to look for.Fri, 26 Jun 2026 00:00:00 GMTinfectious-diseaseebolabundibugyoinfectious-diseasepublic-healthoutbreakwhoMarcus Chenhttps://thefirstcohort.com/articles/2026-06-25-your-kombucha-is-only-as-good-as-the-tea-you-brewed-it-fromhttps://thefirstcohort.com/articles/2026-06-25-your-kombucha-is-only-as-good-as-the-tea-you-brewed-it-fromA new five-tea kombucha study finds the antioxidant punch depends almost entirely on the tea you start with, with green and oolong on top and the label never telling you.Thu, 25 Jun 2026 00:00:00 GMTnutrition-foodkombuchafermentationantioxidantspolyphenolsgut-healthnutritionSarah Okonkwohttps://thefirstcohort.com/articles/2026-06-25-the-gene-that-decides-whether-smoggy-air-wrecks-your-lungshttps://thefirstcohort.com/articles/2026-06-25-the-gene-that-decides-whether-smoggy-air-wrecks-your-lungsA University of Pittsburgh study of nearly 1,000 asthma patients pinpoints seven oxidative-stress genes that decide how badly dirty air damages the lungs.Thu, 25 Jun 2026 00:00:00 GMTautoimmune-inflammationasthmaair-pollutionoxidative-stressgeneticslung-functionpm25Sarah Okonkwohttps://thefirstcohort.com/articles/2026-06-25-summer-sun-won-t-save-you-a-vitamin-d-study-funded-by-the-people-who-sell-the-sphttps://thefirstcohort.com/articles/2026-06-25-summer-sun-won-t-save-you-a-vitamin-d-study-funded-by-the-people-who-sell-the-spA Newcastle screening study found vitamin D deficiency persists through summer in older and ethnic-minority adults in northern Britain. The funder sells the fix.Thu, 25 Jun 2026 00:00:00 GMTnutrition-foodvitamin-dsupplementsnutritionpublic-healthconflict-of-interestdeficiencyLena Marshallhttps://thefirstcohort.com/articles/2026-06-25-his-heart-was-pumping-at-10-percent-the-real-question-is-why-it-took-an-algorithhttps://thefirstcohort.com/articles/2026-06-25-his-heart-was-pumping-at-10-percent-the-real-question-is-why-it-took-an-algorithAn AI tool flagged a 45-year-old's hidden heart failure and the story became 'AI beats your doctor.' The case actually documents a missed standard workup, and it dropped the same week as the FDA clearance.Thu, 25 Jun 2026 00:00:00 GMTinvestigationsai-diagnosticsheart-failureecgmedical-hypefdaSarah Okonkwohttps://thefirstcohort.com/articles/2026-06-24-your-brain-files-speech-where-you-d-least-expect-in-hearing-and-touch-not-the-mohttps://thefirstcohort.com/articles/2026-06-24-your-brain-files-speech-where-you-d-least-expect-in-hearing-and-touch-not-the-moA TMS study from McGill and Yale finds that newly learned speech is stored in the brain's hearing and touch regions, not the motor cortex long assumed to run the show.Wed, 24 Jun 2026 00:00:00 GMTbrain-agingneurosciencespeechbrain-computer-interfacestroketmsSarah Okonkwohttps://thefirstcohort.com/articles/2026-06-24-the-protein-numbers-on-the-government-charts-were-never-meant-to-help-you-thrivehttps://thefirstcohort.com/articles/2026-06-24-the-protein-numbers-on-the-government-charts-were-never-meant-to-help-you-thriveA new Frontiers in Nutrition perspective argues official protein and exercise guidelines were built to prevent deficiency, not to maximize healthspan, and that older adults in particular need far more.Wed, 24 Jun 2026 00:00:00 GMTnutrition-foodproteinhealthspanagingmusclenutritionguidelinesSarah Okonkwohttps://thefirstcohort.com/articles/2026-06-24-the-knee-procedure-that-barely-beats-a-convincing-fakehttps://thefirstcohort.com/articles/2026-06-24-the-knee-procedure-that-barely-beats-a-convincing-fakeA university press release pitches a minimally invasive knee procedure as a way to delay joint replacement, but the only sham-controlled trials show the fake version works nearly as well.Wed, 24 Jun 2026 00:00:00 GMTinvestigationsosteoarthritiskneeembolizationplacebointerventional-radiologyclinical-trialsLena Marshallhttps://thefirstcohort.com/articles/2026-06-24-the-crisis-was-unexpected-the-org-chart-wasn-thttps://thefirstcohort.com/articles/2026-06-24-the-crisis-was-unexpected-the-org-chart-wasn-tInternal NIH correspondence and the public record both point to a pandemic-response architecture, and the people to run it, assembled years before Covid arrived.Wed, 24 Jun 2026 00:00:00 GMTinvestigationsnihpandemic-preparednessfoiacepiaccountabilitycovidMira Petrovhttps://thefirstcohort.com/articles/2026-06-24-the-bird-flu-was-hiding-in-the-udder-the-receptor-map-showed-up-two-years-latehttps://thefirstcohort.com/articles/2026-06-24-the-bird-flu-was-hiding-in-the-udder-the-receptor-map-showed-up-two-years-lateA new University of Pittsburgh study explains why H5N1 infects cow udders instead of lungs. The receptor evidence pointed there in 2024; the federal response did not move as fast.Wed, 24 Jun 2026 00:00:00 GMTinfectious-diseaseh5n1bird fludairy cattleraw milkusdasurveillanceLena Marshallhttps://thefirstcohort.com/articles/2026-06-24-a-blocked-vaccine-study-and-the-statistical-method-its-own-lead-author-warned-abhttps://thefirstcohort.com/articles/2026-06-24-a-blocked-vaccine-study-and-the-statistical-method-its-own-lead-author-warned-abA CDC vaccine-effectiveness study pulled from the agency's own journal landed in JAMA, and the press called it censorship. The method it used has a documented blind spot its own lead author once published on.Wed, 24 Jun 2026 00:00:00 GMTinfectious-diseasecovid-vaccinescdctest-negative-designvaccine-effectivenesspublic-healthbhattacharyaMarcus Chenhttps://thefirstcohort.com/articles/2026-06-23-the-ebola-vaccine-we-celebrated-doesn-t-touch-the-strain-now-burning-through-conhttps://thefirstcohort.com/articles/2026-06-23-the-ebola-vaccine-we-celebrated-doesn-t-touch-the-strain-now-burning-through-conCongo's Ebola outbreak has passed 1,000 cases and is rising faster than any before it, but it is caused by Bundibugyo virus, against which the licensed Ebola vaccine and antibody drugs were never designed to work.Tue, 23 Jun 2026 00:00:00 GMTinfectious-diseaseebolabundibugyo-virusvaccinescongopandemic-preparednessMarcus Chenhttps://thefirstcohort.com/articles/2026-06-23-the-alzheimer-s-field-spent-decades-trying-to-destroy-these-droplets-a-baylor-lahttps://thefirstcohort.com/articles/2026-06-23-the-alzheimer-s-field-spent-decades-trying-to-destroy-these-droplets-a-baylor-laA Baylor lab reports that tubulin redirects Tau and alpha-synuclein away from toxic clumping in the test tube. It is elegant mechanism work, and not yet a drug, an animal, or a person.Tue, 23 Jun 2026 00:00:00 GMTbrain-agingalzheimersparkinsonstaualpha-synucleintubulinneurodegenerationSarah Okonkwohttps://thefirstcohort.com/articles/2026-06-23-fauci-s-pardon-was-supposed-to-end-this-it-s-the-reason-he-can-t-stay-quiethttps://thefirstcohort.com/articles/2026-06-23-fauci-s-pardon-was-supposed-to-end-this-it-s-the-reason-he-can-t-stay-quietRand Paul subpoenaed Anthony Fauci on June 22 after declassified documents reopened the COVID-origins question, and the preemptive pardon meant to shield him is why he cannot refuse to answer.Tue, 23 Jun 2026 00:00:00 GMTinvestigationscovid-originsfaucilab-leakgain-of-functioncongressional-oversightLena Marshallhttps://thefirstcohort.com/articles/2026-06-23-a-cancer-algorithm-found-answers-in-71-children-the-quantum-label-is-the-least-ihttps://thefirstcohort.com/articles/2026-06-23-a-cancer-algorithm-found-answers-in-71-children-the-quantum-label-is-the-least-iA University of Utah team used the linear algebra of quantum mechanics to pull two survival predictors from just 71 neuroblastoma patients. The science is real. The word doing the marketing is not.Tue, 23 Jun 2026 00:00:00 GMTcancerneuroblastomaaioncologybiomarkerschildhood-cancerMarcus Chenhttps://thefirstcohort.com/articles/2026-06-22-your-five-a-day-isn-t-enough-flavanols-says-the-company-that-sells-them-by-the-chttps://thefirstcohort.com/articles/2026-06-22-your-five-a-day-isn-t-enough-flavanols-says-the-company-that-sells-them-by-the-cA new study says following dietary guidelines won't get you enough flavanols for heart protection. Two of its authors work for the company that sells flavanols in a capsule.Mon, 22 Jun 2026 00:00:00 GMTnutrition-foodflavanolsheart-healthconflict-of-interestsupplementsnutritioncocoaSarah Okonkwohttps://thefirstcohort.com/articles/2026-06-22-who-tripled-the-foodborne-death-toll-the-food-didn-t-get-deadlierhttps://thefirstcohort.com/articles/2026-06-22-who-tripled-the-foodborne-death-toll-the-food-didn-t-get-deadlierWHO's new estimate says unsafe food kills 1.5 million people a year, more than triple its 2015 figure, even as it admits the burden has fallen. The jump is an accounting change, not an epidemic.Mon, 22 Jun 2026 00:00:00 GMTnutrition-foodwhofood-safetyfoodborne-illnessheavy-metalsone-healthglobal-healthLena Marshallhttps://thefirstcohort.com/articles/2026-06-22-the-obesity-revolution-everyone-s-promising-comes-from-people-who-d-cash-in-on-ihttps://thefirstcohort.com/articles/2026-06-22-the-obesity-revolution-everyone-s-promising-comes-from-people-who-d-cash-in-on-iA new commentary says the GLP-1 era is just the prelude to a bigger obesity "revolution." The authors have direct financial stakes in what comes next, and the celebrated new pill loses less weight than the shot.Mon, 22 Jun 2026 00:00:00 GMTmetabolic-weightglp-1obesityorforglipronprecision-medicineconflicts-of-interestmetabolicSarah Okonkwohttps://thefirstcohort.com/articles/2026-06-22-the-brain-was-starving-before-the-plaques-showed-up-alzheimer-s-metabolic-reframhttps://thefirstcohort.com/articles/2026-06-22-the-brain-was-starving-before-the-plaques-showed-up-alzheimer-s-metabolic-reframA rising camp says failing mitochondria, not amyloid plaques, may drive Alzheimer's first. The biology is compelling and the amyloid monoculture earned its reckoning, but the metabolic side has its own retractions and not one human trial showing it works.Mon, 22 Jun 2026 00:00:00 GMTbrain-agingalzheimersmitophagyamyloidmetabolic-hypothesislongevityresearch-integritySarah Okonkwohttps://thefirstcohort.com/articles/2026-06-22-retracted-by-its-title-a-vaccine-sids-paper-and-a-standard-that-isn-t-sciencehttps://thefirstcohort.com/articles/2026-06-22-retracted-by-its-title-a-vaccine-sids-paper-and-a-standard-that-isn-t-scienceA vaccine-safety paper sat in a peer-reviewed journal for five years, then was pulled in 2026 with a critic saying its title alone disqualified it. The science against the paper is strong; the retraction that followed wasn't science.Mon, 22 Jun 2026 00:00:00 GMTinvestigationsvaccine-safetysidsvaersretractionscientific-publishingrfkMarcus Chenhttps://thefirstcohort.com/articles/2026-06-22-a-top-cancer-scientist-a-deleted-study-and-the-question-washington-won-t-fundhttps://thefirstcohort.com/articles/2026-06-22-a-top-cancer-scientist-a-deleted-study-and-the-question-washington-won-t-fundA June 2026 Senate subcommittee hearing centered on a Brown University cancer researcher's review of 333 post-vaccination cancer case reports, and on the retractions, censorship, and cyberattack that met it.Mon, 22 Jun 2026 00:00:00 GMTinvestigationscovid-vaccinescancerscientific-censorshipsenate-hearingregulatory-capturemrnaMarcus Chenhttps://thefirstcohort.com/articles/2026-06-22-a-repair-gene-turns-saboteur-and-a-4-billion-drug-class-sees-an-openinghttps://thefirstcohort.com/articles/2026-06-22-a-repair-gene-turns-saboteur-and-a-4-billion-drug-class-sees-an-openingA Penn State lab found that too much of the DNA repair gene EXO1 makes ordinary tumors behave like BRCA-mutant ones in a dish, and respond to the same drugs. The science is clean. The market context is not.Mon, 22 Jun 2026 00:00:00 GMTcancercancerdna-repairparp-inhibitorsoncologybiomarkersLena Marshallhttps://thefirstcohort.com/articles/2026-06-22-a-cheap-amino-acid-pulled-mice-back-from-a-cytokine-storm-the-twist-is-which-orghttps://thefirstcohort.com/articles/2026-06-22-a-cheap-amino-acid-pulled-mice-back-from-a-cytokine-storm-the-twist-is-which-orgA Salk Institute mouse study found that dietary methionine cut deaths from severe inflammation by boosting the kidneys' ability to flush pro-inflammatory cytokines into urine, without blunting the immune response to infection.Mon, 22 Jun 2026 00:00:00 GMTnutrition-foodmethionineinflammationsepsiskidneynutritionlongevitySarah Okonkwohttps://thefirstcohort.com/articles/2026-06-21-your-kidneys-are-quietly-failing-the-who-s-plan-skips-what-s-actually-killing-thhttps://thefirstcohort.com/articles/2026-06-21-your-kidneys-are-quietly-failing-the-who-s-plan-skips-what-s-actually-killing-thThe Lancet is pushing fast implementation of the first WHO kidney resolution, which expands screening and treatment access while leaving the ultraprocessed food and sugar driving the global CKD doubling untouched.Sun, 21 Jun 2026 00:00:00 GMTmetabolic-weightkidney-diseasewhometabolic-healthsglt2ultraprocessed-foodpharmaSarah Okonkwohttps://thefirstcohort.com/articles/2026-06-21-we-fixed-the-ozone-hole-the-replacement-is-now-in-your-bloodhttps://thefirstcohort.com/articles/2026-06-21-we-fixed-the-ozone-hole-the-replacement-is-now-in-your-bloodA new Lancaster modeling study finds CFC replacement refrigerants and anesthetic gases have rained 335,500 tonnes of the forever chemical TFA across the planet since 2000, and it is now the dominant PFAS in American blood.Sun, 21 Jun 2026 00:00:00 GMTinvestigationsforever-chemicalspfasenvironmental-healthmontreal-protocolanestheticsregulatory-captureSarah Okonkwohttps://thefirstcohort.com/articles/2026-06-21-utah-s-quiet-bet-against-the-number-one-killer-of-new-mothershttps://thefirstcohort.com/articles/2026-06-21-utah-s-quiet-bet-against-the-number-one-killer-of-new-mothersUtah is scaling a free, CBT- and mindfulness-based perinatal depression pathway through MyChart in a state where suicide is the leading cause of maternal death.Sun, 21 Jun 2026 00:00:00 GMTbrain-agingmaternal-healthperinatal-depressionpreventiontelehealthwellnessSarah Okonkwohttps://thefirstcohort.com/articles/2026-06-21-ultra-processed-food-is-quietly-taxing-your-attention-the-mediterranean-salad-nehttps://thefirstcohort.com/articles/2026-06-21-ultra-processed-food-is-quietly-taxing-your-attention-the-mediterranean-salad-neA new Monash-led study finds ultra-processed foods track with worse attention and a higher dementia-risk score even after adjusting for Mediterranean diet quality. The biology of why is more interesting than the headlines admit.Sun, 21 Jun 2026 00:00:00 GMTbrain-agingultra-processed-foodscognitiondementianutritionbrain-healthSarah Okonkwohttps://thefirstcohort.com/articles/2026-06-21-twelve-genes-one-overlooked-neuron-and-the-rett-brain-that-was-already-off-courshttps://thefirstcohort.com/articles/2026-06-21-twelve-genes-one-overlooked-neuron-and-the-rett-brain-that-was-already-off-coursA Baylor team's single-cell map of female Rett mice finds 12 dysregulated genes and a previously unsuspected vulnerable interneuron, weeks before any symptom appears.Sun, 21 Jun 2026 00:00:00 GMTbrain-agingrett-syndromemecp2neurologysingle-cellbrain-developmenttrofinetideSarah Okonkwohttps://thefirstcohort.com/articles/2026-06-21-the-supervised-prehab-worked-the-home-version-hospitals-want-to-sell-you-did-nothttps://thefirstcohort.com/articles/2026-06-21-the-supervised-prehab-worked-the-home-version-hospitals-want-to-sell-you-did-notTwo randomized trials in older surgical patients, one positive and one null, draw the same line under what "prehabilitation" actually requires, and why the version a hospital can hand you on paper did nothing.Sun, 21 Jun 2026 00:00:00 GMTbrain-agingprehabilitationsurgeryexercisenutritionfrailtylongevitySarah Okonkwohttps://thefirstcohort.com/articles/2026-06-21-the-secret-reason-cancer-drugs-stop-working-was-published-in-februaryhttps://thefirstcohort.com/articles/2026-06-21-the-secret-reason-cancer-drugs-stop-working-was-published-in-februaryA Montreal team's antibody against the SLAMF6 brake on T cells made the rounds this week as a fresh discovery. The paper went up in February, the work is in mice, and the antibody has not been given to a person.Sun, 21 Jun 2026 00:00:00 GMTcanceroncologyimmunotherapycheckpoint-inhibitorspreclinicalpress-cycleLena Marshallhttps://thefirstcohort.com/articles/2026-06-21-the-amyloid-versus-tau-war-in-alzheimer-s-might-be-the-wrong-fighthttps://thefirstcohort.com/articles/2026-06-21-the-amyloid-versus-tau-war-in-alzheimer-s-might-be-the-wrong-fightA four-person UC Riverside chemistry group argues amyloid beta and tau compete for the same microtubule binding sites, a unifying mechanism that cuts under Alzheimer's research's three-decade amyloid-versus-tau fight.Sun, 21 Jun 2026 00:00:00 GMTbrain-agingalzheimersamyloidtaumicrotubulesneurodegenerationdrug-developmentSarah Okonkwohttps://thefirstcohort.com/articles/2026-06-21-the-ai-models-just-failed-the-clinical-test-we-use-to-spot-executive-dysfunctionhttps://thefirstcohort.com/articles/2026-06-21-the-ai-models-just-failed-the-clinical-test-we-use-to-spot-executive-dysfunctionA new PNAS Nexus study put the same Stroop task neuropsychologists use to screen for executive dysfunction in front of GPT-5, Claude Opus, and Gemini. The accuracy collapse arrives months after the FDA quietly loosened oversight of AI clinical decision support.Sun, 21 Jun 2026 00:00:00 GMTinvestigationsaifdaclinical-decision-supportexecutive-functionmental-healthSarah Okonkwohttps://thefirstcohort.com/articles/2026-06-21-ivermectin-and-cancer-the-review-the-horse-paste-crowd-wasn-t-supposed-to-gethttps://thefirstcohort.com/articles/2026-06-21-ivermectin-and-cancer-the-review-the-horse-paste-crowd-wasn-t-supposed-to-getA 2025 systematic review finds coherent anticancer biology in ivermectin across ten tumor types. The human evidence to match it does not exist. The question of why is what the punchline was designed to bury.Sun, 21 Jun 2026 00:00:00 GMTcancerivermectincancerrepurposed-drugsoncologyclinical-trialsLena Marshallhttps://thefirstcohort.com/articles/2026-06-21-it-grows-like-a-cancer-not-a-parasite-and-it-s-in-37-of-seattle-s-coyoteshttps://thefirstcohort.com/articles/2026-06-21-it-grows-like-a-cancer-not-a-parasite-and-it-s-in-37-of-seattle-s-coyotesA European strain of Echinococcus multilocularis has been found in 37 percent of Puget Sound coyotes, the first wild-host detection on the U.S. West Coast outside Alaska.Sun, 21 Jun 2026 00:00:00 GMTinfectious-diseaseparasitic-diseasezoonosispublic-healthpacific-northwestsurveillanceborder-policySarah Okonkwohttps://thefirstcohort.com/articles/2026-06-21-brewed-tea-has-the-longevity-receipts-the-supplement-aisle-has-a-liver-problemhttps://thefirstcohort.com/articles/2026-06-21-brewed-tea-has-the-longevity-receipts-the-supplement-aisle-has-a-liver-problemA 2025 review finds 1.5 to 2 cups of brewed tea daily correlate with about 10% lower all-cause and 14% lower cardiovascular mortality. The EGCG-extract supplements built on the same chemistry have been linked to over 100 liver-injury cases, while bubble tea can match a Coke for sugar.Sun, 21 Jun 2026 00:00:00 GMTnutrition-foodteapolyphenolslongevitysupplementsbubble-teawellnessSarah Okonkwohttps://thefirstcohort.com/articles/2026-06-21-a-dc-judge-dismissed-the-study-329-suit-the-court-did-not-say-the-paper-is-honeshttps://thefirstcohort.com/articles/2026-06-21-a-dc-judge-dismissed-the-study-329-suit-the-court-did-not-say-the-paper-is-honesA DC court dismissed an attempt to force JAACAP and Elsevier to retract Study 329. The ruling did not find the paper sound. It found that no reader has standing to make a journal stop selling a fraudulent article.Sun, 21 Jun 2026 00:00:00 GMTinvestigationsstudy-329paroxetineghostwritingretractionacademic-publishinggskMira Petrovhttps://thefirstcohort.com/articles/2026-06-21-a-14-patient-hand-exoskeleton-study-lands-in-science-advances-with-a-headline-thhttps://thefirstcohort.com/articles/2026-06-21-a-14-patient-hand-exoskeleton-study-lands-in-science-advances-with-a-headline-thA Vienna-led team published a 14-patient feasibility study of a wearable hand exoskeleton with closed-loop electrical stimulation. The mechanism is genuinely novel; the headline is doing work the data cannot.Sun, 21 Jun 2026 00:00:00 GMTbrain-agingneurorehabilitationexoskeletonstrokespinal-cord-injurymedical-devicesfeasibility-studyMarcus Chenhttps://thefirstcohort.com/articles/2026-06-20-magic-mushrooms-and-an-80-year-old-s-memory-what-the-hype-actually-has-and-whathttps://thefirstcohort.com/articles/2026-06-20-magic-mushrooms-and-an-80-year-old-s-memory-what-the-hype-actually-has-and-whatAn 80-something woman with advanced Alzheimer's took five grams of mushrooms and started speaking again. The biology behind why that might happen is real. The trial base it rests on is thinner than the headlines admit.Sat, 20 Jun 2026 00:00:00 GMTbrain-agingpsychedelicsalzheimersaging-brainneuroplasticitypsilocybinSarah Okonkwohttps://thefirstcohort.com/articles/2026-06-20-becerra-got-the-fauci-whistleblower-file-the-hhs-inspector-general-did-nothttps://thefirstcohort.com/articles/2026-06-20-becerra-got-the-fauci-whistleblower-file-the-hhs-inspector-general-did-notA whistleblower told the Director of National Intelligence in August 2021 that Anthony Fauci lied to Congress about gain-of-function funding. The file was routed to Xavier Becerra, Fauci's cabinet boss, instead of the independent HHS Inspector General. The paper trail is now public.Sat, 20 Jun 2026 00:00:00 GMTinvestigationsfaucicovid-originswhistleblowerbecerraintelligence-communityaccountabilityMira Petrovhttps://thefirstcohort.com/articles/2026-06-20-a-reality-not-an-emergency-the-lancet-picks-another-political-sidehttps://thefirstcohort.com/articles/2026-06-20-a-reality-not-an-emergency-the-lancet-picks-another-political-sideThe Lancet's new editorial recasts immigration enforcement as the public-health pathology. The receipts on the journal that published it run from the Daszak letter to the Surgisphere fraud.Sat, 20 Jun 2026 00:00:00 GMTinvestigationslancetmedical-journalsinstitutional-captureeditorial-activismpublic-healthimmigrationLena Marshallhttps://thefirstcohort.com/articles/2026-06-20-a-molecule-your-body-already-makes-coaxed-exhausted-brain-cells-back-to-fightinghttps://thefirstcohort.com/articles/2026-06-20-a-molecule-your-body-already-makes-coaxed-exhausted-brain-cells-back-to-fightingSpanish and Swiss researchers report that OLE, a fatty-acid amino-acid the body already makes, coaxed sluggish microglia to surround amyloid plaques and improve memory in Alzheimer's mice.Sat, 20 Jun 2026 00:00:00 GMTbrain-agingalzheimersmicroglianeuroinflammationdrug-discoverybrain-agingSarah Okonkwohttps://thefirstcohort.com/articles/2026-06-19-vitamin-c-just-landed-on-an-8-preservative-hypertension-list-it-was-the-only-onehttps://thefirstcohort.com/articles/2026-06-19-vitamin-c-just-landed-on-an-8-preservative-hypertension-list-it-was-the-only-oneA French cohort of 112,395 adults, followed eight years, flagged eight common preservatives for hypertension. Ascorbic acid was the only one that also independently associated with cardiovascular disease, and the lead author is calling on EFSA and FDA to reopen the file.Fri, 19 Jun 2026 00:00:00 GMTnutrition-foodfood-additivespreservativeshypertensioncardiovascular-diseaseultraprocessed-foodSarah Okonkwohttps://thefirstcohort.com/articles/2026-06-19-the-200k-pediatric-diabetes-shot-just-won-a-bigger-label-the-number-that-won-isnhttps://thefirstcohort.com/articles/2026-06-19-the-200k-pediatric-diabetes-shot-just-won-a-bigger-label-the-number-that-won-isnThe FDA gave Tzield an accelerated nod for kids 8 to 17 newly diagnosed with Stage 3 type 1 diabetes. The C-peptide number won. The endpoints families would actually feel did not.Fri, 19 Jun 2026 00:00:00 GMTdrugs-fdatype-1-diabetesfdateplizumabpediatricsanofiimmunotherapySarah Okonkwohttps://thefirstcohort.com/articles/2026-06-19-moderna-s-mrna-flu-shot-got-a-9-0-vote-the-comparator-question-that-killed-its-fhttps://thefirstcohort.com/articles/2026-06-19-moderna-s-mrna-flu-shot-got-a-9-0-vote-the-comparator-question-that-killed-its-fAn FDA panel voted 9-0 to back Moderna's first mRNA flu vaccine. Four months earlier, the same agency refused to even read the file over the comparator the trial used. The comparator did not change.Fri, 19 Jun 2026 00:00:00 GMTdrugs-fdafdamrna-vaccinesmodernainfluenzavrbpacreactogenicityMarcus Chenhttps://thefirstcohort.com/articles/2026-06-18-your-food-has-139-000-molecules-standard-nutrition-science-tracks-about-150https://thefirstcohort.com/articles/2026-06-18-your-food-has-139-000-molecules-standard-nutrition-science-tracks-about-150A May 2025 NEJM review pegs the chemical complexity of the human diet at more than 139,000 molecules. USDA-style databases track around 150. That gap is not a footnote, and it is why so much nutrition guidance keeps aging badly.Thu, 18 Jun 2026 00:00:00 GMTnutrition-foodnutritionfoodomicsdietary-guidelinesultraprocessed-foodsmicrobiomedrug-discoverySarah Okonkwohttps://thefirstcohort.com/articles/2026-06-18-the-cheaper-staph-antibiotic-just-won-the-biggest-trial-ever-runhttps://thefirstcohort.com/articles/2026-06-18-the-cheaper-staph-antibiotic-just-won-the-biggest-trial-ever-runThe largest randomized trial ever run for staph bloodstream infection finds the cheap generic antibiotic cefazolin works as well as the older standard, with less kidney damage and no pharma money behind the answer.Thu, 18 Jun 2026 00:00:00 GMTinfectious-diseaseantibioticsstaph-aureusclinical-trialsantibiotic-stewardshipinfectious-diseaseLena Marshallhttps://thefirstcohort.com/articles/2026-06-18-decades-of-failed-diarrhea-vaccines-kept-hitting-the-wrong-coat-a-washu-team-jushttps://thefirstcohort.com/articles/2026-06-18-decades-of-failed-diarrhea-vaccines-kept-hitting-the-wrong-coat-a-washu-team-jusA WashU-led team identified a structurally conserved patch on three mucus-cleaving enzymes that ETEC, Shigella, and other gut pathogens all use to breach the intestinal barrier, offering a single antibody target the field has chased for decades.Thu, 18 Jun 2026 00:00:00 GMTinfectious-diseasevaccinesinfectious-diseaseetecshigellapublic-healthgut-pathogensMarcus Chenhttps://thefirstcohort.com/articles/2026-06-18-a-viral-diabetes-and-dementia-explainer-left-out-the-trial-that-just-killed-itshttps://thefirstcohort.com/articles/2026-06-18-a-viral-diabetes-and-dementia-explainer-left-out-the-trial-that-just-killed-itsA widely shared "ten ways diabetes and dementia are linked" explainer is going around this week, and it skips the Phase 3 trial that, weeks earlier, demolished its brain-protection story for semaglutide.Thu, 18 Jun 2026 00:00:00 GMTbrain-agingglp-1alzheimerssemaglutidediabetesevoke-trialSarah Okonkwohttps://thefirstcohort.com/articles/2026-06-18-a-200-flu-pill-just-got-a-cheaper-twin-the-10-percent-resistance-problem-came-wihttps://thefirstcohort.com/articles/2026-06-18-a-200-flu-pill-just-got-a-cheaper-twin-the-10-percent-resistance-problem-came-wiThe FDA cleared the first generic of baloxavir, the one-pill flu drug, in time for the 2026–2027 season. Cheaper is real. The mutation that turns the drug into a sugar pill is real too.Thu, 18 Jun 2026 00:00:00 GMTdrugs-fdainfluenzafdagenericsantiviralsbaloxavirresistanceMarcus Chenhttps://thefirstcohort.com/articles/2026-06-17-the-fda-just-approved-a-third-over-the-counter-naloxone-the-maker-once-doubled-thttps://thefirstcohort.com/articles/2026-06-17-the-fda-just-approved-a-third-over-the-counter-naloxone-the-maker-once-doubled-tThe agency calls Rextovy's OTC approval a win for access. The manufacturer's pricing history, and the market it just walked into, complicate the story.Wed, 17 Jun 2026 00:00:00 GMTdrugs-fdafdanaloxoneopioid-crisisotcpharma-pricingamphastarLena Marshallhttps://thefirstcohort.com/articles/2026-06-17-sleep-apnea-s-heart-damage-may-run-through-the-gut-not-the-airwayhttps://thefirstcohort.com/articles/2026-06-17-sleep-apnea-s-heart-damage-may-run-through-the-gut-not-the-airwayResearchers at UCSD report that knocking out a single bile-acid receptor abolishes the arterial plaque sleep-apnea conditions would otherwise drive in mice. The mechanism fits the CPAP era's underwhelming trial record better than the airway story ever did.Wed, 17 Jun 2026 00:00:00 GMTmetabolic-weightsleep-apneagut-microbiomecardiovascularbile-acidspreclinicalLena Marshallhttps://thefirstcohort.com/articles/2026-06-17-american-infant-mortality-just-hit-a-record-low-the-international-comparison-ishttps://thefirstcohort.com/articles/2026-06-17-american-infant-mortality-just-hit-a-record-low-the-international-comparison-isPreliminary CDC data put the 2025 U.S. infant mortality rate at 5.4 per 1,000 live births, a record low. The international comparison the headlines lean on is partly an artifact of how countries count. The domestic gap is not.Wed, 17 Jun 2026 00:00:00 GMTinfectious-diseaseinfant-mortalitypublic-healthcdcmaternal-healthrsvMarcus Chenhttps://thefirstcohort.com/articles/2026-06-17-a-heart-attack-drug-just-regrew-kidney-tissue-in-mice-and-the-receipts-have-no-phttps://thefirstcohort.com/articles/2026-06-17-a-heart-attack-drug-just-regrew-kidney-tissue-in-mice-and-the-receipts-have-no-pA UCLA monoclonal antibody designed to help hearts heal after a heart attack also repaired injured kidneys in mice, and it was developed without a dollar of pharma money.Wed, 17 Jun 2026 00:00:00 GMTdrugs-fdaregenerative-medicinekidneymonoclonal-antibodypreclinicalpublicly-fundedSarah Okonkwohttps://thefirstcohort.com/articles/2026-06-17-a-272-000-person-study-linked-higher-tyrosine-to-shorter-lifespans-in-men-the-suhttps://thefirstcohort.com/articles/2026-06-17-a-272-000-person-study-linked-higher-tyrosine-to-shorter-lifespans-in-men-the-suA UK Biobank analysis of 272,475 people using Mendelian randomization links higher blood tyrosine to about 0.91 fewer years of life in men, with no signal in women. The amino acid is sold widely as a focus and stress supplement. The study measured blood levels, not pills.Wed, 17 Jun 2026 00:00:00 GMTbrain-agingtyrosinesupplementsmendelian-randomizationuk-biobanklongevitysex-differencesSarah Okonkwohttps://thefirstcohort.com/articles/2026-06-16-the-textbook-said-b-cells-take-turns-a-new-temporal-map-of-a-malaria-infection-shttps://thefirstcohort.com/articles/2026-06-16-the-textbook-said-b-cells-take-turns-a-new-temporal-map-of-a-malaria-infection-sA new Nature Immunology temporal map of B cell responses to malaria in mice catches class-switching, clonal expansion, and somatic hypermutation overlapping from the first week, scrambling the tidy stepwise story textbooks still teach.Tue, 16 Jun 2026 00:00:00 GMTinfectious-diseaseb-cellsmalariaimmunologyvaccinesmouse-studySarah Okonkwohttps://thefirstcohort.com/articles/2026-06-16-the-shingles-vaccine-keeps-cutting-dementia-risk-the-reason-may-not-be-the-shinghttps://thefirstcohort.com/articles/2026-06-16-the-shingles-vaccine-keeps-cutting-dementia-risk-the-reason-may-not-be-the-shingFour big studies now tie the shingles vaccine to lower dementia risk. The most useful finding is that the same effect shows up with an RSV vaccine that shares its adjuvant.Tue, 16 Jun 2026 00:00:00 GMTbrain-agingdementiavaccinesshinglesgskadjuvantsalzheimersMarcus Chenhttps://thefirstcohort.com/articles/2026-06-16-the-bitter-finish-in-your-protein-shake-isn-t-the-protein-it-s-the-mineralshttps://thefirstcohort.com/articles/2026-06-16-the-bitter-finish-in-your-protein-shake-isn-t-the-protein-it-s-the-mineralsA new sensory study traces the bitter, peppery aftertaste in whey protein shakes to minerals that get concentrated during filtration, not the protein itself. The fix is a manufacturing tweak. The co-author is the supplier that sells the alpha-lactalbumin line.Tue, 16 Jun 2026 00:00:00 GMTnutrition-foodproteinsupplementsnutritionfood-sciencesensorydairySarah Okonkwohttps://thefirstcohort.com/articles/2026-06-16-calcium-and-vitamin-d-got-demoted-in-the-bmj-the-trial-data-are-more-stubborn-thhttps://thefirstcohort.com/articles/2026-06-16-calcium-and-vitamin-d-got-demoted-in-the-bmj-the-trial-data-are-more-stubborn-thA BMJ meta-analysis of 153,902 older adults reports calcium and vitamin D supplements offer little meaningful benefit against fractures and falls, though the combined arm showed a statistically significant 16% reduction in hip fracture risk.Tue, 16 Jun 2026 00:00:00 GMTnutrition-foodcalciumvitamin-dbone-healthsupplementsbmjosteoporosisLena Marshallhttps://thefirstcohort.com/articles/2026-06-16-aaron-siri-wrote-a-book-made-of-court-filingshttps://thefirstcohort.com/articles/2026-06-16-aaron-siri-wrote-a-book-made-of-court-filingsA new book by attorney Aaron Siri assembles a decade of FOIA wins, court filings, and depositions into one record of what the federal vaccine docket does and does not say.Tue, 16 Jun 2026 00:00:00 GMTinvestigationsvaccinesfoiaicanfdacdcpharma-liabilityMira Petrovhttps://thefirstcohort.com/articles/2026-06-15-the-sugar-free-mice-got-sicker-and-the-press-release-left-out-what-they-were-eathttps://thefirstcohort.com/articles/2026-06-15-the-sugar-free-mice-got-sicker-and-the-press-release-left-out-what-they-were-eatA 16-week mouse study presented at ENDO 2026 reported that sugar-free animals developed insulin resistance, gut dysbiosis and fatty liver at the same body weight as controls. The press release never says what replaced the sugar, and that single missing detail decides what the study actually means.Mon, 15 Jun 2026 00:00:00 GMTnutrition-foodnutritionmicrobiomemetabolic-healthanimal-studygut-healthSarah Okonkwohttps://thefirstcohort.com/articles/2026-06-15-testosterone-prescriptions-quadrupled-the-workups-didn-thttps://thefirstcohort.com/articles/2026-06-15-testosterone-prescriptions-quadrupled-the-workups-didn-tA Michigan Medicine chart review presented at ENDO 2026 found that only 12 percent of men prescribed testosterone got the guideline-required workup, even as the U.S. wrote 11 million testosterone prescriptions in 2024.Mon, 15 Jun 2026 00:00:00 GMTdrugs-fdatestosteronehypogonadismprescribingendocrinologypharma-marketingtelehealthMarcus Chenhttps://thefirstcohort.com/articles/2026-06-15-middle-aged-americans-are-weaker-lonelier-and-forgetting-more-than-their-parentshttps://thefirstcohort.com/articles/2026-06-15-middle-aged-americans-are-weaker-lonelier-and-forgetting-more-than-their-parentsA 17-country study finds U.S. adults in their 50s are doing worse on memory, grip strength, loneliness, and depression than their parents were. The United States is the only country going meaningfully backward.Mon, 15 Jun 2026 00:00:00 GMTbrain-agingmidlifecognitive-declinemental-healthlongevitypublic-healthSarah Okonkwohttps://thefirstcohort.com/articles/2026-06-15-astellas-brings-real-world-numbers-for-its-menopause-drug-to-endo-2026-the-blackhttps://thefirstcohort.com/articles/2026-06-15-astellas-brings-real-world-numbers-for-its-menopause-drug-to-endo-2026-the-blackAstellas presented its first real-world numbers for Veozah at ENDO 2026, framed as a win. The 656-woman observational study had no placebo arm and the company's release did not mention the FDA black-box warning for liver injury.Mon, 15 Jun 2026 00:00:00 GMTdrugs-fdamenopausefezolinetantastellasfda-safetyindustry-funded-researchMarcus Chenhttps://thefirstcohort.com/articles/2026-06-14-your-thymus-quietly-stages-a-lung-researchers-just-named-the-cell-playing-the-pahttps://thefirstcohort.com/articles/2026-06-14-your-thymus-quietly-stages-a-lung-researchers-just-named-the-cell-playing-the-paA new Nature Immunology study identifies an alveolar lung-like cell hiding inside the thymus, where it appears to teach the immune system not to attack your real lungs.Sun, 14 Jun 2026 00:00:00 GMTautoimmune-inflammationthymusautoimmunitycentral-tolerancemteclung-autoimmunityimmunologySarah Okonkwohttps://thefirstcohort.com/articles/2026-06-14-the-battlefield-medicine-revolution-was-built-on-fake-woundshttps://thefirstcohort.com/articles/2026-06-14-the-battlefield-medicine-revolution-was-built-on-fake-woundsA British prosthetics graduate is heading to NHS ambulance crews and the British military to build realistic trauma wounds, the artisan end of the twenty-year battlefield-medicine revolution that turned hemorrhage into a survivable injury.Sun, 14 Jun 2026 00:00:00 GMTinfectious-diseasemilitary-medicinetrauma-caresimulationtcccpublic-health-readinessmoulageMarcus Chenhttps://thefirstcohort.com/articles/2026-06-14-brain-gains-into-your-90s-are-probably-real-the-index-measuring-them-has-a-patenhttps://thefirstcohort.com/articles/2026-06-14-brain-gains-into-your-90s-are-probably-real-the-index-measuring-them-has-a-patenA three-year UT Dallas study tracking nearly 4,000 adults to age 94 says brain function can climb at any age. The biology is plausible. The catch is that the people measuring the gain are the same people patenting the yardstick.Sun, 14 Jun 2026 00:00:00 GMTbrain-agingbrain-agingneuroplasticitycognitionbrain-traininglongevityconflicts-of-interestSarah Okonkwohttps://thefirstcohort.com/articles/2026-06-14-a-fentanyl-vaccine-for-mice-an-overdose-decline-for-humanshttps://thefirstcohort.com/articles/2026-06-14-a-fentanyl-vaccine-for-mice-an-overdose-decline-for-humansScripps Research published a clever chemistry redesign that let mice's immune systems recognize an entire class of fentanyl analogues. The headlines called it an overdose blocker. The mice are doing fine. Humans are years away, and the overdose decline is already happening without it.Sun, 14 Jun 2026 00:00:00 GMTdrugs-fdafentanylvaccinesaddiction-treatmentscripps-researchoverdose-deathsLena Marshallhttps://thefirstcohort.com/articles/2026-06-14-a-dod-funded-fentanyl-vaccine-is-headed-to-phase-1-antibodies-don-t-stop-a-supplhttps://thefirstcohort.com/articles/2026-06-14-a-dod-funded-fentanyl-vaccine-is-headed-to-phase-1-antibodies-don-t-stop-a-supplA Pentagon-funded fentanyl vaccine licensed to startup ARMR Sciences will begin Phase 1 in the Netherlands in early 2026. Three decades of failed addiction vaccines, and a supply chain that runs through Chinese precursor labs, are the context the press release leaves out.Sun, 14 Jun 2026 00:00:00 GMTdrugs-fdafentanylopioidsvaccinesaddictionpublic-healthdodMarcus Chenhttps://thefirstcohort.com/articles/2026-06-13-the-same-mutations-that-drive-blood-cancer-keep-turning-up-in-alzheimer-s-brainshttps://thefirstcohort.com/articles/2026-06-13-the-same-mutations-that-drive-blood-cancer-keep-turning-up-in-alzheimer-s-brainsA new Cell paper finds Alzheimer's brains are riddled with the same mutations that drive blood cancers, in the immune cells that are supposed to be protecting neurons.Sat, 13 Jun 2026 00:00:00 GMTbrain-agingalzheimersmicrogliasomatic-mutationsneurodegenerationclonal-hematopoiesisamyloidSarah Okonkwohttps://thefirstcohort.com/articles/2026-06-13-medicare-s-product-hopping-loophole-is-back-on-the-chopping-block-the-bigger-phahttps://thefirstcohort.com/articles/2026-06-13-medicare-s-product-hopping-loophole-is-back-on-the-chopping-block-the-bigger-phaThe Trump administration on Thursday proposed closing the product-hopping loophole that lets drugmakers reset Medicare's negotiation clock by tweaking inactive ingredients. It is the same fix the same administration quietly tabled in October.Sat, 13 Jun 2026 00:00:00 GMTdrugs-fdadrug-pricingmedicarepharmaglp-1product-hoppingregulatory-captureSarah Okonkwohttps://thefirstcohort.com/articles/2026-06-13-a-near-starvation-diet-shifted-inflammation-in-gum-disease-patients-the-trial-wahttps://thefirstcohort.com/articles/2026-06-13-a-near-starvation-diet-shifted-inflammation-in-gum-disease-patients-the-trial-waA 28-patient feasibility trial put severe gum-disease patients on three cycles of a 750-calorie ProLon diet. Inflammation markers trended lower; clinical gum measures weren't reported. The biology question is real; the data is thin.Sat, 13 Jun 2026 00:00:00 GMTautoimmune-inflammationfastingperiodontitisinflammationpilot-trialprolonnutritionSarah Okonkwohttps://thefirstcohort.com/articles/2026-06-13-a-korean-lab-found-cancer-s-dna-repair-off-switch-in-a-mousehttps://thefirstcohort.com/articles/2026-06-13-a-korean-lab-found-cancer-s-dna-repair-off-switch-in-a-mouseA Korean state lab reports that a tool compound called UNI418 strips out the DNA-repair proteins cancer cells use to escape PARP inhibitors. The data are preclinical: cell lines and mouse xenografts. UNI418 is not yet a drug.Sat, 13 Jun 2026 00:00:00 GMTcancercancerparp-inhibitorsdna-repairpreclinicaldrug-resistanceLena Marshallhttps://thefirstcohort.com/articles/2026-06-10-the-ai-vaccine-that-passed-its-first-trial-three-years-agohttps://thefirstcohort.com/articles/2026-06-10-the-ai-vaccine-that-passed-its-first-trial-three-years-agoCambridge finished the Phase 1 trial in 2023. The press tour arrived in 2026. The paper, when you read it, said the immunogenicity was modest.Wed, 10 Jun 2026 00:00:00 GMTinfectious-diseasevaccinesai-drug-designcoronavirusclinical-trialspandemic-preparednessregulatory-captureLena Marshallhttps://thefirstcohort.com/articles/2026-06-10-nitrate-from-spinach-behaves-nothing-like-nitrate-from-tap-water-a-27-year-cohorhttps://thefirstcohort.com/articles/2026-06-10-nitrate-from-spinach-behaves-nothing-like-nitrate-from-tap-water-a-27-year-cohor54,804 Danes followed for a quarter-century: less dementia from vegetable nitrate, more from drinking water. The risk signal shows up at roughly one-ninth of what the US EPA still permits.Wed, 10 Jun 2026 00:00:00 GMTbrain-agingnitratedementiadrinking-waterepan-nitrosaminesregulatory-captureSarah Okonkwohttps://thefirstcohort.com/articles/2026-06-10-europe-had-this-sunscreen-in-1999-the-fda-approved-it-tuesdayhttps://thefirstcohort.com/articles/2026-06-10-europe-had-this-sunscreen-in-1999-the-fda-approved-it-tuesdayA new chemical UV filter Europe approved in 1999 just cleared the FDA after a 21-year wait, while Americans relied on ingredients the agency's own 2019 review could not call safe.Wed, 10 Jun 2026 00:00:00 GMTdrugs-fdasunscreenfdaregulatory-captureskin-cancerwellnessphotoprotectionSarah Okonkwohttps://thefirstcohort.com/articles/2026-06-10-disappointment-not-reward-is-what-breaks-a-habit-half-of-older-adults-are-on-druhttps://thefirstcohort.com/articles/2026-06-10-disappointment-not-reward-is-what-breaks-a-habit-half-of-older-adults-are-on-druAn OIST team caught the mouse brain firing acetylcholine the moment an expected reward failed to land. That surge is what lets the animal switch strategy. Close to half of community-dwelling older adults are on drugs that block the same receptors.Wed, 10 Jun 2026 00:00:00 GMTbrain-agingneurosciencebrain-chemistryhabitsanti-cholinergicsbehavioral-flexibilityaddictionSarah Okonkwohttps://thefirstcohort.com/articles/2026-06-10-american-doctors-get-about-1-2-hours-of-nutrition-training-a-year-rfk-jr-just-fohttps://thefirstcohort.com/articles/2026-06-10-american-doctors-get-about-1-2-hours-of-nutrition-training-a-year-rfk-jr-just-foKennedy got eight organizations across U.S. medical training and 73 medical schools to commit to nutrition in licensing, accreditation, and a 40-hour pledge. The board exam matters; the rest is partly hedging.Wed, 10 Jun 2026 00:00:00 GMTnutrition-foodnutritionmedical-educationmaharfkusmlechronic-diseaseSarah Okonkwohttps://thefirstcohort.com/articles/2026-06-10-8-300-brazilian-elders-one-saltshaker-and-the-80-percent-of-sodium-nobody-mentiohttps://thefirstcohort.com/articles/2026-06-10-8-300-brazilian-elders-one-saltshaker-and-the-80-percent-of-sodium-nobody-mentioA Frontiers in Public Health survey of 8,336 Brazilians over 60 found older men reach for the saltshaker most. Buried in the same paper: the shaker only accounts for 6 to 20 percent of total sodium. The other 70-plus percent already arrived from the factory.Wed, 10 Jun 2026 00:00:00 GMTnutrition-foodnutritionpublic-healthultra-processed-foodcognitive-declinesodiumSarah Okonkwohttps://thefirstcohort.com/articles/2026-06-09-the-thin-trial-behind-england-s-next-supermarket-layout-mandatehttps://thefirstcohort.com/articles/2026-06-09-the-thin-trial-behind-england-s-next-supermarket-layout-mandateA non-randomized trial of 36 English discount stores produced a moment-of-implementation bump in produce sales that lost statistical significance by three months, and a household-purchasing signal that never landed. The authors' immediate call for a national layout mandate is the louder finding.Tue, 09 Jun 2026 00:00:00 GMTnutrition-foodpublic-healthnutritionukfood-policyregulationchoice-architectureMarcus Chenhttps://thefirstcohort.com/articles/2026-06-09-the-macaques-get-a-reprieve-pharma-gets-a-faster-pipelinehttps://thefirstcohort.com/articles/2026-06-09-the-macaques-get-a-reprieve-pharma-gets-a-faster-pipelineThe FDA's new draft guidance lets oncology developers cut animal studies for certain biologics and conjugated products. The replacement laboratory methods are still being validated.Tue, 09 Jun 2026 00:00:00 GMTdrugs-fdafdaoncologyanimal-testingbiologicsantibody-drug-conjugatesregulatory-reformLena Marshallhttps://thefirstcohort.com/articles/2026-06-09-the-alzheimer-s-drug-that-bets-the-plaques-are-a-symptomhttps://thefirstcohort.com/articles/2026-06-09-the-alzheimer-s-drug-that-bets-the-plaques-are-a-symptomAn ETH Zurich team spent nearly twenty years tracing why Alzheimer's nerve cells run out of energy, and the answer points to a protein the amyloid-clearing drugs never touched.Tue, 09 Jun 2026 00:00:00 GMTbrain-agingalzheimersneurosciencemitochondriadrug-developmentamyloid-hypothesiseth-zurichSarah Okonkwohttps://thefirstcohort.com/articles/2026-06-09-six-melanoma-patients-six-weeks-one-common-variable-the-question-oncology-is-chohttps://thefirstcohort.com/articles/2026-06-09-six-melanoma-patients-six-weeks-one-common-variable-the-question-oncology-is-choAn oncologist's bedside pattern, a Senate hearing, and a mechanism paper sitting in a mainstream oncology journal: the case that repeated mRNA boosters may be lifting the brakes off cancers oncologists thought they had quiet is no longer fringe enough to wave away.Tue, 09 Jun 2026 00:00:00 GMTcancermrna-vaccinesoncologyimmune-tolerancemelanomaigg4regulatory-captureLena Marshallhttps://thefirstcohort.com/articles/2026-06-09-fish-oil-rewired-the-t-cells-in-non-obese-diabetic-rats-and-the-glucose-moved-wihttps://thefirstcohort.com/articles/2026-06-09-fish-oil-rewired-the-t-cells-in-non-obese-diabetic-rats-and-the-glucose-moved-wiA Brazilian team gave EPA-heavy fish oil to a non-obese diabetic rat strain for eight weeks. Glucose, insulin sensitivity, and lipids all moved in the friendlier direction. The T-cell balance shifted alongside them, and that is the part of the paper worth chewing on.Tue, 09 Jun 2026 00:00:00 GMTautoimmune-inflammationomega-3type-2-diabetesinsulin-resistanceinflammationpreclinicallipidsSarah Okonkwohttps://thefirstcohort.com/articles/2026-06-09-altair-missed-its-primary-endpoint-the-press-tour-found-something-elsehttps://thefirstcohort.com/articles/2026-06-09-altair-missed-its-primary-endpoint-the-press-tour-found-something-elseA phase 3 trial testing chemotherapy in ctDNA-positive colorectal cancer patients missed its primary endpoint at p=0.107, and a post-hoc reanalysis is doing the public-facing work.Tue, 09 Jun 2026 00:00:00 GMTcancercolorectal-cancerctdnaclinical-trialsoncologypharma-skepticismLena Marshallhttps://thefirstcohort.com/articles/2026-06-07-the-supplement-aisle-has-spent-twenty-years-getting-older-americans-wronghttps://thefirstcohort.com/articles/2026-06-07-the-supplement-aisle-has-spent-twenty-years-getting-older-americans-wrongA May 2026 review by two geriatric researchers, syndicated this week by ScienceDaily, restates what twenty years of trial data have already shown: the supplement aisle is built around vague promises older Americans do not need, while protein, the gap that actually moves aging outcomes, sits in the mSun, 07 Jun 2026 00:00:00 GMTnutrition-foodsupplementsagingvitamin-dnutritionpublic-healthsarcopeniaMarcus Chenhttps://thefirstcohort.com/articles/2026-06-07-the-ozempic-resistance-headline-the-data-didn-t-quite-earnhttps://thefirstcohort.com/articles/2026-06-07-the-ozempic-resistance-headline-the-data-didn-t-quite-earnA new study identifies PAM-gene variants tied to weaker six-month HbA1c response to GLP-1 diabetes drugs, but the 'why Ozempic may not work' framing imports a weight-loss conclusion the paper doesn't reach, and the buried trials that used longer-acting GLP-1 drugs showed no carrier effect at all.Sun, 07 Jun 2026 00:00:00 GMTmetabolic-weightglp-1ozempicpharmacogenomicsnovo-nordiskdiabetesresearch-spinLena Marshallhttps://thefirstcohort.com/articles/2026-06-07-the-oral-glp-1-race-just-got-a-third-serious-contender-and-its-curve-was-still-chttps://thefirstcohort.com/articles/2026-06-07-the-oral-glp-1-race-just-got-a-third-serious-contender-and-its-curve-was-still-cStructure Therapeutics' once-daily oral GLP-1 aleniglipron hit 11.3 percent placebo-adjusted weight loss at 36 weeks and kept climbing in the open label. The catch: oral semaglutide and orforglipron already cleared the FDA.Sun, 07 Jun 2026 00:00:00 GMTmetabolic-weightglp-1obesitymetabolicoral-medicationsstructure-therapeuticsphase-2bSarah Okonkwohttps://thefirstcohort.com/articles/2026-06-07-the-hernia-faq-that-forgets-to-mention-the-implanthttps://thefirstcohort.com/articles/2026-06-07-the-hernia-faq-that-forgets-to-mention-the-implantA polished hernia FAQ walks patients through recovery time, return-to-work, and lifestyle. It skips the question with 26,153 pending lawsuits behind it, and the no-mesh option the international guideline still keeps on the table.Sun, 07 Jun 2026 00:00:00 GMTinvestigationsherniasurgerymedical-devicesmeshchronic-painlitigationSarah Okonkwohttps://thefirstcohort.com/articles/2026-06-07-the-herbal-steroid-that-hits-pharma-s-holy-grail-kidney-targethttps://thefirstcohort.com/articles/2026-06-07-the-herbal-steroid-that-hits-pharma-s-holy-grail-kidney-targetA Shanghai lab reports a steroid from a Yunnan mountain plant, already sold over the counter to bodybuilders, suppresses the same kidney-fibrosis pathway Big Pharma keeps circling and never quite closes on.Sun, 07 Jun 2026 00:00:00 GMTautoimmune-inflammationkidneyfibrosislongevityherbaltgf-betaSarah Okonkwohttps://thefirstcohort.com/articles/2026-06-07-the-401-cbc-and-the-32-cbc-are-the-same-testhttps://thefirstcohort.com/articles/2026-06-07-the-401-cbc-and-the-32-cbc-are-the-same-testA Reddit pitch for a Quest reseller put receipts on a markup the insurance-billed lab market has spent years obscuring. A Florida cost study confirms what the consumer market already figured out.Sun, 07 Jun 2026 00:00:00 GMTinvestigationslab-testinghealthcare-pricingdirect-to-consumerquest-diagnosticsprice-transparencyLena Marshallhttps://thefirstcohort.com/articles/2026-06-07-retatrutide-s-triple-receptor-triumph-came-with-a-one-in-five-skin-sensation-sighttps://thefirstcohort.com/articles/2026-06-07-retatrutide-s-triple-receptor-triumph-came-with-a-one-in-five-skin-sensation-sigEli Lilly's investigational retatrutide hit bariatric-surgery-level weight loss at ADA 2026. The highest-dose arm of TRIUMPH-4 also saw 20.9% of patients report abnormal skin sensations, and a small cardiac imbalance turned up in the type-2 trial. Both got far less stage time than the headline numbeSun, 07 Jun 2026 00:00:00 GMTmetabolic-weightglp-1obesityretatrutideeli-lillyada-2026drug-safetySarah Okonkwohttps://thefirstcohort.com/articles/2026-06-07-ozempic-s-30-percent-breast-cancer-headline-and-the-trial-evidence-it-walked-pashttps://thefirstcohort.com/articles/2026-06-07-ozempic-s-30-percent-breast-cancer-headline-and-the-trial-evidence-it-walked-pasA single-system observational study at ASCO 2026 attached a roughly 30% lower breast-cancer rate to GLP-1 use. The randomized record already on the table is quieter.Sun, 07 Jun 2026 00:00:00 GMTcancerozempicglp-1breast-cancerasco-2026pharmaLena Marshallhttps://thefirstcohort.com/articles/2026-06-07-lilly-s-triple-agonist-hit-30-weight-loss-the-glucagon-bet-is-whyhttps://thefirstcohort.com/articles/2026-06-07-lilly-s-triple-agonist-hit-30-weight-loss-the-glucagon-bet-is-whyLilly's triple agonist hit nearly 30% weight loss at 104 weeks at ADA 2026. The glucagon bet is what makes retatrutide different from semaglutide and Mounjaro, and it's what makes the open safety signals different too.Sun, 07 Jun 2026 00:00:00 GMTmetabolic-weightretatrutideobesitytype-2-diabetesglp-1eli-lillyada-2026Sarah Okonkwohttps://thefirstcohort.com/articles/2026-06-07-he-shou-wu-s-hair-loss-pitch-is-better-than-i-expected-its-liver-record-is-worsehttps://thefirstcohort.com/articles/2026-06-07-he-shou-wu-s-hair-loss-pitch-is-better-than-i-expected-its-liver-record-is-worseResearchers at Guangdong Pharmaceutical University argue Polygonum multiflorum could become the next pattern-baldness lead. The follicle biology is interesting. The case series of acute liver failure on four continents are not.Sun, 07 Jun 2026 00:00:00 GMTnutrition-foodhair-losstraditional-chinese-medicinehepatotoxicitysupplement-safetydermatologypolygonum-multiflorumSarah Okonkwohttps://thefirstcohort.com/articles/2026-06-07-a-senate-subcommittee-just-put-the-covid-shot-cancer-question-on-the-recordhttps://thefirstcohort.com/articles/2026-06-07-a-senate-subcommittee-just-put-the-covid-shot-cancer-question-on-the-recordA Senate Homeland Security subcommittee took testimony on whether mRNA COVID shots can plausibly cause cancer, and on the parallel campaign to keep that question out of the journals. Dr. John Campbell walked his audience through it.Sun, 07 Jun 2026 00:00:00 GMTinvestigationscovid-vaccinesmrnasenate-hearingregulatory-capturecancerrfk-jrMarcus Chenhttps://thefirstcohort.com/articles/2026-06-07-a-16-month-old-died-at-an-arkansas-splash-pad-its-chlorinator-had-been-broken-fohttps://thefirstcohort.com/articles/2026-06-07-a-16-month-old-died-at-an-arkansas-splash-pad-its-chlorinator-had-been-broken-foA new global synthesis on free-living amoebae explains why a single bad month at a public splash pad is enough to kill a child, and why the CDC's existing protocol would have caught it.Sun, 07 Jun 2026 00:00:00 GMTinfectious-diseaseamoebaenaegleria-fowleriwater-safetypublic-healthinfrastructureMarcus Chenhttps://thefirstcohort.com/articles/2026-06-07-a-16-foot-fire-tornado-burned-an-oil-slick-with-40-less-soot-cleanup-crews-havehttps://thefirstcohort.com/articles/2026-06-07-a-16-foot-fire-tornado-burned-an-oil-slick-with-40-less-soot-cleanup-crews-haveA federally funded field trial used a controlled fire whirl to burn up to 95% of a crude oil pool while cutting soot by 40%, raising the question of why the standard in-situ burn, with its measured worker-lung cost, has gone unchallenged for thirty-five years.Sun, 07 Jun 2026 00:00:00 GMTinvestigationsoil-spillfire-whirlenvironmental-healthparticulate-matterdeepwater-horizonSarah Okonkwohttps://thefirstcohort.com/articles/2026-06-06-the-founder-of-kentucky-s-biggest-rehab-chain-was-indicted-this-week-the-wire-frhttps://thefirstcohort.com/articles/2026-06-06-the-founder-of-kentucky-s-biggest-rehab-chain-was-indicted-this-week-the-wire-frA federal grand jury in the Eastern District of Kentucky indicted the founder of Addiction Recovery Care on June 4 for selling the same COVID-era tax credit twice. The bigger case, the FBI Medicaid investigation into the company he built, is still open.Sat, 06 Jun 2026 00:00:00 GMTinvestigationsmedicaid-fraudopioid-crisisregulatory-capturekentuckyfederal-indictmentpolitical-donationsMira Petrovhttps://thefirstcohort.com/articles/2026-06-06-pancreatic-cancer-s-undruggable-wall-just-cracked-the-follow-up-is-8-5-months-anhttps://thefirstcohort.com/articles/2026-06-06-pancreatic-cancer-s-undruggable-wall-just-cracked-the-follow-up-is-8-5-months-anRevolution Medicines' daraxonrasib nearly doubled median overall survival versus chemotherapy in previously treated metastatic pancreatic cancer at ASCO 2026, with 8.5 months of follow-up and a two-billion-dollar Royalty Pharma deal already riding on what comes next.Sat, 06 Jun 2026 00:00:00 GMTcancerpancreatic-cancerkrasfdaoncologydrug-pricingclinical-trialsLena Marshallhttps://thefirstcohort.com/articles/2026-06-06-cops-shoved-a-doctor-at-the-ada-meeting-the-editorial-they-tore-up-has-its-own-chttps://thefirstcohort.com/articles/2026-06-06-cops-shoved-a-doctor-at-the-ada-meeting-the-editorial-they-tore-up-has-its-own-cPolice escorted ADA members out of New Orleans on Friday for passing out an editorial against Trump's NIH overhaul. The shove was bad. The editorial defending the status quo has a credibility problem the press is mostly missing.Sat, 06 Jun 2026 00:00:00 GMTinvestigationsdiabetesnihmahapediatric-obesityresearch-fundingfree-speechSarah Okonkwohttps://thefirstcohort.com/articles/2026-06-06-a-senate-hearing-finally-put-the-cancer-question-on-the-record-the-journal-notichttps://thefirstcohort.com/articles/2026-06-06-a-senate-hearing-finally-put-the-cancer-question-on-the-record-the-journal-noticSen. Ron Johnson's June 3 subcommittee hearing on plausible mechanisms linking mRNA injections to cancer, the South Korean cohort behind it, and the editorial notice Springer had posted on the paper months earlier.Sat, 06 Jun 2026 00:00:00 GMTinvestigationscovid-vaccinesmrnacancersenate-hearingretractionsron-johnsonLena Marshallhttps://thefirstcohort.com/articles/2026-06-04-harvard-just-mapped-how-a-mouse-smells-and-it-quietly-rewrites-what-smell-loss-mhttps://thefirstcohort.com/articles/2026-06-04-harvard-just-mapped-how-a-mouse-smells-and-it-quietly-rewrites-what-smell-loss-mHarvard used MERFISH to image roughly 1,100 odorant receptors across the mouse nose at once and found tidy stripes, not chaos. The clinical stakes for smell loss just got harder to wave off.Thu, 04 Jun 2026 00:00:00 GMTbrain-agingolfactionneuroscienceanosmiasmell-lossparkinsonsharvardSarah Okonkwohttps://thefirstcohort.com/articles/2026-06-04-alnylam-bet-2-billion-on-ai-designed-rnai-the-check-it-actually-wrote-was-30-milhttps://thefirstcohort.com/articles/2026-06-04-alnylam-bet-2-billion-on-ai-designed-rnai-the-check-it-actually-wrote-was-30-milAlnylam paid Inceptive Nucleics $30 million up front, with up to $2 billion in milestones tied to outcomes the rest of AI drug discovery has spent a decade failing to deliver.Thu, 04 Jun 2026 00:00:00 GMTdrugs-fdarnaiai-drug-discoveryalnylambiotech-dealssirnapharmaMarcus Chenhttps://thefirstcohort.com/articles/2026-06-04-a-gut-hormone-keeps-showing-up-in-the-brain-s-reward-circuit-and-600-000-veteranhttps://thefirstcohort.com/articles/2026-06-04-a-gut-hormone-keeps-showing-up-in-the-brain-s-reward-circuit-and-600-000-veteranA VA cohort of 606,000 diabetic veterans on GLP-1 drugs showed lower risks of new substance use disorders and large drops in overdose and drug-related death versus a peer diabetes drug. The mechanism story is where it gets interesting.Thu, 04 Jun 2026 00:00:00 GMTmetabolic-weightglp-1addictionneuroscienceveterans-healthpharmareward-circuitSarah Okonkwohttps://thefirstcohort.com/articles/2026-06-03-yale-s-olive-oil-cancer-story-did-not-actually-test-olive-oilhttps://thefirstcohort.com/articles/2026-06-03-yale-s-olive-oil-cancer-story-did-not-actually-test-olive-oilA Yale mouse study reported in Cancer Discovery is being sold as proof that olive oil fuels pancreatic cancer. The lab fed the mice purified oleic acid, the effect only showed up in males, and no one has tested it in a person.Wed, 03 Jun 2026 00:00:00 GMTnutrition-foodpancreatic-cancerferroptosisomega-3mediterranean-dietpreclinicalyaleLena Marshallhttps://thefirstcohort.com/articles/2026-06-03-the-fda-approved-a-better-penile-implant-for-most-men-ed-is-the-heart-warning-thhttps://thefirstcohort.com/articles/2026-06-03-the-fda-approved-a-better-penile-implant-for-most-men-ed-is-the-heart-warning-thThe FDA approved Coloplast's Titan Prime inflatable penile prosthesis on June 3, 2026. For the men whose vasculature is past saving, it is a meaningful device upgrade. For most men with new ED, the more useful conversation is what the small arteries are failing to do years before the coronaries notiWed, 03 Jun 2026 00:00:00 GMTdrugs-fdaerectile-dysfunctionmens-healthcardiovascularmetabolicfdadevicesSarah Okonkwohttps://thefirstcohort.com/articles/2026-06-03-the-crunchy-mom-and-the-maha-mom-were-fighting-the-same-war-the-pesticide-lobbyhttps://thefirstcohort.com/articles/2026-06-03-the-crunchy-mom-and-the-maha-mom-were-fighting-the-same-war-the-pesticide-lobbyFor one strange year, the EWG hiking-boots crowd and the MAHA red-hat moms were fighting the same pesticide war. Then Trump invoked the Defense Production Act on behalf of Bayer, the final MAHA report quietly stopped mentioning glyphosate, and a coalition that was actually winning got stomped by a CWed, 03 Jun 2026 00:00:00 GMTinvestigationsglyphosatepesticidesmahaenvironmental-healthrfk-jrfood-policySarah Okonkwohttps://thefirstcohort.com/articles/2026-06-03-half-a-billion-in-detainee-health-care-and-the-federal-watchdog-quietly-closedhttps://thefirstcohort.com/articles/2026-06-03-half-a-billion-in-detainee-health-care-and-the-federal-watchdog-quietly-closedA KFF and AP investigation pulled more than 300 sworn allegations of medical neglect from 33,000 ICE habeas petitions, even as the detention ombudsman office quietly closed and the federal detainee care bill passed half a billion dollars.Wed, 03 Jun 2026 00:00:00 GMTinvestigationsice-detentionprivate-contractorsmedical-neglectfederal-oversighthealthcare-spendingLena Marshallhttps://thefirstcohort.com/articles/2026-06-03-another-clot-problem-at-abiomed-the-fda-flags-an-impella-introducer-and-the-patthttps://thefirstcohort.com/articles/2026-06-03-another-clot-problem-at-abiomed-the-fda-flags-an-impella-introducer-and-the-pattFDA flags Abiomed's 14Fr Low Profile Introducer Kit after a higher than expected complaint rate of clots forming on the device during prolonged Impella CP support. Three serious injuries reported, no deaths. The pattern keeps growing.Wed, 03 Jun 2026 00:00:00 GMTdrugs-fdafdaabiomedimpellamedical-devicesrecallcardiacSarah Okonkwohttps://thefirstcohort.com/articles/2026-06-03-a-senior-niaid-scientist-got-caught-smuggling-113-vials-through-detroit-he-sayshttps://thefirstcohort.com/articles/2026-06-03-a-senior-niaid-scientist-got-caught-smuggling-113-vials-through-detroit-he-saysTwo NIAID scientists are charged with bringing 113 undeclared vials into Detroit during an active Congo mpox outbreak. One allegedly told a federal officer he does it all the time.Wed, 03 Jun 2026 00:00:00 GMTinvestigationsnihniaidbiosafetympoxrocky-mountain-labspublic-trustMarcus Chenhttps://thefirstcohort.com/articles/2026-06-02-xocova-clears-the-fda-what-it-actually-prevents-is-the-smaller-storyhttps://thefirstcohort.com/articles/2026-06-02-xocova-clears-the-fda-what-it-actually-prevents-is-the-smaller-storyThe FDA approved Shionogi's ensitrelvir for post-exposure COVID prevention, citing a 67% relative risk reduction. Look at what the trial actually measured and a different story comes into focus.Tue, 02 Jun 2026 00:00:00 GMTinfectious-diseasecovid-19antiviralsfdapost-exposure-prophylaxisshionogiMarcus Chenhttps://thefirstcohort.com/articles/2026-06-02-six-negative-tests-forty-two-days-what-australia-s-biosecurity-order-won-t-say-ohttps://thefirstcohort.com/articles/2026-06-02-six-negative-tests-forty-two-days-what-australia-s-biosecurity-order-won-t-say-oAustralia extended facility detention of six hantavirus contacts to a full 42 days under the Biosecurity Act after they tested negative. WHO's own guidance reserves that option for the high-risk tier; most peer countries chose monitoring.Tue, 02 Jun 2026 00:00:00 GMTinvestigationsbiosecurity-actquarantinehantavirusaustraliapublic-healthcivil-libertiesMira Petrovhttps://thefirstcohort.com/articles/2026-06-02-fda-s-new-gene-therapy-shortcut-leans-on-platform-knowledge-six-months-ago-theyhttps://thefirstcohort.com/articles/2026-06-02-fda-s-new-gene-therapy-shortcut-leans-on-platform-knowledge-six-months-ago-theyFDA's new gene therapy draft guidance invites sponsors to lean on "platform knowledge" to streamline submissions, six months after the agency revoked Sarepta's AAVrh74 platform designation following three patient deaths.Tue, 02 Jun 2026 00:00:00 GMTdrugs-fdafdagene-therapyregulatory-capturerare-diseaseaccelerated-approvalgenome-editingSarah Okonkwohttps://thefirstcohort.com/articles/2026-06-02-andrew-huberman-s-peptide-masterclass-and-the-published-evidencehttps://thefirstcohort.com/articles/2026-06-02-andrew-huberman-s-peptide-masterclass-and-the-published-evidenceAndrew Huberman's June 1 episode on peptides walks through BPC-157 and seven other compounds. The published human evidence for its lead substance runs to fewer than thirty people.Tue, 02 Jun 2026 00:00:00 GMTdrugs-fdapeptidesbpc-157hubermanfdamelanotanregulationLena Marshallhttps://thefirstcohort.com/articles/2026-05-30-hepatitis-delta-has-waited-forty-nine-years-for-a-drug-the-fda-made-american-pathttps://thefirstcohort.com/articles/2026-05-30-hepatitis-delta-has-waited-forty-nine-years-for-a-drug-the-fda-made-american-patThe FDA cleared bulevirtide for chronic hepatitis delta this week, six years after Europe started using it and three years after a U.S. application was turned down on manufacturing grounds. The wait is its own story.Sat, 30 May 2026 00:00:00 GMTdrugs-fdahepatitisfdagileadregulatory-delayviral-hepatitisaccelerated-approvalMarcus Chenhttps://thefirstcohort.com/articles/2026-05-29-vietnam-s-new-integrity-rule-arrives-251-retractions-latehttps://thefirstcohort.com/articles/2026-05-29-vietnam-s-new-integrity-rule-arrives-251-retractions-lateVietnam's Ministry of Science and Technology issued a research-integrity framework with permanent bans on May 25, 2026. The Retraction Watch database already lists 251 retractions carrying Vietnamese affiliations.Fri, 29 May 2026 00:00:00 GMTinvestigationsresearch-integrityvietnampaper-millsretractionsaccountabilityregulationMira Petrovhttps://thefirstcohort.com/articles/2026-05-29-doctor-mike-plays-never-have-i-ever-with-a-firefighter-watch-what-s-around-the-bhttps://thefirstcohort.com/articles/2026-05-29-doctor-mike-plays-never-have-i-ever-with-a-firefighter-watch-what-s-around-the-bDoctor Mike's lighthearted Never Have I Ever video sits at the top of a funnel that includes a $997 media academy, a UNICEF vaccine-ambassador title, and an ongoing pitch to pharmaceutical executives about social-media trust.Fri, 29 May 2026 00:00:00 GMTinvestigationsmediainfluencer-medicinepharma-marketingpublic-trustvaccinesdoctor-mikeMarcus Chenhttps://thefirstcohort.com/articles/2026-05-29-america-s-ebola-fortress-history-has-tested-this-strategy-and-it-failedhttps://thefirstcohort.com/articles/2026-05-29-america-s-ebola-fortress-history-has-tested-this-strategy-and-it-failedWashington has built a wall around the Ebola outbreak in Central Africa. The last time America tried this, the evidence says the wall leaked, and so did the response.Fri, 29 May 2026 00:00:00 GMTinfectious-diseaseebolapublic-healthbiosecurityinfectious-diseaseregulatory-failureMarcus Chen